




The Neural Mechanisms Mediating  










A Thesis  





Presented in Partial Fulfillment of the Requirement 
For the Degree of  
Doctor of Philosophy (Psychology) at 
Concordia University 









School of Graduate Studies 
 
This is to certify that the thesis prepared 
By:  Tracey D’Cunha                                                                                                              
Entitled: The Neural Mechanisms Mediating the Augmentation of Heroin Seeking Induced 
by Chronic Food Restriction.                                                                                                    
and submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy (Psychology) 
complies with the regulations of the University and meets the accepted standards with 
respect to originality and quality. 
 
Signed by the final examining committee: 
________________________________________________ Chair 
Dr. Ian Irwin 
 
________________________________________________ External Examiner 
Dr. Paul Clarke 
 
________________________________________________ External to Program 
Dr. Andreas Bergdahl 
 
________________________________________________ Examiner 
Dr. Wayne Brake 
 
________________________________________________ Examiner 
Dr. Nadia Chaudhri 
 
________________________________________________ Supervisor 
Dr. Uri Shalev 
 
Approved by   ________________________________________________ 
Dr. Karen Li, Graduate Program Director 
 
August 10, 2018 ________________________________________________ 





The Neural Mechanisms Mediating the Augmentation of Heroin Seeking 
Induced by Chronic Food Restriction 
 
Tracey D’Cunha, Ph.D. 
Concordia University, 2018 
 
 Addiction can be defined as a chronic relapsing disorder that is characterized by a loss of 
control over drug consumption. One of the major obstacles in the treatment of drug addiction is 
relapse, with the majority of individuals relapsing within the first year of drug abstinence. In 
humans, restricted food intake can modulate the main triggers of relapse thereby increasing drug 
craving and relapse. In animal models of relapse, caloric restriction will also increase drug seeking. 
The experiments presented in this thesis investigated the neuronal mechanisms that mediate the 
augmentation of heroin seeking induced by chronic food restriction in the rat. The mesolimbic 
dopamine pathway is heavily implicated in reward and motivation. Therefore, the experiments 
presented in Chapter 3 explored the role of dopamine in the mesolimbic pathway, specifically the 
nucleus accumbens, in the augmentation of heroin seeking induced by chronic food restriction. 
Extracellular dopamine in the nucleus accumbens core and shell subregions was differentially 
altered during the heroin-seeking test in chronically food restricted rats. Blockade of dopamine D1-
like receptors in the nucleus accumbens shell decreased heroin seeking, whereas blockade of D1-
like receptors in the nucleus accumbens core selectively reduced heroin seeking in the food 
restricted rats.  
 Hormones involved in energy balance and food intake, such as leptin and ghrelin are 
implicated in drug-related behaviors. Thus, the experiments in Chapter 4 investigated the role of 
leptin and ghrelin in heroin seeking induced by chronic food restriction. As expected, chronic food 
restriction decreased plasma levels of leptin and increased plasma levels of ghrelin. Furthermore, 
administration of leptin or a ghrelin receptor antagonist into the ventral tegmental area exclusively 
decreased heroin seeking in the food restricted rats. These results suggest that leptin and ghrelin 
may modulate drug seeking by acting upstream from the mesolimbic dopamine pathway.  
 Finally, in addition to the dense innervations from dopamine projections, the nucleus 
accumbens also receives a multitude of glutamatergic innervations from a variety of brain regions. 
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Hence, in Chapter 5 we investigated the role of glutamate in the nucleus accumbens on the 
augmentation of heroin seeking induced by chronic food restriction. Contrary to our predictions, 
there were no changes in extracellular glutamate in the nucleus accumbens during ongoing heroin 
seeking. Moreover, administration of a glutamate receptor antagonist had no effect on heroin 
seeking induced by chronic food restriction. Taken together, these findings demonstrate that the 
augmentation of heroin seeking induced by chronic food restriction is mediated by dopamine 
transmission in the nucleus accumbens and can be modulated by hormones involved in metabolic 
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CHAPTER 1: GENERAL INTRODUCTION 
 In the last 20 years, North America has seen a steady increase in the use of prescription 
opioids for pain management. Globally, Canada has the 2nd highest use of prescription opioids, 
behind only the United States of America (Murphy, Goldner, & Fischer, 2015). Between 1998 
and 2007, the spending per Canadian on opioid drugs more than doubled (Rehm, Fischer, & 
Gittins, 2009). Since 2010, overall levels of prescription opiate use have increased by nearly 
70%, specifically in non-medical use (Fischer, Keates, Buhringer, Reimer, & Rehm, 2014). 
Numerous patients are being routinely prescribed relatively strong opioids for post-operative 
pain relief (Helmerhorst, Teunis, Janssen, & Ring, 2017). While most patients have the full 
intention of taking these medications for pain relief as directed by their physician, the possibility 
remains that they may transition to subsequent abuse and dependence on these substances 
(Helmerhorst et al., 2017).  
 In fact, recent reports indicate that just under 1% of the general population of adults in 
Canada has abused prescription opiates. More alarmingly, is that approximately 3% of students 
in grades 7 to 12 have reported abusing prescription pain relief drugs in the previous year as 
recreational drug use (Murphy et al., 2015). With this rise of prescription opiate abuse, especially 
among young individuals, there is an increased risk for individuals to transition to heroin use. 
Recently it has been revealed that the trajectory to heroin use among younger and older 
individuals follows very divergent paths. Young heroin users (ages 20-29) report transitioning 
from opioid pills to snorting and then injecting heroin, whereas older heroin users (age 30 and 
up) report transitioning to heroin from non-opioid drugs such as cannabis, methamphetamine, 




Figure 1.1 The cycle of addiction is characterized by drug use followed by periods of abstinence, 
and then relapse to resume drug use. 
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This increase in heroin use is a major concern for society. It is estimated that the 
economic burden placed on the Canadian population for substance abuse (excluding tobacco) is 
approximately $22.8 billion annually (Etches, 2013). In addition to this economic burden, there 
are marked health and social impacts, especially premature deaths. The extent of prescription 
opiate-related harms has also increased in Canada, as approximately 5000 – 10,000 Canadians 
have died prematurely as a result of prescription opiate-related overdose (Fischer et al., 2014). In 
2016, there were almost 3000 apparent opioid-related deaths in Canada, and the latest data for 
the first half of 2017 has almost 1500 deaths with the number expected to increase (Special 
Advisory Committee on the Epidemic of Opioid Overdoses. National report: Apparent opioid-
related deaths in Canada, 2017). Although the first use of a drug may be voluntary, continued 
use may lead to urges that become compulsive. Even when an individual can abstain from drug 
use, 40-60% will relapse within the first year (McLellan, Lewis, O'Brien, & Kleber, 2000). 
Therefore, addiction is considered a chronic relapsing disorder that is characterized by 
compulsive drug seeking and a loss of control over drug consumption (O'Brien & McLellan, 
1996). The cycle of addiction (Figure 1.1) is a life-long battle with the vicious cycle of drug use, 
abstinence, and relapse. Relapse remains one of the major obstacles in the treatment of drug 
addiction (O'Brien, 1997).  
 In particular, heroin users exhibit a life characterized by repeated cycles of drug abuse 
and abstinence. At the end of a study that followed heroin users for over 3 decades, 40% of the 
subjects reported heroin use in the previous year (Hser, Hoffman, Grella, & Anglin, 2001). 
Moreover, 20% of the subjects were still regularly using heroin. Detoxification programs and 
prolonged periods of abstinence do not guarantee a safeguard against relapse. Even 15 years into 
drug abstinence, 25% of subjects in the study had relapsed (Hser et al., 2001). Relapse occurring 
after such extended periods of abstinence cannot be explained by physical withdrawal symptoms, 
since these are acute and dissipate 24-72 hours following drug cessation (Alper, Lotsof, Frenken, 
Luciano, & Bastiaans, 1999). Furthermore, death among individuals in the study was estimated 
to be 50-100 times higher than the general population of the same age (Hser et al., 2001). The 
causes of relapse and the barriers faced for an individual to remain abstinent from drug use is key 
knowledge that is necessary to help develop drug treatment programs.  
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Triggers to Relapse 
 There are three main factors that may trigger relapse to drug use, even when individuals 
have abstained for decades. First, re-exposure to the previously abused drug, also known as drug 
priming, will increase the subjective craving and desire for the drug, leading to relapse (de Wit, 
1996). Second, a variety of stressors can increase drug craving and subsequent relapse (Sinha, 
2001). For example, clinical populations of drug users report that stressful life events and 
situations increased drug craving (Hyman, Fox, Hong, Doebrick, & Sinha, 2007; Sinha, 2001). 
Guided imagery of stressful life events, tailored to an individual’s personal experience, also 
increased subjective self-reports of drug craving (Sinha, 2009). Stressors can include both acute 
and chronic forms of stress (Brown, Vik, Patterson, Grant, & Schuckit, 1995; Preston & Epstein, 
2011). Lastly, cues that have previously been paired with drug availability and drug consumption 
also increase drug craving and relapse (Childress et al., 1993). It is thought that these drug-
associated cues trigger craving through Classical or Pavlovian conditioning (Stewart, 1983), and 
drug craving is the conditioned response following exposure to the cues. Both proximal cues, 
including drug paraphernalia, and distal cues, such as the environment related to drug taking, 
elicit arousal and craving (Childress et al., 1993).  
 Contrary to prior beliefs, the strength of these triggers leading to drug relapse does not 
fade with time. Instead evidence shows that drug craving actually increases over the abstinence 
period, a phenomenon termed the incubation of drug craving (Grimm, Hope, Wise, & Shaham, 
2001). This incubation of drug craving in humans has been demonstrated for a variety of 
substances including cigarettes, alcohol, and methamphetamine (Li, Caprioli, & Marchant, 
2015). Therefore, exposure to one of the three triggers to relapse at any point in the abstinence 
period is a risk that may trigger drug craving and subsequent relapse.  
Dietary Manipulations and Drug Use in Humans 
 A period of abstinence from drug use is a vulnerable time where the risk for relapse 
increases, or incubates, and the individual may be more susceptible to the factors that trigger 
relapse. Dietary manipulations, such as restricted food intake, during the abstinence period can 
modulate the three main triggers to relapse. Furthermore, restricted food intake can affect both 
drug seeking and drug taking. For example, restricted food intake during times of war led to 
increased intake of coffee and tobacco products (Franklin, Shiele, Brozek, & Keys, 1948). 
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Malnourished Peruvian Indians also increase coca leaf chewing during times of food shortage 
(Hanna & Hornick, 1977). Furthermore, the severity of dieting in young women is positively 
associated with the prevalence of alcohol, cigarette, and marijuana use (Krahn, Kurth, 
Demitrack, & Drewnowski, 1992). Therefore, caloric restriction and diet should be an area of 
consideration in the development of treatment programs for drug addiction, since there is a high 
comorbidity rate between eating disorders and substance user disorders (Harrop & Marlatt, 2010; 
Holderness, Brooks-Gunn, & Warren, 1994).  
 In fact, empirical evidence indicates that food restriction increases the risk for relapse in 
abstinent smokers. Specifically, individuals that were assigned to a treatment group that had a 
combined abstinence program along with a nutrition plan to avoid weight gain following 
smoking cessation, reported higher levels of craving than the abstinence only treatment group 
(Hall, Tunstall, Vila, & Duffy, 1992). Furthermore, when individuals that were calorically 
restricted during abstinence did relapse, they smoked more cigarettes than the group on the 
abstinence only program did. These results were unanticipated as the authors thought that the 
additional intervention for potential weight gain would help rather than hinder the individual’s 
progress for smoking cessation.  
 Unbalanced diet and insufficient nutrition is a widespread problem in many individuals 
abusing drugs. Active heroin users report eating infrequently and display a loss of interest in 
food (Neale, Nettleton, Pickering, & Fischer, 2012). However, it is reassuring that following 
treatment programs and with cessation of drug use, the individuals experience a return of their 
appetite. This increase in appetite usually results in weight gain, which in most individuals can 
trigger an increase in anxiety. Increased anxiety levels surrounding the issue of becoming 
overweight can lead to maladaptive behaviors to control appetite (Neale et al., 2012). The major 
concern here is that controlling appetite during abstinence via caloric restriction may have the 
unintended negative consequences of increasing drug craving and subsequent relapse. 
Collectively, these results bring to light that food restriction during the abstinence period may 
inadvertently hinder treatment by increasing drug craving and relapse, even though the intention 
is to maintain a healthy body weight.  
Animal Models of Relapse 
Accordingly, treatment programs for drug addiction need to take into consideration the 
nutrition of individuals in the program, as dieting and food restriction during drug abstinence 
 5 
 
may increase drug craving and subsequent relapse. Studies are needed to investigate the 
mechanisms that mediate how dieting and food restriction affect drug craving. The problem is 
that clinical studies in humans are largely based on correlative data and self-reports on what 
triggers drug craving, making it difficult to infer causal relationships. Furthermore, although 
more controlled laboratory studies can uncover the causal links to what causes drug craving, 
craving on its own does not always lead to drug relapse. Ethical considerations preclude 
researchers from trying to trigger relapse in an abstinent user in order to study the mechanisms 
that triggered the relapse. Overall, ethical constraints limit the type of research that can be 
conducted on human subjects. Thus, animal models provide a useful approach to studying the 
underlying neurobiology of what triggers relapse to drug use. Animal models also allow for 
greater control of experimental parameters and approaches that are deemed unethical in human 
subjects (Shaham, Shalev, Lu, de Wit, & Stewart, 2003).  
Reinstatement Procedure 
One of the most commonly used animal models of relapse is the reinstatement procedure, 
as it has both face and predictive validity (Epstein, Preston, Stewart, & Shaham, 2006; Shalev, 
Grimm, & Shaham, 2002). Reinstatement is defined as the resumption of behavior that has been 
previously extinguished (Bouton & Swartzentruber, 1991). In the reinstatement of conditioned 
place preference (CPP) paradigm, animals are exposed to two different environments. One 
environment is repeatedly paired with drug injections, while another contextually distinct 
environment is not paired with the drug. Preference for the drug-paired environment develops 
through Pavlovian conditioning due to the drug’s reinforcing effects. This preference is then 
extinguished with repeated pairings in the absence of the drug. Finally, a trigger to relapse such 
as drug re-exposure with a priming injection, reinstates the preference for the previously drug-
paired environment (Mueller & Stewart, 2000). One drawback to this procedure is that animals 
receive passive exposure to the drug as it is administered by the experimenter. Evidence 
indicates that there are differences in behavior and tolerance to the drug when the drug is self-
administered by the animal, versus when it is administered by the experimenter (Weise-Kelly & 
Siegel, 2001).  
In contrast, the reinstatement procedure where the animal can self-administer the drug 
allows for greater ecological validity. In this procedure animals are first trained to self-administer 
a drug of abuse by performing an operant task, such as lever-pressing or nose-poking. Once the 
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animal establishes stable self-administration of the drug, the drug is removed, and the behavior is 
extinguished. Extinction is reached when the animal demonstrates a low level of responding and 
reaches a predetermined criterion. Next, a trigger is used to elicit renewed drug seeking under 
extinction conditions. The drug-seeking test is done under extinction conditions in order to avoid 
the psychomotor effects of the drug on the behavior. As in humans, the same three factors that 
trigger relapse – drug re-exposure, drug-associated cues, and stress – also reinstate drug seeking 
in animals (de Wit & Stewart, 1981; Meil & See, 1996; Shaham & Stewart, 1995). 
Renewal Procedure 
 Although the reinstatement procedure is a well validated animal model of relapse, it is 
unable to dissociate the respective contribution of the discrete (proximal) cues from the 
contextual (distal) cues towards drug seeking. The renewal procedure builds on the reinstatement 
procedure but allows for the study of the mechanisms underlying relapse to drug seeking elicited 
by drug-associated contextual cues (Crombag & Shaham, 2002). The first phase of the renewal 
procedure, like in reinstatement procedure, is self-administration training for a substance, which 
is then followed by an extinction phase. However, in the renewal procedure animals are trained 
to self-administer a drug in a context with distinct contextual cues, referred to as context A. 
Extinction occurs under the same conditions as self-administration but with the removal of the 
drug, and this occurs in context B. Contexts A and B differ in their tactile, visual, and olfactory 
properties (Crombag & Shaham, 2002). On test day, the experimental group is brought back to 
context A for a drug-seeking test under extinction conditions, where they demonstrate a renewal 
of drug seeking. Animals in the control group are tested in the same context as extinction 
training, context B, and do not show an increase in drug seeking. This renewal of drug seeking is 
not due to the change in a context, as a novel context does not increase drug seeking (Crombag 
& Shaham, 2002). As a model for the human condition, this procedure is useful as the drug-
taking environment differs from the context of detoxification and treatment programs. This 
procedure provides a useful way of investigating the role of contextual cues in drug seeking, and 
can potentially help in the development of treatment programs since returning to the original 
drug-taking context following a rehabilitation program may increase the risk for relapse in a 




 One of the weaknesses of the reinstatement and renewal procedures is that they do not 
capture the negative consequences of drug use. The punishment-based model does directly assess 
the motivation to seek drugs when there are negative consequences to those actions (Marchant, 
Li, & Shaham, 2013). As in the other procedures, the first phase of this procedure is self-
administration training for a drug of abuse. Next, the drug remains available to the animal with 
the addition of a negative consequence when drug is consumed, such as a mild electric foot-
shock (Marchant et al., 2014). These negative consequences typically result in a rapid 
suppression of drug taking. Once animals have suppressed drug taking, the resumption of drug 
seeking is induced by a trigger, such as re-exposure to the drug-associated context. Once again, 
this procedure has the advantage of mimicking the human condition by incorporating the 
negative consequences of drug taking into the model (Marchant et al., 2013). Some of the issues 
with this paradigm are that there is a great deal of variability between animals on their foot-shock 
sensitivity. Foot-shock punishment can also not completely capture the psychological and social 
negative consequences of drug addiction in humans. Furthermore, the drug is still available, and 
we can therefore not eliminate the psychomotor effects of having the drug in the body (Marchant 
et al., 2013).  
Forced-withdrawal and Voluntary Abstinence-based Procedures 
Another criticism of the reinstatement procedure is that extinction training does not 
mimic the human condition of abstinence. Abstinence-based models were published in the late 
1990s and try to address this weakness of the reinstatement model (Neisewander, O'Dell, Tran-
Nguyen, Castañeda, & Fuchs, 1996; Tran-Nguyen et al., 1998). There are three main phases of 
abstinence-based procedures: self-administration training, abstinence, and testing. In the first 
phase animals are trained to self-administer a drug of abuse by lever-pressing or nose-poking for 
the delivery of a drug infusion that is paired with a discrete cue. Next, animals are housed in the 
animal facility for varying periods of time during the abstinence phase. Last, animals are brought 
back to the drug self-administration context for a drug-seeking test. Testing takes place under 
extinction conditions where responses on the previously drug-associated lever (or nose poke) 
result in a contingent presentation of the drug-associated discrete cue but no delivery of the drug. 
This increase in non-reinforced responding on the lever (or nose poke) is the operational measure 
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for the relapse to drug seeking. Although in the literature it is often referred to as the abstinence 
phase, or sometimes as “forced” abstinence, withdrawal is a more accurate term, as the animals 
do not voluntarily abstain from drug use, but rather have it imposed by the experimenter 
(Venniro, Caprioli, & Shaham, 2016). 
An extension to this procedure is the incubation of drug craving (Grimm et al., 2001; 
Shalev, Morales, Hope, Yap, & Shaham, 2001). Here, animals are tested during the early days of 
withdrawal and following varying time periods (either in a repeated measures design or a 
between groups design where one group is tested early in withdrawal and a different group is 
tested later in the withdrawal period). As previously mentioned, incubation of drug craving is 
also demonstrated in human subjects with drug dependence problems (Bedi et al., 2011; Li et al., 
2014; Wang, Shi, et al., 2013). One advantage of all procedures that incorporate a withdrawal 
period is that they have higher ecological validity and are closer to the human condition as 
compared to extinction training in the reinstatement procedure.  
 However, one criticism of withdrawal-based procedures is that although they are a better 
model for translation to the human condition, drug abstinence in humans is usually a voluntary 
behavior, and in these procedures, withdrawal is imposed on the animals by the experimenter. To 
address the issue of experimenter-imposed withdrawal, Caprioli and colleagues (2015) modified 
the procedure to try and make the withdrawal phase voluntary for the animals. This newly 
developed procedure is referred to as the voluntary abstinence incubation of craving (Caprioli et 
al., 2015). This procedure has 4 phases: self-administration training for a palatable food reward, 
followed by self-administration training for a drug, then voluntary abstinence, and finally a drug-
seeking test. First, animals are trained to self-administer a palatable food pellet that is paired with 
a distinct discrete cue. Next, animals are trained to self-administer a drug of abuse that is paired 
with a discrete cue that is different from the palatable food-associated cue. Once stable self-
administration is established, the voluntary abstinence phase begins where animals are given 
mutually exclusive choice sessions between the palatable food and the drug. Finally, animals are 
tested for cue-induced drug seeking in extinction tests during early and late abstinence, with the 
palatable food unavailable. Interestingly, animals almost exclusively choose the palatable food 
reward during choice sessions during voluntary abstinence. Nevertheless, animals show robust 
levels of drug seeking during the cue-induced test. The authors state that this is a strength of the 
procedure as it mimics the human condition, whereby when alternative non-drug rewards are 
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taken away it can increase the incidence of relapse in abstaining drug users (Caprioli et al., 
2015). Based on all the aforementioned animal models of drug addiction and relapse, the 
incorporation of a withdrawal phase offers the advantage of ecological validity as it closely 
mimics the human condition.  
Dietary Manipulations in Animal Models of Reward and Addiction 
 Dietary manipulations, specifically caloric or food restriction, can affect drug reward, 
drug intake, and drug seeking in humans as well as in animal models of addiction. Both acute 
food deprivation, defined as a brief period with absolutely no access to food, and chronic food 
restriction, defined as an extended period of time with limited access to food, increase drug self-
administration to a variety of drugs (Carroll, France, & Meisch, 1979; Carroll & Meisch, 1981; 
Carroll & Meisch, 1984). In addition to effecting drug consumption, food restriction can also 
increase drug reward and drug seeking. Early studies on reward have demonstrated that animals 
will reliably self-stimulate for electrical brain stimulation in certain brain regions (Olds & 
Milner, 1954). One way to evaluate rewarding stimulation is through the determination of 
intracranial self-stimulation response rates against the resulting stimulation frequency (rate-
frequency curve). An increase in the rewarding efficacy of the brain stimulation is reflected by 
leftward shifts on the rate-frequency curve. The threshold frequency that is necessary to maintain 
intracranial self-stimulation in the lateral hypothalamus is decreased by both drugs of abuse and 
chronic food restriction. However, the effects of food restriction on the threshold to maintain 
brain stimulation reward is complex, as it is dependent on the placement of the stimulating 
electrode within the lateral hypothalamus (Fulton, Woodside, & Shizgal, 2000). There is also an 
additive effect of chronic food restriction and drugs of abuse on brain stimulation reward. 
Chronic food restriction results in further reductions of the threshold frequency on top of the 
leftward shift induced by the administration of the drug alone (Abrahamsen, Bermanm, & Carr, 
1995; Abrahamsen & Carr, 1996; Cabeza de Vaca & Carr, 1998; Carr, 2007; Fulton, Woodside, 
& Shizgal, 2000).   
In more direct assessments of drug seeking, food deprivation and food restriction will 
increase drug reward and drug seeking. Using the CPP paradigm, both food deprivation and food 
restriction increased the conditioned reinforcing properties of both morphine and amphetamine 
(Gaiardi, Bartoletti, Bacchi, Gubellini, & Babbini, 1987; Jung et al., 2016; Stuber, Evans, 
Higgins, Pu, & Figlewicz, 2002). We have also demonstrated that acute food deprivation (24 – 
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48 h) reinstates extinguished drug-seeking (Shalev, Highfield, Yap, & Shaham, 2000; Tobin, 
Newman, Quinn, & Shalev, 2009).  
 Unlike animal models, acute food deprivation and chronic food restriction differentially 
affect drug seeking in humans. Although acute food deprivation increases both drug taking and 
drug seeking in animals (Carroll, France, & Meisch, 1979; Carroll & Meisch, 1981; Carroll & 
Meisch, 1984; Shalev, Highfield, Yap, & Shaham, 2000; Tobin, Newman, Quinn, & Shalev, 
2009), prolonged food restriction, and not acute deprivation, is related to increased drug taking 
and seeking in humans (Cheskin, Hess, Henningfield, & Gorelick, 2005; Zacny & de Wit, 1992). 
Therefore, we focused on the effects of chronic food restriction on drug seeking in a withdrawal-
based animal model of relapse. Although the voluntary abstinence-based procedure parallels the 
human condition the most, to study the effects of chronic food restriction on heroin seeking we 
used an extended forced-withdrawal period, as the voluntary abstinence-based procedure could 
introduce confounds. Since the alternative non-drug reward in the voluntary abstinence 
procedure is a palatable food reward pellet, it may differentially motivate the food restricted 
animals versus the free-fed animals. Using the forced withdrawal-based procedure we found that 
14 days of chronic food restriction during the withdrawal phase significantly augments heroin 
seeking in rats with a history of heroin self-administration (D'Cunha, Sedki, Macri, Casola, & 
Shalev, 2013). However, it remains unclear what neural mechanisms underlie this chronic food 
restriction-induced augmentation of heroin seeking. There are a variety of factors that may be 
involved in this behavior, which will be outlined in the subsequent sections of this introduction.  
The Role of Dopamine in Drug Seeking 
 One of the most studied and heavily implicated neurotransmitter systems in the 
neurobiology of reward and addiction is the mesocorticolimbic dopamine (DA) pathway (Di 
Chiara, Acquas, Tanda, & Cadoni, 1993; Kalivas & Duffy, 1995; Kelley & Berridge, 2002; 
Wise, 2009). The cell bodies in this pathway originate in the ventral tegmental area (VTA) and 
send projections to various areas in the brain including the prefrontal cortex (PFC), nucleus 
accumbens (NAc), and basolateral amygdala (BLA; Ungerstedt, 1971). Of particular interest is 
the NAc, as both natural rewards as well as drugs of abuse stimulate DA transmission in this 
region (Di Chiara et al., 1993). The NAc is subdivided into 2 subregions based on their 
innervations, projections, and function: the core, which surrounds the anterior commissure, and 
the shell, which encases the medial portion of the core (Ikemoto, 2007). While both the shell and 
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core receive projections from the VTA, the medial portion of the NAc shell receives the majority 
of its projections from the posteromedial VTA, whereas the lateral portion of the shell and the 
core receive the majority of their projections from the anteromedial VTA (Ikemoto, 2007). In 
turn, both the shell and the core send their projections to the ventral pallidum (VP), which is part 
of the basal ganglia and is important for motor control (Alexander & Crutcher, 1990). However, 
like its afferents, the subregions of the NAc also project to different regions of the VP. The shell 
projects primarily to the ventromedial part of the VP, whereas the core projects primarily to the 
dorsolateral part of the VP (Heimer, Zahm, Churchill, Kalivas, & Wohltmann, 1991). 
Furthermore, the NAc shell but not the core, projects to the extended amygdala, and is thought to 
be a transition area between the striatal complex and the extended amygdala (Heimer et al., 
1991). In addition, the NAc MSNs also send projections to non-dopaminergic neurons in the 
VTA, but it is unknown if the targets are GABAergic or glutamatergic neurons (Xia et al., 2011). 
Therefore, as the NAc receives information from the VTA and other inputs, it is positioned in an 
anatomical region where it may mediate and integrate sensory and limbic inputs about reward 
and thus affect behavioral output (Mogenson, Jones, & Yim, 1980). 
 Drugs of abuse all result in increased levels of DA in the NAc (Bozarth, 1986). However, 
due to pharmacological differences among drug classes, they increase DA by different 
mechanisms. Opiates, such as morphine and heroin, indirectly increase extracellular DA in the 
NAc by disinhibition of DA neurons in the VTA through the attenuation of GABAergic synapses 
on these cells (Johnson & North, 1992). On the other hand, psychostimulants, like cocaine, 
inhibit the actions of the DA transporter (DAT) allowing DA to remain in the synapse longer 
(Koob, 1992). There is also a differential response in DA transmission between the shell and the 
core. Specifically, extracellular DA is elevated more in the shell than in the core in response to 
intravenous administration of a variety of drugs, such as amphetamine, cocaine, or morphine 
(Pontieri, Tanda, & Di Chiara, 1995).  
Once released, DA acts on two different classes of G-protein coupled receptors. The DA 
D1-like class of receptors include the D1 and D5 receptors which are coupled to the Gs alpha 
subunit and activate adenylyl cyclase, thereby mediating excitatory neurotransmission. The DA 
D2-like class of receptors include D2, D3, and D4 receptors which are coupled to the Gi/Go 
subunits and inhibit the actions of adenylyl cyclase, thereby mediating inhibitory 
neurotransmission (Sokoloff & Schwartz, 1995). Neurotransmission through DA receptors in the 
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NAc plays a pivotal role in the consumption of natural rewards and drugs of abuse with 
differential effects in the shell versus the core. For instance, both D1 receptor antagonist 
SCH23390 and D2 receptor antagonist eticlopride decrease food and cocaine self-administration 
when administered into the NA core. However, SCH23390 and eticlopride administered into the 
NAc shell selectively decreased cocaine self-administration and had no effect on food self-
administration (Bari & Pierce, 2005). 
DA transmission in the NAc is not only affected by the consumption of rewards but is 
also implicated in the motivation to seek reward, both for natural rewards and drugs of abuse. 
Cues that have been previously paired with the availability of a reward stimulate DA release 
(Bassareo, De Luca, & Di Chiara, 2007; Bassareo, Musio, & Di Chiara, 2011; Schultz, Dayan, & 
Montague, 1997). Specifically, cues previously associated with drugs of abuse elevate DA in the 
NAc shell but not the core. Whereas, cues previously associated with food availability elevate 
DA in the NAc core but not the shell (Bassareo et al., 2011). Furthermore, blocking DA 
receptors in the NAc will reduce seeking for natural rewards and drugs of abuse. For example, 
administration of the D1 receptor antagonist SCH23390 or the D2 antagonist raclopride into the 
NAc blocked cue-evoked reinstatement of food seeking (Guy, Choi, & Pratt, 2011). Similarly, 
administration of SCH23390 into the shell or core reduced cue-induced sucrose seeking 30 days 
into the withdrawal phase (Grimm et al., 2011). In the same manner, administration of 
SCH23390 into the NAc blocked the reinstatement of CPP for morphine induced by acute food 
deprivation (Sadeghzadeh, Babapour, & Haghparast, 2015). Additionally, SCH23390 
administered into the core or shell also decreased context-induced reinstatement or renewal of 
alcohol seeking, and renewal of punished alcohol seeking (Chaudhri, Sahuque, & Janak, 2009; 
Marchant & Kaganovsky, 2015). Administration of the D2 receptor antagonist sulpride into the 
shell and not the core dose-dependently decreased cocaine-primed reinstatement (Anderson, 
Schmidt, & Pierce, 2006).  
 Evidence suggests that there is a specific role for D1-like and not D2-like receptors in 
opioid seeking induced by drug-associated cues and stress. Systemic administration of the D1 
receptor antagonist SCH23390, and not the D2 receptor antagonist raclopride, attenuated acute 
food deprivation-induced reinstatement of heroin seeking (Tobin et al., 2009). Specifically, these 
results are mediated by D1 transmission in the NAc shell and not the core, as SCH23390 
administration into the NAc shell, but not core, attenuated acute food deprivation-induced 
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reinstatement of heroin seeking (Tobin, Sedki, Abbas, & Shalev, 2013). There is also a critical 
role for D1 transmission in the NAc shell in morphine seeking following prolonged withdrawal, 
as morphine seeking is attenuated by administration of SCH23390 in the NAc shell but not the 
D2 receptor antagonist eticlopride (Gao, Li, Zhu, Brimijoin, & Sui, 2013). Furthermore, blocking 
D1 receptors in the shell (but not the core) attenuated context-induced reinstatement of heroin 
seeking, whereas blocking D1 receptors in the core (but not the shell) attenuated discrete cue-
induced reinstatement of heroin seeking (Bossert, Poles, Wihbey, Koya, & Shaham, 2007). 
Taken together, this line of evidence suggests that DA transmission through the NAc shell and/or 
core, specifically through D1 receptors, may be involved in the augmentation of heroin seeking 
induced by chronic food restriction. Therefore, in Chapter 3 we examined extracellular 
concentrations of dopamine in the NAc to assess changes in DA during heroin seeking. Next, we 
assessed the effect of blocking D1 receptors in the NAc shell and core on the augmentation of 
heroin seeking induced by chronic food restriction during a prolonged period of withdrawal.  
The Role of the Endocrine System in Reward-related Behavior 
 Leptin is a hormone that signals satiety and is produced by the ob gene and released by 
peripheral adipocytes into the blood (Ahima, Saper, Flier, & Elmquist, 2000; Friedman & 
Halaas, 1998). In times of starvation and limited food availability, adipose tissue is decreased 
thereby placing the animal in a state of negative energy balance and leading to lower levels of 
circulating leptin. This reduction in circulating leptin is detected by various nuclei in the 
hypothalamus, including the arcuate nucleus, ventromedial nucleus of the hypothalamus (VMH), 
lateral hypothalamus (LH), dorsomedial nucleus of the hypothalamus (DMH), and 
paraventricular nucleus of the hypothalamus (PVN). When these hypothalamic nuclei detect a 
reduction in leptin it results in a concerted hormonal, behavioral, and metabolic response to 
increase food intake and body weight. Conversely, when endogenous levels of leptin are 
increased in times of food availability, the outcome is a decrease in food intake, thereby reducing 
adipose tissue and subsequently body weight (Friedman & Halaas, 1998). It should be noted that 
chronically elevated levels of endogenous leptin (often seen in obese animals and humans) can 
result in leptin resistance, which blocks the outcome of reduced food intake and subsequent body 
weight loss. Similarly, exogenously administered leptin (intracerebroventricularly, i.c.v.) reduces 
food intake and subsequent body weight. Once the exogenous source of leptin is removed, food 
intake is increased to re-establish body weight (Halaas et al., 1997).  
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 From an evolutionary perspective, it is therefore not surprising that leptin is directly 
involved in the rewarding aspects of food intake and energy balance. In fact, in addition to its 
hypothalamic targets, leptin receptor mRNA has also been found in the DA neurons of the 
mesolimbic pathway that originate in the VTA (Hommel et al., 2006). Functionally, leptin 
administration into the VTA decreased the firing rate of DA neurons and also decreased food 
intake (Hommel et al., 2006). Leptin also has direct effects on the motivation to work for a 
reward, which can be assessed using a progressive ratio schedule of reinforcement. In a 
progressive ratio schedule of reinforcement, the response requirement to receive a reward 
increases following each delivered reward. Using this procedure, acute i.c.v. administration of 
leptin decreased sucrose self-administration in rats that were maintained on an ad libitum diet 
(Figlewicz, Bennett, Naleid, Davis, & Grimm, 2006). Furthermore, it has been demonstrated that 
chronic replacement of leptin in food restricted rats can block the development of a sucrose 
conditioned place preference (Figlewicz, Higgins, Ng-Evans, & Havel, 2001).  Collectively, 
these results suggest that leptin can modulate the neural circuitry underlying food reward and 
directly affect behavior.  
 Leptin plays a pivotal role in the rewarding aspects of food intake and energy balance, 
thus it can also affect the reinforcing properties of non-food rewards, such as electrical brain 
stimulation and drugs of abuse. As previously mentioned, both drugs of abuse and chronic food 
restriction lower the threshold frequency for electrical brain stimulation reward, which is 
interpreted as an increase in the rewarding properties of the stimulation. Intracerebroventricular 
infusions of leptin reversed the chronic food restriction-induced sensitization of brain stimulation 
reward, reflected by rightward shifts on the rate-frequency curve (Fulton et al., 2000). 
Furthermore, leptin can affect drug seeking as i.c.v. leptin attenuated heroin reinstatement 
induced by acute food deprivation (Shalev, Yap, & Shaham, 2001). Additionally, intra-VTA 
leptin blocked the ability of cocaine to establish a conditioned place preference and blocked cue-
induced cocaine seeking in a self-administration paradigm (You et al., 2016). Thus, leptin has a 
direct effect on drug-seeking behaviors and may therefore play a role in the augmentation of 
heroin seeking induced by chronic food restriction.  
 Ghrelin, a peptide released from the gut, binds to the growth hormone secretagogue 
receptor (GHS-R1a) and has the opposite actions of leptin by acting as a hunger signal (Kojima 
et al., 1999). Plasma levels of ghrelin spike prior to a meal and then quickly fall following food 
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consumption (Toshinai et al., 2001). Ghrelin and its receptors can also affect the reinforcing 
properties of food. Administration of the GHS-R1a antagonist, JMV 2959, decreased body 
weight gain and consumption of a palatable chocolate drink, but surprisingly had no effect on 
regular chow intake (Egecioglu et al., 2010). Furthermore, systemic administration of JMV 2959 
also decreased the breakpoint for the self-administration of sucrose pellets under a progressive 
ratio schedule of reinforcement (Skibicka, Hansson, Egecioglu, & Dickson, 2012).  
 Like leptin, ghrelin’s actions also extend beyond the reinforcing and rewarding properties 
of food. Rats that lack the GHS receptors required four times the current intensity to acquire 
electrical intracranial self-stimulation in the LH as compared to their wild type counterparts 
(Wellman et al., 2012). Ghrelin itself induces a conditioned place preference and increased DA 
in the NAc (Jerlhag, 2008), which is likely because ghrelin receptors are located in the VTA 
(Guan et al., 1997). Administration of ghrelin directly into the VTA increased the activity of 
mesolimbic VTA DA neurons and also increased food intake in rats (Abizaid et al., 2006; 
Skibicka, Hansson, Alvarez-Crespo, Friberg, & Dickson, 2011). Moreover, intra-VTA 
administration of ghrelin increased the breakpoint for sucrose self-administration under a 
progressive ratio schedule of reinforcement, whereas, intra-VTA administration of JMV 2959 
decreased the breakpoint for sucrose self-administration (Skibicka et al., 2011).  
 As expected, ghrelin and its receptors can also modulate the reinforcing properties of 
drug reward. Ghrelin receptor antagonism attenuated drug-induced locomotion, accumbal DA 
release, and conditioned place preference for a variety of drugs including alcohol, cocaine, 
amphetamine, and nicotine (Jerlhag, Egecioglu, Dickson, & Engel, 2010; Jerlhag et al., 2009; 
Jerlhag & Engel, 2011). Central administration of ghrelin also increased the breakpoint of heroin 
reinforcement under a progressive ratio schedule (Maric, Sedki, Ronfard, Chafetz, & Shalev, 
2011). Furthermore, systemic administration of the ghrelin receptor antagonist JMV 2959 dose-
dependently reduced morphine-induced DA release in the NAc (Sustkova-Fiserova, Jerabek, 
Havlickova, Kacer, & Krsiak, 2014), and inhibited the ability of morphine to induce a condition 
place preference (Jerabek et al., 2017).  
 Taken together, these findings demonstrate that the hormones leptin and ghrelin are 
involved in the reinforcing and rewarding properties of drugs of abuse. Therefore, they may 
modulate the augmentation of heroin seeking induced by chronic food restriction. Thus, in 
Chapter 4 we measured how plasma levels of leptin and ghrelin are altered following chronic 
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food restriction in heroin experienced rats. Next, we examined the role of central and intra-VTA 
administration of leptin in heroin seeking following food restriction. Finally, we examined the 
effect of intra-VTA administration of the ghrelin receptor antagonist JMV 2959 on heroin 
seeking following food restriction.  
The Role of Glutamate in Drug Seeking 
 As previously mentioned, the mesolimbic DA pathway, especially the NAc, is heavily 
implicated in the neurobiology of reward-seeking and drug addiction (Di Chiara et al., 1993; 
Kalivas & Duffy, 1995; Kelley & Berridge, 2002; Wise, 2009). The NAc is referred to as the 
limbic-motor interface as it integrates internal and external sensory information coming from 
various inputs to regulate goal-directed behavior (Mogenson et al., 1980). The NAc is primarily 
composed of GABAergic medium spiny neurons (MSNs) which compose 90-95% of the total 
neuronal population, with the remaining 5-10% being GABAergic and cholinergic interneurons 
(Kawaguchi, Wilson, Augood, & Emson, 1995; Wilson & Groves, 1980). The NAc receive 
dense dopaminergic innervation from the VTA, as well as a multitude of glutamatergic afferents 
from the medial prefrontal cortex (mPFC), basolateral amygdala (BLA), medial thalamic nuclei 
(mThal), and the ventral hippocampus (vHipp; Brog, Apongse, Deutch, & Zahm, 1993). It is 
hypothesized that these glutamatergic afferents to the NAc individually encode discrete elements 
of behavior that help shape reward-seeking behavior. In addition, pathway-specific disruptions 
are linked to various aspects of drug-seeking behavior.  
The PFC is involved in executive function and plays a critical role in encoding extinction 
learning (Peters, Kalivas, & Quirk, 2009). The dorsal mPFC, known as the prelimbic cortex 
(PLC) sends dense glutamatergic projections to the NAc core, and has been demonstrated to play 
a role in cocaine-primed reinstatement (McFarland, Lapish, & Kalivas, 2003), heroin-primed and 
cue-induced heroin reinstatement (LaLumiere & Kalivas, 2008). Inactivation of the PLC-NAc 
core pathway via GABA agonists reduced both drug-primed and cue-induced reinstatement of 
heroin seeking, indicating that this projection is critical for initiating drug seeking (LaLumiere & 
Kalivas, 2008). Furthermore, blocking DA signaling in the PLC and glutamate signaling in the 
contralateral NAc core attenuated cue-induced cocaine seeking (McGlinchey, James, Mahler, 
Pantazis, & Aston-Jones, 2016). Thus, it has been suggested that this projection from the PLC to 
the NAc core is the final common pathway in the relapse circuit for both cocaine and heroin 
seeking (Scofield et al., 2016). Conversely, the ventral mPFC, or infralimbic cortex (ILC) to the 
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NAc shell is thought to inhibit drug seeking. Inactivation of this projection via GABA agonists 
reinstated extinguished cocaine seeking (Peters, LaLumiere, & Kalivas, 2008). In contrast, 
administration of GABA agonists (muscimol and baclofen) into the ILC and a DA D1 receptor 
antagonist (SCH 23390) into either the contralateral or ipsilateral NAc shell decreased context-
induced heroin reinstatement (Bossert et al., 2012).  
The BLA is suggested to encode the valence of reward-associated stimuli and convey this 
information to the NAc (Ambroggi, Ishikawa, Fields, & Nicola, 2008; Everitt, Cardinal, 
Parkinson, & Robbins, 2003). Both BLA and NAc neurons respond to reward-associated cues, 
however, the excitations in the BLA occur prior to the NAc (Ambroggi et al., 2008). 
Specifically, it is thought that the integration of glutamatergic signals from the BLA in 
conjunction with DA signaling from the VTA in the NAc promotes motivated behavioral 
responding (Ambroggi et al., 2008; Stuber et al., 2011). This projection is also implicated in 
addiction and drug seeking, as optogenetic inhibition of this pathway inhibited cue-induced 
reinstatement of cocaine seeking (Stefanik & Kalivas, 2013).  
It is well established that the hippocampus is involved in memory (Squire, 1992) and the 
encoding of spatial information (O'Keefe & Dostrovsky, 1971). Unlike glutamatergic afferents 
from other regions, the vHipp – specifically the ventral subiculum (vSub) – uniquely projects to 
the medial NAc shell (Brog et al., 1993). This projection from the vHipp to the NAc shell is 
selectively potentiated 2 weeks after repeated non-contingent administration of cocaine, as 
measured by increased AMPA/NMDA ratios (Britt et al., 2012). Moreover, recent evidence has 
demonstrated that the pathway from the vSub to the NAc shell is associated with drug seeking in 
the renewal procedure. For example, inactivation of the vSub via administration of GABA 
agonists (muscimol and baclofen) decreased context-induced renewal of heroin seeking (Bossert 
& Stern, 2014). Additionally, inactivation of the vSub with GABA agonists and administration 
of a D1R antagonist in the contralateral or ipsilateral NAc shell also decreased context-induced 
renewal of heroin seeking (Bossert & Stern, 2014).  
Lastly, the final major glutamatergic projection to the NAc is from the mThal, 
specifically the paraventricular nucleus of the thalamus (PVT; Brog et al., 1993). Less is known 
about the role of this pathway, but these projections do converge on the same targets as 
dopaminergic projections from the VTA, suggesting that DA may modulate glutamate 
transmission in this region (Pinto, Jankowski, & Sesack, 2003). Recent evidence suggests that 
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this pathway also plays a pivotal role in drug seeking. Morphine withdrawal induced neuronal 
activation in PVT neurons projecting to the NAc, indicating this projection may be implicated in 
opiate dependence (Zhu, Wienecke, Nachtrab, & Chen, 2016). Reducing the activity of this 
pathway via chemogenetic inhibition blocked cocaine-primed reinstatement but enhanced cue-
induced cocaine reinstatement (Wunsch et al., 2017). More evidence is needed to clarify the 
precise role this projection plays in mediating drug seeking, but since the dopaminergic 
projections coincide with the PVT’s glutamatergic afferents to the NAc it is highly likely that 
this pathway plays a role in addiction and drug seeking.  
Glutamate plays a pivotal role in mediating synaptic plasticity, which is required for 
animals to learn and adapt to a constantly changing environment. Drug addiction can be 
perceived as a maladaptive learning process, and drugs of abuse can have a lasting impact on 
synaptic plasticity (Kalivas, 2009). Specifically, drugs of abuse modulate glutamate 
transmission, which can have a direct impact on synaptic plasticity and result in reinforcing 
drug-seeking behaviors that are maladaptive and to the detriment of the animal (Kalivas & 
O'Brien, 2008). Kalivas (2009) has proposed a glutamate homeostasis hypothesis of addiction 
based on the effects of cocaine on striatal synaptic physiology. For example, cocaine 
administration increased extracellular glutamate levels in the NAc following cocaine behavioral 
sensitization (Pierce, Bell, Duffy, & Kalivas, 1996). As previously mentioned, there can be 
differences in the neuroadaptations that occur following passive drug administration versus drug 
self-administration (Weise-Kelly & Siegel, 2001). Interestingly, short durations of cocaine self-
administration had no effect on extracellular glutamate in the NAc core, but basal glutamate 
levels were reduced following chronic cocaine self-administration. Once chronic cocaine self-
administration has been established, extracellular glutamate levels within the NAc core rose to 
over 200% of basal levels during ongoing cocaine self-administration (Miguens et al., 2008). 
Similar findings are present in both the NAc core and shell, however, rats that were trained to 
self-administer saline and then given yoked-cocaine administration did not show these changes 
(Suto, Ecke, You, & Wise, 2010).  
Glutamate neurotransmission in the NAc is not only affected during ongoing drug self-
administration but also during drug seeking. Extracellular glutamate levels in the NAc are 
elevated during both cocaine-primed reinstatement (McFarland et al., 2003), and cue-induced 
heroin reinstatement (LaLumiere & Kalivas, 2008). Moreover, an odor previously paired with 
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cocaine availability also increased extracellular glutamate levels in both the NAc core and shell 
(Suto, Elmer, Wang, You, & Wise, 2013). These changes in extracellular glutamate levels may 
be due to higher levels of presynaptic release or changes in glutamate uptake by glial glutamate 
transporters in the synaptic cleft. Indeed, chronic exposure to various drugs of abuse such as 
cocaine (Reissner et al., 2015) and heroin (Shen, Scofield, Boger, Hensley, & Kalivas, 2014a) 
reduced the expression of the glutamate transporter (GLT-1). As chronic drug exposure 
downregulates GLT-1, there is a disruption in the equilibrium between extrasynaptic and 
synaptic glutamate levels which promotes spillover of synaptic glutamate out of the synaptic 
cleft and into the extracellular space in the NAc. This spillover of glutamate can result in 
glutamate activating postsynaptic glutamate receptors resulting in synaptic potentiation, which is 
associated with drug seeking and relapse (Kalivas, 2009; Scofield et al., 2016). 
Once in the synapse, glutamate can act on 2 different classes of receptors: ionotropic 
glutamate receptors (iGluRs) and metabotropic glutamate receptors (mGluRs). Ionotropic GluRs 
are synaptic ligand-gated ion channels that mediate fast excitatory neurotransmission and include 
3 receptor subtypes: α-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid (AMPA), N-
methyl-D-aspartate (NMDA), and Kainate receptors. On the other hand, mGluRs are G-protein 
coupled receptors that mediate slower synaptic processes. They are composed of 8 receptor 
subtypes categorized into 3 groups: Group I consist of mGluR1 and mGluR5, which are 
primarily postsynaptic; Group II includes mGluR2 and mGluR3; and Group III includes mGluR4 
and mGluR6 – mGluR8. Group II and III mGluRs are all largely presynaptic inhibitory 
autoreceptors on glutamatergic terminals, whose activation reduce vesicular release (Conn & 
Pin, 1997; Gass & Olive, 2008; Guo, Wang, Xiang, & Zhao, 2009; Niswender & Conn, 2010).  
Drugs of abuse have a long-lasting impact on glutamate receptors. Numerous studies 
have focused on the role of iGluRs and particularly AMPA receptors (AMPAR) in drug reward 
and addiction. During basal conditions, MSNs are extremely hyperpolarized and have low 
spontaneous activity. Thus, the activity of these MSNs relies heavily on excitatory glutamatergic 
inputs from cortical and limbic regions (O'Donnell & Grace, 1993), which is mediated primarily 
by AMPARs (Wolf, 2010; Wolf & Ferrario, 2010).  
AMPARs are assembled as tetramers, from the subunits GluA1, GluA2, GluA3, and 
GluA4. When AMPARs are composed of subunits with a short C-terminus – GluA2 or GluA3 – 
they are constitutively cycled into and out of synapses. Alternatively, AMPARs composed of 
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subunits with a long C-terminus – GluA1 – are inserted into synapses in an activity-dependent 
manner, and are regulated by a series of homeostatic mechanisms. There are many homeostatic 
mechanisms that regulate and maintain AMPARs in the synapse. Synaptic scaling is a form of 
homeostatic plasticity in which prolonged blockade of activity leads to increased excitatory 
synaptic transmission, whereas prolonged increases in activity produces the opposite effect 
(Turrigiano, 2008; Turrigiano & Nelson, 2004). The major postsynaptic mechanism of synaptic 
scaling involves alterations in AMPAR levels, such that synaptic AMPAR levels are increased in 
response to activity blockade, and are decreased after prolonged increases in activity (Sun & 
Wolf, 2009). NAc MSNs demonstrate bidirectional synaptic scaling as both long-term 
potentiation (LTP; an increase in synaptic strength) and long-term depression (LTD; a reduction 
in synaptic strength; Wolf, 2010).  
As previously mentioned, both non-contingent (Pierce et al., 1996) and contingent 
cocaine self-administration (Miguens et al., 2008; Suto et al., 2010) increased extracellular 
glutamate levels in the NAc. This phenomenon is only seen during ongoing cocaine exposure. In 
contrast, basal levels of extracellular glutamate are decreased after both non-contingent and 
contingent cocaine, due to the reduced activity of the cysteine-glutamate antiporter, which is the 
main regulator of extracellular glutamatergic tone (Kalivas, 2009). This reduction in basal 
glutamate levels in the NAc may result in increased expression of synaptic AMPAR through the 
mechanism of synaptic scaling. Accordingly, both non-contingent administration of cocaine in 
behavioral sensitization models (Ferrario et al., 2010), and contingent administration of cocaine 
in the incubation of cocaine craving, resulted in increased AMPAR in the NAc (Conrad et al., 
2008). This increase in AMPAR in the NAc does not occur during cocaine exposure but rather 
requires a prolonged withdrawal period to develop (Wolf, 2010). Thus, this increase in surface 
AMPAR is not found in cocaine-experienced rats when measured on the 1st day of withdrawal, 
but only develops and is evident in the NAc during a prolonged withdrawal period. This pattern 
of changes in AMPAR parallels behavior (i.e. drug seeking), as drug seeking incubates over the 
withdrawal period and higher levels are observed following weeks of withdrawal, not withdrawal 
day 1 (Conrad et al., 2008).  
Specifically, the increase in surface AMPAR in the NAc is increased in levels of GluA2-
lacking AMPARs associated with the incubation of cue-induced cocaine seeking (Conrad et al., 
2008). AMPARs lacking the GluA2 subunit have a higher permeability to Ca2+, which results in 
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higher conductance. As a result, a small fluctuation in the number of these receptors along a 
synapse can have robust changes in synaptic strength and overall firing activity (Wolf & 
Ferrario, 2010). In line with these findings, blocking AMPARs in the NAc will consistently 
block drug seeking (Cornish & Kalivas, 2000; Di Ciano & Everitt, 2001; LaLumiere & Kalivas, 
2008; Suto et al., 2004). For instance, administration of the AMPAR antagonist CNQX (6-
cyano-7-nitroquinoxaline-2,3-dione) in the NAc attenuated cocaine-primed reinstatement of drug 
seeking (Cornish & Kalivas, 2000). Similarly, CNQX administered into the NAc core attenuated 
both heroin-primed and cue-induced reinstatement of heroin seeking (LaLumiere & Kalivas, 
2008).  
One of the major problems with extrapolating these findings is that the glutamate 
homeostasis hypothesis of drug addiction has been formulated from experiments and conclusions 
drawn using psychostimulants, particularly cocaine. There are likely limitations to generalizing 
these findings to opiate addiction as there are both behavioral and neurobiological distinctions 
between psychostimulant and opiate addiction (Badiani, Belin, Epstein, Calu, & Shaham, 2011). 
Therefore, more research is required to establish the role of glutamate transmission in the NAc 
on opioid addiction. Furthermore, recent evidence indicates that chronic food restriction can also 
alter AMPARs in the NAc. Specifically, chronic food restriction increased levels of the GluA1 
subunit of AMPARs in the NAc (Peng, Cabeza de Vaca, Ziff, & Carr, 2014; Peng, Ziff, & Carr, 
2011). Therefore, glutamate transmission and AMPAR in the NAc may be involved in the 
augmentation of heroin seeking following chronic food restriction.  
In order to explore the role of glutamate in heroin seeking, we first measured changes in 
extracellular glutamate in the NAc shell and core during ongoing heroin seeking. Next, since 
both chronic food restriction and prolonged drug withdrawal can modulate AMPARs in the NAc, 
we examined how blocking AMPARs in the NAc core and shell would affect the augmentation 
of heroin seeking induced by chronic food restriction.  
Rationale for Current Studies 
 The underlying neural mechanisms mediating the augmentation of heroin seeking 
induced by chronic food restriction remain undetermined. Therefore, this thesis explored three 
potential systems that may be involved in this behavior. The goal of the first set of experiments 
in Chapter 3 was to study the role of DA and DA D1-like receptors in the NAc in the 
augmentation of heroin seeking following chronic food restriction. Our hypothesis was that 
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chronic food restriction would increase extracellular levels of DA in the NAc during heroin 
seeking. Furthermore, blocking DA D1-like receptors in the NAc would attenuate heroin seeking 
and block the augmentation of heroin seeking induced by chronic food restriction. To test our 
hypotheses, we first assessed extracellular DA concentrations in the NAc shell and core during 
baseline conditions and then during the heroin-seeking test in freely behaving rats. In a separate 
set of experiments, we administered the D1-like receptor antagonist SCH 39166 into either the 
NAc shell or core immediately prior to the heroin-seeking test.  
 In Chapter 4, the next set of experiments explored the role of the endocrine system in the 
augmentation of heroin seeking induced by chronic food restriction. Particularly, we were 
interested in the roles of two key hormones involved in food intake and energy balance: leptin, a 
key satiety signal, and ghrelin, a key hunger signal. Our hypotheses were that chronic food 
restriction would alter levels of leptin and ghrelin which would then affect heroin seeking. 
Specifically, if we stimulate the leptin system or block the ghrelin system we will block the 
augmentation of heroin seeking induced by chronic food restriction. To test this hypothesis, we 
first measured circulating levels of plasma leptin and ghrelin in heroin-experienced, sated and 
food restricted rats. Next, in separate experiments we administered either leptin or the ghrelin 
receptor antagonist JMV 2959, to evaluate their effects on the augmentation of heroin seeking 
induced by chronic food restriction.  
 Finally, in the last set of experiments in Chapter 5 we investigated the role of glutamate 
and the glutamate AMPA receptors in the augmentation of heroin seeking induced by chronic 
food restriction. Our hypothesis was that chronic food restriction would: (1) increase 
extracellular levels of glutamate in the NAc during heroin seeking; and (2) alter glutamate 
transmission in the NAc by modulating AMPA receptors. To test these hypotheses, we first 
measured extracellular concentrations of glutamate in the NAc shell and core during baseline 
conditions and then during the heroin-seeking test. In a separate set of experiments, we 
administered the AMPA receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-
benzo[f]quinoxaline-2,3-dione) into either the NAc shell or core immediately prior to the heroin-
seeking test. Together, these studies will provide insight on the neural mechanisms underlying 




CHAPTER 2: GENERAL METHODOLOGY 
Subjects 
 A total of 562 (Chapter 3: n = 196, Chapter 4: n = 206, Chapter 5: n = 160) male Long 
Evans rats (Charles River, St. Constant, Quebec, Canada, or Raleigh, North Carolina, USA) were 
used in the various experiments. Rats were pair-housed in clear shoebox cages and allowed 1 
week to acclimate to the animal colony prior to undergoing any surgical procedures. Rats were 
kept on a reverse 12 h light-dark cycle (lights OFF 9:30am) at 21˚C. Following recovery from 
surgery (described below) rats were individually housed in operant conditioning chambers with 
ad libitum access to food and water during heroin self-administration training.  
 Following heroin self-administration training, rats were returned to the animal colony for 
the withdrawal and food restriction phase (described below). Rats in the in vivo microdialysis 
experiments were housed in clear Plexiglass chambers with a grid floor for baseline sampling 
prior to the heroin-seeking test (see Chapters 3 & 5 for more details). Following baseline 
microdialysis collection, rats were transferred back to the operant conditioning chambers for the 
heroin-seeking test. Rats in the intracranial injection experiments were brought back to the 
operant conditioning chambers on the last day of the withdrawal phase for the heroin-seeking 
test. All animals were treated in accordance with the guidelines of the Canadian Council on 
Animal Care and approval for all procedures was granted by the Concordia University Animal 
Research Ethics Committee.  
Surgical Procedures 
 Rats in all experiments underwent intravenous catheterization to allow for heroin self-
administration. Catheters were constructed out of silastic tubing (Inner Diameter: 0.51 mm, 
Outer Diameter: 0.94 mm; Dow Corning, Midland, MI, USA) that were cut to 12 cm. 
Intravenous catheterization was completed under ketamine and xylazine (90 and 13 mg/kg, ip). 
Once rats were fully anesthetized, 2 incisions were made: one on the skull and one on the neck. 
The jugular vein was then isolated, and a small incision was made. Approximately 3 cm of one 
end of the catheter was then inserted into this incision on the jugular vein and secured in place 
with 3 silk sutures. This was then followed by threading the other end of the catheter 
subcutaneously to the skull where it was attached to a modified 22-gauge cannula (Plastics One, 
Roanoke, VA, USA).  
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 During the intravenous catheterization, rats also received intracranial cannulae to allow 
for microinjections. Rats in the in vivo microdialysis experiments received a unilateral cannula 
(counterbalanced between the right and left hemispheres) aimed at either the NAc shell or core to 
allow for in vivo microdialysis (see Chapters 3 & 5 for specific details). Rats in the intracranial 
injection studies received either a unilateral guide cannula aimed at the lateral ventricles or 
bilateral guide cannulae aimed at the NAc shell, NAc core, or VTA (for specific details refer to 
Chapters 3 – 5). Guide cannulae were mounted adjacent to the modified catheter cannula on the 
skull using jeweller’s screws and dental cement. Following surgery rats were given penicillin 
(450,000 IU/rat, sc) and the analgesic ketoprofen (5 mg/kg, sc, CDMV, Quebec, Canada). 
Throughout self-administration, rats were flushed daily with heparin and gentamicin in sterile 
saline (7.5IU + 12.0 μg per day per rat) to prevent catheter blockage.  
Apparatus 
 Operant conditioning chambers (Med Associates Inc., St. Albans, VT, USA, 32.0 cm × 
24.0 cm × 25.0 cm; or Coulbourn Instruments, Holliston, MA, 29.0 cm × 29.0 cm × 25.5 cm) 
were used for heroin self-administration and the heroin-seeking tests. Operant conditioning 
chambers were located within individual sound attenuating boxes, and each chamber contained 
two levers located 5.0 cm (Med Associates) or 11.0 cm (Coulbourn Instruments) above the grid 
floor. One lever was designated as the “active” drug-paired lever and the other as the “inactive” 
non-drug paired lever (counterbalanced left and right designations between rats). The chamber 
also contained a cue-light and an audio indicator (Sonalert, 2.9 KHz, 10-20 dB above 
background level) located above the active lever, and a red house-light positioned on the top of 
the wall opposite the levers. During the heroin self-administration rats were attached to a liquid 
swivel (Instech Laboratories, Plymouth Meeting, PA, USA or Lomir Biomedical Inc., Quebec, 
Canada) which was connected to an infusion pump (Med Associates Inc.) via Tygon tubing 
(Inner Diameter: 0.50 mm, Outer Diameter: 1.52 mm; Saint-Gobain Performance Plastics, 
Granville, NY, USA) which was shielded by a metal spring. In the in vivo microdialysis 
experiments (Chapter 3 & 5) baseline microdialysis sampling took place in a clear Plexiglass 





 For drug self-administration heroin (diacetylmorphine HCl; National Institute on Drug 
Abuse, Baltimore, Maryland, USA) was dissolved in sterile saline and delivered in a 
concentration of 0.10 mg/kg/infusion. All other compounds used for intracranial injections are 
detailed in their respective chapter methodology.  
General Procedure 
 The experiments presented in the following chapters all followed the same general 
procedure (specific details are described in each chapter). There were three main phases in all 
experiments: heroin self-administration training, a withdrawal phase, and a heroin-seeking test 
phase.  
Self-Administration Training 
 Following recovery from the surgical procedures, rats were habituated to the operant 
conditioning chambers for 24 h prior to 10 days of heroin self-administration training. During 
self-administration, rats underwent daily three-3 h sessions separated by a 3 h period under a 
fixed interval (FI) 20 s schedule of reinforcement. The first self-administration session of the day 
began with the onset of the dark phase and was marked by the extension of the levers, the 
illumination of a red house-light and the activation of a white-light/tone complex cue above the 
active lever. The white-light/tone complex remained on for 30 s or until the rat pressed the active 
lever. Responses on the inactive, non-drug paired, lever had no programmed consequences. 
Responses on the active, drug-paired lever, resulted in the activation of the infusion pump (5 s 
for the Coulbourn Chambers or 12 s for the Med Associates Chambers; 0.13 ml/infusion) and the 
initiation of a 20-s timeout period during which responses on the active lever were recorded but 
not reinforced. At the end of the 3 h self-administration session the active lever retracted, and the 
house-light turned off. To aid in lever discrimination, the inactive lever remained extended in the 
operant chamber.  
Withdrawal Phase 
 At the end of the heroin self-administration training, rats were transferred back to the 
animal care facility and housed individually in clear shoebox cages for a 24 h drug washout 
period. Rats were matched on the number of infusions, active lever responses, and body weight 
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during the last 5 days of training and divided into a food restricted (FDR) group or left free fed in 
the sated group. Rats were weighed daily. The FDR rats received approximately 15 g of standard 
rat chow daily at 1:30 pm, and the food ration was adjusted daily in order to bring their body 
weight down to approximately 90% of their original body weight at the start of the withdrawal 
phase.  
Heroin-Seeking Test 
 In the in vivo microdialysis experiments in Chapters 3 & 5, rats had a microdialysis probe 
lowered into the targeted brain region the day preceding the heroin-seeking test. Baseline 
dialysate samples were collected in the animal care facility for approximately one hour before 
rats were moved to the operant conditioning chambers for the heroin-seeking test. In the other 
experiments from Chapters 3 – 5 rats received intracranial injections in the animal care facility 
approximately 10 – 30 minutes (dependent on the compound that was injected, see specific 
experiment for further details) prior to being brought back to the operant conditioning chambers 
for the heroin-seeking test.  
 For the heroin-seeking test, rats were brought back to the operant chambers on the 14th 
day of food restriction. All FDR rats had empty food hoppers in their operant chambers. The 
heroin-seeking test took place under extinction conditions over a 3 h session. Responses on the 
active lever resulted in the same consequences as self-administration training (presentation of the 
white-light/tone complex for 20 s, during which the house-light was turned off) with the 
exception that no heroin infusions were administered. As during self-administration training, 
responses on the inactive lever had no programmed consequences.  
Histology 
 At the end of the experiment rats were euthanized with carbon dioxide gas and 
decapitated. Brains were fixed with 4% paraformaldehyde solution for one week before being 
sliced on a cryostat in 40 μm coronal sections. Sections were then mounted onto slides and 
stained with cresyl violet. Cannula and microdialysis probe locations were determined under a 







CHAPTER 3: AUGMENTATION OF HEROIN-SEEKING FOLLOWING CHRONIC FOOD 
RESTRICTION IN THE RAT: DIFFERENTIAL ROLE FOR DOPAMINE TRANSMISSION 












Caloric restriction during drug abstinence increases the risk for relapse in addicts. In rats, 
chronic food restriction during a period of withdrawal following heroin self-administration 
augments heroin seeking. The mechanisms underlying this effect are largely unknown. Here, we 
investigated the role of nucleus accumbens (NAc) shell and core dopamine (DA) in food 
restriction-induced augmentation of heroin seeking. Rats were trained to self-administer heroin 
(0.1 mg/kg/infusion) for 10 days. Next, rats were moved to the animal colony for a withdrawal 
period, during which rats were food restricted to 90% of their original body weight (FDR group) 
or given unrestricted access to food (sated group). On day 14 of food restriction, rats were 
returned to the operant conditioning chambers for a heroin-seeking test under extinction 
conditions. Extracellular DA levels were assessed using in vivo microdialysis. In separate 
experiments, the DA D1-like receptor antagonist SCH39166 (12.5, 25.0, or 50.0 ng/side) was 
administered into the NAc before the heroin-seeking test. In the NAc shell, pre-test exposure to 
the heroin-associated context increased DA only in FDR rats; but in the NAc core, DA increased 
regardless of feeding condition. Food restriction significantly augmented heroin seeking and 
increased DA in the NAc shell and core during the test. Intra-NAc shell administration of 
SCH39166 decreased heroin seeking in all rats. In contrast, in the NAc core, SCH39166 
selectively decreased the augmentation of heroin-seeking induced by chronic food restriction. 
Taken together, these results suggest that activation of the DA D1-like receptor in the NAc core 






In humans, a reciprocal association exists between the abuse of drugs like tobacco, 
cocaine and heroin, and food intake. Drug use decreases food intake, and caloric restriction can 
increase drug consumption, craving and relapse. For example, the level of dietary restriction has 
been positively correlated with the use of alcohol, cigarettes, and marijuana in young women 
(Krahn et al., 1992). Furthermore, the risk for relapse in abstinent smokers is higher in subjects 
that are concurrently calorie restricted (Hall et al., 1992). Prolonged food restriction seems to be 
a critical factor, since shorter food restriction period (24-72 h) did not change cigarette smoking 
(Cheskin et al., 2005) or responses to intravenous fentanyl administration (Zacny & de Wit, 
1992). In animal models of addiction and relapse, caloric restriction reliably augments drug 
taking and seeking. Both acute food deprivation (complete removal) and chronic food restriction 
(prolonged, restricted availability) increase self-administration of a variety of substances, 
including opiate and psychostimulant drugs (Carroll & Meisch, 1981; Carroll, Stotz, Kliner, & 
Meisch, 1984), and the conditioned rewarding properties of morphine in the conditioned place 
preference paradigm (CPP; Gaiardi et al., 1987; Jung et al., 2016). Recently, we found that 
chronic (14 days) food restriction augments heroin seeking in rats under prolonged withdrawal 
(D'Cunha et al., 2013).  
The neural mechanisms underlying the augmentation of heroin seeking induced by 
chronic food restriction remain unknown. However, drug- and food-associated cues have been 
found to elicit significant elevations in extracellular dopamine (DA) levels in the nucleus 
accumbens (NAc) shell and core (Bassareo et al., 2011). In addition, chronic food restriction 
increases DA receptor signalling in the NAc (Carr, Tsimberg, Berman, & Yamamoto, 2003). 
Here, we investigated the role of DA transmission in the NAc in food restriction-induced 
augmentation of heroin seeking. We used in vivo microdialysis to determine changes in 
extracellular DA in the NAc shell and core. Previous studies suggest that DA D1-like receptors 
are important for context- and discriminative cue-induced reinstatement of heroin, cocaine, and 
natural rewards seeking (Marchant & Kaganovsky, 2015). Moreover, we have recently reported 
that blockade of DA D1-, but not D2-like receptors, attenuated acute food deprivation-induced 
reinstatement of heroin seeking (Tobin et al., 2013). In addition, chronic food restriction 
increases synaptic plasticity in NAc cells expressing DA D1-like, but not D2-like, receptors 
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(Carr et al., 2010; Carr et al., 2003). Consequently, here we administered a DA D1-like receptor 
antagonist into the NAc shell and core to determine if DA transmission via the D1-like receptors 
is causally related to the augmentation of heroin seeking induced by chronic food restriction.  
MATERIALS AND METHODS  
Subjects 
Male Long Evans rats (Charles River, St. Constant, Quebec, Canada; n = 196) were used 
in six different experiments. Rats were pair-housed until surgery, and then individually housed 
after surgery (see Supplementary Online Material for further details on housing).  
All rats were treated in accordance with the guidelines of the Canadian Council on 
Animal Care and approval for all procedures was granted by the Concordia University Animal 
Research Ethics Committee.   
Surgical procedures 
Intravenous catheterization was completed under ketamine and xylazine (90.0 and 13.0 
mg/kg, ip) as previously described (Sedki, D'Cunha, & Shalev, 2013). Following surgery rats 
were given penicillin (450,000 IU/rat, sc) and the analgesic ketoprofen (5 mg/kg, sc, CDMV, 
Quebec, Canada). For rats in the microdialysis experiments, unilateral guide cannulae, 
counterbalanced between the right and left hemispheres, were implanted targeting the NAc shell 
(Experiment 1) or NAc core (Experiment 2) during the intravenous surgical procedure (Ito, 
Dalley, Howes, Robbins, & Everitt, 2000). For DA receptor antagonist administration, bilateral 
guide cannulae targeting the NAc shell (Experiment 3) or NAc core (Experiment 4) were 
implanted during the intravenous surgical procedure (Tobin et al., 2013). See also 
Supplementary Online Material. 
Apparatus 
 Operant conditioning chambers (Med Associates Inc., St. Albans, VT; or Coulbourn 
Instruments, Holliston, MA) equipped with two levers were used. See also Supplementary 




Heroin (diacetylmorphine HCl; National Institute for Drug Abuse, Research Triangle 
Park, NC, USA) was dissolved in physiological saline and delivered at a dose of 0.1 
mg/kg/infusion. The DA D1-like receptor antagonist SCH39166 (Tocris Bioscience, 
Minneapolis, MN, USA) was diluted in sterile saline to produce the following doses: 0.0, 12.5, 
25.0, 50.0 ng/side. These doses were previously shown to impair the acquisition of morphine 
conditioned place preference with minimal motor side-effects (Fenu, Spina, Rivas, Longoni, & 
Di Chiara, 2006). 
Procedure 
 Different rats were used for each of the experiments, which followed a similar procedure. 
There were three phases: heroin self-administration training in the operant conditioning 
chambers, a withdrawal phase in the animal care facility (ACF), and a testing phase in the 
operant conditioning chambers, or in clear Plexiglas chambers (context control experiments).  
Training 
 Following two post-surgery recovery days, rats underwent daily three 3-h sessions 
separated by a 3 h period, under a fixed-interval-20 (FI-20) schedule of heroin reinforcement (0.1 
mg/kg/infusion), as previously described (D'Cunha et al., 2013), over 10 days. Active lever 
responses resulted in a heroin infusion and initiation of a 20-s timeout period during which a 
tone-light compound cue was activated. Active lever responses made during the timeout were 
recorded but not reinforced. Inactive lever responses were recorded but had no programmed 
consequences. See also Supplementary Online Material. 
Withdrawal and Food Restriction 
  Following the heroin self-administration phase, rats were transferred back to the ACF 
and housed in individual cages. After a 24 h drug washout period, rats were matched for number 
of infusions, active lever responses, and body weight during the last 5 days of training and 
assigned to a food restricted (FDR) or sated group. FDR rats were fed daily at 1:30 pm and the 
food ration was adjusted daily to bring the body weight of the FDR group to approximately 90% 
of their first withdrawal day body weight. 
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In vivo microdialysis and heroin-seeking tests 
 Approximately 14 h prior to the heroin-seeking test, microdialysis probes (Bioanalytical 
Systems Inc., West Lafayette, IN, USA, or made in the laboratory; Sorge, Rajabi, & Stewart, 
2005) were lowered into the targeted brain region, under light isoflurane anaesthesia. Probes 
targeted at the NAc shell (Experiment 1) had a 2.0 mm semipermeable active membrane (280 
μm OD), whereas probes targeted at the NAc core (Experiment 2) had a 1.5 mm active 
membrane. Baseline collection started in the ACF, and dialysate samples were collected every 10 
min over 1 h at a flow rate of 1.0 µl/min. Next, rats were transported from the animal facility to 
the drug self-administration training room (Experiments 1A, 2A) or to an unfamiliar room for the 
context-change control experiments (1B, 2B). Microdialysis pumps were plugged into a battery 
pack so that the flow rate and sampling continued during transfer. Rats were then transferred to 
the operant conditioning chambers for the heroin-seeking test (Experiments 1A, 2A) or to a 
Plexiglas chamber (Experiments 1B, 2B). After the move to the testing chamber, but prior to the 
initiation of the test, one dialysate sample was collected (corresponding with the context change). 
Testing took place under extinction conditions over a 3-h session, and dialysate samples were 
collected every 10 min. Active lever responses resulted in the same consequences as in training 
except that no heroin infusions occurred. No levers or cues were presented in the Plexiglas 
chambers. See also Supplementary Online Material. 
Intracranial injections and heroin-seeking tests 
 Rats were administered the D1-like receptor antagonist, SCH39166, approximately 10 
min prior to the heroin-seeking test (Experiments 3, 4). Testing took place under extinction 
conditions over one 3-h session. See also Supplementary Online Material. 
Analytical Chemistry 
 Extracellular DA was isolated in the dialysate samples using high performance liquid 
chromatography (HPLC) and quantified using electrochemical detection as previously described 




 Statistical analyses were conducted using SPSS (IBM, SPSS Statistics, version 20). Data 
were analyzed using ANOVA followed by post-hoc tests with a Bonferroni correction for 
multiple comparisons where appropriate. See also Supplementary Online Material. 
RESULTS 
 For experiments 1 and 2, 60 rats were trained, but 10 rats were excluded due to technical 
problems or incorrect probe placement (Figure 3.1A, B). For experiments 3 and 4, 136 rats were 
trained, but 24 rats were removed due to incorrect cannulae placements (Figure 3.1C, D). All rats 
acquired reliable heroin self-administration behaviour (Table 3.1). In all experiments, at test day 
the food-restricted rats were at approximately 90% of their body weight at the start of the 
withdrawal phase (Table 3.1).  
Experiment 1A: Changes in extracellular DA in the NAc shell  
 Behaviour: Exposure to 14 days of food restriction resulted in a robust overall 
augmentation of active lever responses made by the FDR (n = 10) compared to the sated group 
(n = 8; Figure 3.2A inset). Active lever responses recorded in 10 min bins (Figure 3.2A) were 
higher in the FDR rats (feeding condition: F (1,16) = 7.769, p = 0.013, η2 = 0.327), with a 
statistically significant decrease over time (F (17,272) = 9.131, p < 0.001, η2 = 0.344) but no 
interaction of feeding condition x time (F (17,272) = 1.388, p = 0.142, η2 = 0.052). There were no 
statistically significant differences between groups in the number of inactive lever responses.  
Microdialysis: There were no statistically significant differences in absolute baseline 
dialysate concentrations of DA (Table 3.2). Chronic food restriction resulted in increased 
extracellular DA throughout the sampling period (Figure 3.2B; feeding condition: F (1,16) = 4.699, 
p = 0.046, η2 = 0.227), and there were no statistically significant effects for time (F (18,288) = 
1.202, p = 0.258, η2 = 0.065) or feeding condition x time (F (18,288) = 1.158, p = 0.296, η2 = 
0.063). Planned comparisons revealed a statistically significant increase in extracellular DA in 
FDR rats compared to baseline following exposure to the heroin self-administration context (t (9) 
= -2.316, p = 0.046, d = 1.544; Figure 3.2B). Extracellular DA at the initiation of the heroin-
seeking test was elevated in the FDR rats compared to baseline levels (t (9) = -3.951, p = 0.003, d 














































Figure 3.1. Cannula placements for all experiments. Approximate locations of active region of 
microdialysis probe targeting the NAc shell (A) for Experiment 1A (n = 18; black line) and 
Experiment 1B (n = 9; gray line), or the NAc core (B) for Experiment 2A (n = 14; black line) and 
Experiment 2B (n = 9; gray line). Approximate anatomical position for microinjector tips targeting 
the NAc shell (C) for Experiment 3 (n = 66; open circles) or NAc core (D) for Experiment 4 (n = 46; 
open triangles). Images modified from the brain atlas of Paxinos & Watson (2005) of Figures 17 – 
20 (+1.56 - +1.92 mm anterior to Bregma). 
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Table 3.1. Mean ± SEM of the number of infusions taken, and the number of active and inactive 
lever responses made on the last training day (9 h) in each experiment, as well as body weight 
for the FDR and sated rats on the 14th day of food restriction (the drug seeking test). 
 
 Mean ± SEM 
 Self-administration training day 10 Food-restriction day 14 










1A 40.18 ± 5.37 120.76 ± 30.13 4.76 ± 1.85 315.60 ± 5.09 422.25 ± 8.82 
1B 40.78 ± 8.13 108.22 ± 34.92 4.56 ± 0.91 295.00 ± 6.81 401.75 ± 24.95 
2A 34.50 ± 4.02 79.79 ± 13.38 12.57 ± 6.25 309.78 ± 6.19 431.400 ± 9.21 
2B 54.44 ± 14.09 230.00 ± 96.91 4.00 ± 1.00 305.25 ± 10.91 421.60 ± 13.32 
3 46.38 ± 3.05 186.06 ± 53.48 9.87 ± 1.09 316.36 ± 2.46 428.41 ± 4.52 






Experiment 1B: Specificity of changes in extracellular DA in the NAc shell to the drug context  
 In a separate group of rats, following heroin self-administration training and 14 days of 
food restriction as in Experiment 1, rats were transferred to an unfamiliar room and into a 
Plexiglas chamber (novel context). Absolute baseline dialysate concentrations of DA were not 
statistically significantly different between FDR (n = 5) and sated rats (n = 4; Table 3.2). There 
were no changes in extracellular DA in either the FDR or sated groups as compared to baseline 
(Figure 3.2C; feeding condition: F (1,7) = 0.339, p = 0.579, η2 = 0.046; time: F (19,133) = 1.399, p = 
0.138, η2 = 0.144; feeding condition x time: F (19,133) = 1.325, p = 0.178, η2 = 0.136).  
Experiment 2A: Changes in extracellular DA in the NAc core  
 Behaviour: FDR rats (n = 9) displayed a considerable increase in the total number of 
responses on the active lever compared to sated rats (n = 5; Figure 3.3A inset). Active lever 
responses recorded in 10 min bins in FDR rats were substantially higher than in sated rats over 
the first 20 min of the test session (Figure 3.3B; feeding condition: F (1,12) = 5.218, p = 0.041, η2 
= 0.303; time: F (17,204) = 6.281, p < 0.001, η2 = 0.297; feeding condition x time: F (17,204) = 2.858, 
p < 0.001, η2 = 0.135). There were no statistically significant differences in the number of 
inactive lever responses between groups.  
Microdialysis: There were no statistically significant differences in absolute baseline 
dialysate concentrations of DA (Table 3.2). Extracellular DA in the NAc core increased 
following the move to the operant conditioning chamber but decreased back to baseline during 
the test session (Figure 3.3B; time: F (19,228) = 7.630, p = 0.007, η2 = 0.075). There were no 
statistically significant effects for feeding condition (F (1,12) = 0.979, p = 0.342, η2 = 0.367) or 
feeding condition x time (F (19,228) = 1.174, p = 0.282, η2 = 0.056). Planned comparisons found 
that both the FDR rats (t (8) = -3.166, p = 0.01, d = 2.239), and the sated rats (t (4) = -3.959, p = 
0.017, d = 3.959) demonstrated a statistically significant increase in extracellular DA following 
exposure to the operant chamber compared to baseline levels. However, extracellular DA 
remained elevated compared to baseline following the initiation of the heroin-seeking test in only 





Figure 3.2. Chronic food restriction-induced augmentation of heroin seeking and extracellular 
dopamine in the NAc shell. (A) Total number of active and inactive lever responses for FDR (n = 
10) and sated (n = 8) rats (inset), and active lever responses in 10-min time intervals during the 3 
h heroin-seeking test in Experiment 1, * p = 0.013 compared to sated rats. (B) Extracellular 
dopamine following re-exposure to the drug environment and during the heroin seeking test in 
the FDR and sated rats, * p < 0.05 compared to baseline levels, # p = 0.007 compared to sated 
rats. (C) Extracellular dopamine following exposure to a novel context in the FDR (n = 5) or 
sated (n = 4) rats. 
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Table 3.2. Mean ± SEM of the absolute concentrations of baseline dopamine levels of the FDR 
and sated rats. 
 
 Mean ± SEM absolute [DA] in pg/µl Statistics 
Experiment FDR Sated t-test & Cohen’s d effect size 
1A 0.125 ± 0.022 0.147 ± 0.025 t (14) = -0.646, p = 0.529, d = -0.345 
1B 0.107 ± 0.016 0.089 ± 0.005 t (7) = 0.949, p = 0.374, d = 0.717 
2A 0.092 ± 0.015  0.109 ± 0.026 t (12) = -0.626, p = 0.543, d = -0.361 





Experiment 2B: Specificity of changes in extracellular DA in the NAc core to the drug context 
Absolute baseline dialysate concentrations of DA in the NAc core did not differ between 
FDR (n = 4) and sated (n = 5) groups. FDR rats displayed a short-term increase in NAc core 
extracellular DA after the move to the novel chamber (Figure 3.3C; feeding condition: F (1,7) = 
1.177, p = 0.314, η2 = 0.144; time: F (19,133) = 2.484, p = 0.001, η2 = 0.202; feeding condition x 
time: F (19,133) = 2.786, p < 0.001, η2 = 0.227). Planned comparisons revealed that the increase 
from baseline in extracellular DA in the FDR rats following exposure to the novel context did 
not reach statistical significance (t (3) = -2.376, p = 0.098, d = 2.744), but was statistically 
significantly higher than the in sated rats (t (7) = 2.823, p = 0.026, d = 2.134).  
Experiment 3: Administration of the DA D1-like receptor antagonist, SCH39166, into the NAc 
Shell 
The final analysis included the following 8 groups: FDR-0.0 ng (n = 8), FDR-12.5 ng (n 
= 8), FDR-25.0 ng (n = 8), FDR-50.0 ng (n = 8), sated-0.0 ng (n = 9), sated-12.5 ng (n = 9), 
sated-25.0 ng (n = 8), sated-50.0 ng (n = 8). Overall, the FDR groups responded more on the 
active lever during the 3-h heroin-seeking test compared to the sated groups (Figure 3.4A; 
feeding condition: F (1,58) = 20.35, p < 0.001, η2 = 0.234). Administration of SCH39166 into the 
NAc shell statistically significantly decreased active lever responding regardless of food 
restriction condition (SCH39166 dose: F (3,58) = 2.765, p = 0.05, η2 = 0.095). No statistically 
significant effect for feeding condition x SCH39166 dose interaction was observed (F (3,58) = 
0.100, p = 0.959, η2 = 0.003). Finally, no statistically significant effects were observed for 
inactive lever responding during the test. 
Experiment 4: Administration of the DA D1-like receptor antagonist, SCH39166, into the NAc 
Core 
The final analysis included the following 6 groups: FDR-0.0 ng (n = 8), FDR-12.5 ng (n 
= 9), FDR-25.0 ng (n = 7), sated-0.0 ng (n = 7), sated-12.5 ng (n = 7), sated-25.0 ng (n = 8). 
Overall, the FDR groups responded more on the active lever during the 3-h heroin-seeking test 
compared to the sated groups (Figure 3.4B; feeding condition: F (1,40) = 22.703, p < 0.001, η2 = 




Figure 3.3. Chronic food restriction-induced augmentation of heroin seeking and 
extracellular dopamine in the NAc core. (A) Total number of active and inactive lever 
responses for FDR (n = 9) and sated (n = 5) rats (inset), and active lever responses in 10-
min time intervals during the 3-h heroin-seeking test in Experiment 2. * p = 0.041 compared 
to sated rats. (B) Extracellular dopamine following re-exposure to the drug environment and 
during the heroin seeking test in the FDR and sated rats, @ p < 0.05 FDR and sated groups 
compared to baseline, * p = 0.012 FDR group compared to baseline. (C) Extracellular 
dopamine following exposure to a novel context in FDR (n = 4) and sated (n = 5) rats, # p = 
0.026 compared to sated rats. 
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Importantly, there was a statistically significant interaction between feeding condition x 
SCH39166 dose (F (2,40) = 3.86, p = 0.029, η2 = 0.107). Following Bonferroni corrections, post-
hoc analyses revealed a statistically significant higher number of responses in the FDR-0.0 ng 
group compared to the sated-0.0 ng group (t (40) = 4.967, p < 0.0001, d = 1.990), but no 
differences between the FDR-12.5 ng and sated-12.5 ng groups, or between the FDR-25.0 ng and 
sated-25.0 ng groups. In addition, the number of active lever responses made by the FDR-0.0 ng 
group was statistically significantly higher than the FDR-12.5 ng group (t (40) = 2.847, p = 0.02, 
d = 0.978), but not the FDR-25.0 ng (t (40) = 2.283, p = 0.08, d = 1.690). Finally, no statistically 
significant effects were observed for inactive lever responding during the test. 
DISCUSSION 
Chronic food restriction augmented heroin seeking following two weeks of withdrawal, 
as we have previously demonstrated (D'Cunha et al., 2013). Re-exposure to the self-
administration context increased extracellular DA levels in the NAc shell and core. However, the 
increase in extracellular DA levels in the NAc core occurred in both the sated and FDR rats, 
while in the NAc shell, exposure to the drug context selectively increased extracellular DA levels 
in FDR rats. Exposure to a novel context increased extracellular DA levels in the NAc core, but 
not shell, only in the FDR rats. Initiation of the heroin-seeking test maintained the increase in 
extracellular DA levels in the NAc shell and core of FDR rats. DA levels then quickly returned 
to baseline in the NAc core, while extracellular DA levels in the NAc shell remained elevated. 
Finally, administration of the DA D1-like receptor antagonist SCH39166 into the NAc shell 
decreased heroin seeking in both feeding conditions. In contrast, intra-NAc core SCH39166 
decreased heroin seeking selectively in the FDR group.  
Effects of exposure to heroin-associated context on extracellular DA in NAc shell and core in 
FDR and sated rats 
To the best of our knowledge, ours is the first report on changes in extracellular DA 
levels following exposure to a heroin-associated context, independent of the discrete drug-





Figure 3.4. The effect of injections of the dopamine D1-like receptor antagonist SCH 39166 into 
the NAc shell (A) or NAc core (B) on the augmentation of heroin seeking induced by chronic 
food restriction. * p = 0.05 compared to the sated groups. # p < 0.0001 FDR-0.0 ng group 
compared to sated-0.0 ng group. & p = 0.02 FDR-0.0 ng group compared to FDR-12.5 ng group. 
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 Previous reports on conditioned changes in DA levels in the mesolimbic pathway 
terminals are inconsistent. Increases in extracellular DA in the NAc following exposure to an 
amphetamine- or cocaine-associated context have been reported (Duvauchelle, Ikegami, Asami, 
et al., 2000; Duvauchelle, Ikegami, & Castaneda, 2000; Stuber et al., 2002). In contrast, other 
investigations did not find changes in extracellular or tissue DA levels following exposure to 
cocaine- or morphine-conditioned contextual stimuli (Brown & Fibiger, 1992; Walter & 
Kuschinsky, 1989). Unfortunately, in most of the studies cited above, no distinctions were made 
between the NAc shell and core. Importantly, even when changes in NAc extracellular DA levels 
were found following exposure to the drug context (Duvauchelle, Ikegami, Asami, et al., 2000; 
Stuber et al., 2002), those changes were not temporally or quantitatively associated with the 
conditioned behavioural response. 
Stuber et al (2002) reported a conditioned increase in extracellular DA levels in the NAc 
core following exposure to an amphetamine-paired environment in sated rats, but not in food 
restricted rats (to 90% of their baseline bodyweight). This finding contrasts with the statistically 
significant increase in extracellular DA levels in the NAc core that we observed in both the sated 
and FDR rats following exposure to the heroin self-administration environment. However, in 
FDR rats, an increase in NAc core DA also occurred in a novel context, suggesting that the 
transfer between environments induced a non-specific DA response. This response might be 
more related to arousal than to conditioned drug effects (Brown & Fibiger, 1992). Discrepancies 
compared to previous reports on NAc DA response to drug-associated context could also result 
from the use of passive, Pavlovian conditioning, while instrumental conditioning was used here.  
Mesolimbic DA is thought to be critically involved in the generation of incentive salience 
to drug-associated stimuli, leading to approach and engagement with the drug-related stimuli 
(Berridge, 2007). Since the generation of incentive salience is strongly modulated by 
physiological states (Berridge, 2007), this could explain the heroin-context specific increase in 
NAc shell DA in FDR rats. In the current study, rats’ behaviour in the operant conditioning 
chambers was not monitored during the 10-min period leading to the initiation of the heroin-
seeking test. We therefore have no direct assessment of the association between the change in 
NAc DA levels and non-instrumental drug context-conditioned behaviours. 
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Effects of exposure to heroin-associated discrete cues on extracellular DA in NAc shell and 
core in FDR and sated rats 
The increase in extracellular DA levels in the NAc shell and core that was selective to the 
FDR groups following the initiation of the heroin-seeking test, coincided with the intense active 
lever pressing over the first 10-min time bin. This suggests that food restriction-induced 
augmentation of heroin seeking is associated with increased NAc extracellular DA levels. As 
mentioned above, food restriction can sensitize neural systems that are involved in incentive 
motivational processes, including DA systems (Berridge & Robinson, 1998), resulting in cue-
induced elevation of NAc core and shell DA in FDR rats. 
Bassareo et al. (2011, 2015) found elevated DA levels in the NAc following exposure to 
sucrose- and morphine-conditioned stimuli, albeit only in the shell. The differences between our 
results and those reported by Bassareo et al. (2011) may be due to the use of 
Pavlovian/contextual conditioned cues by Bassareo et al. (2011), versus the instrumental/discrete 
cues in the present report. However, an explanation based on the difference in the conditioning 
procedures and the nature of the cues seems unlikely, since a selective increase in DA in the NAc 
shell, but not core, was reported by Bassareo et al. (2015) using an instrumental conditioning 
procedure with sucrose-associated discrete cues. Importantly, comparisons with Bassareo et al.’s 
(2015) study should be made with caution, considering the non-drug reward used in their 
procedure and the known differential effects of non-drug and drug conditioned stimuli on DA 
transmission in the NAc (Bassareo et al., 2011). Thus, the reasons for the less selective increase 
in NAc DA in FDR rats versus the NAc shell selective effect reported by Bassareo et al. (2011, 
2015) are not clear. 
Sated rats in the current study showed no statistically significant changes in DA levels in 
NAc shell or core during the heroin-seeking test. This finding is in line with the unaltered DA 
levels in the NAc following response-contingent exposure to cocaine-associated cues reported by 
Ito et al. (2000), and Neisewander et al. (1996). Interestingly, rats in Ito et al.’s (2000) study 
were mildly food restricted throughout the experiment. This apparent lack of food-restriction 
effect on drug-cue-induced NAc DA could be explained by their experimental procedure that 
involved cocaine-seeking tests under a second-order schedule of reinforcement. In contrast, rats 
in the current study experienced a prolonged period of withdrawal before the heroin-seeking test. 
It has been established that behavioural and neurochemical adaptations occur over drug 
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withdrawal periods, resulting in an enhanced response over time (incubation of drug craving; 
(Grimm et al., 2001; Pickens et al., 2011). 
Finally, extracellular DA in the NAc shell remained higher in the FDR group compared 
to the sated one throughout most of the heroin-seeking test, while lever pressing rapidly 
extinguished in both groups. Moreover, the initiation of the test session was characterized by 
robust heroin seeking, in both feeding condition groups, that is typically observed following a 
withdrawal period (Fuchs, Lasseter, Ramirez, & Xie, 2008; Grimm et al., 2001; Neisewander et 
al., 1996; Shalev, Morales, et al., 2001). This dissociation between levels of DA in the NAc and 
the magnitude of drug seeking has been noted in previous reports with cocaine- and heroin-
trained rats (Ito et al., 2000; Neisewander et al., 1996; Wise et al., 1995).  
Taken together, our data indicate that there is a weak, or no relation between changes in 
extracellular DA levels in the NAc shell and heroin seeking following prolonged withdrawal, in 
both FDR and sated rats. In contrast, changes in DA levels in the NAc core seem to parallel the 
changes in lever pressing throughout the heroin-seeking test, but only in the FDR rats, suggesting 
a differential role for DA in NAc core in sated and FDR rats.  
Effects of intra-NAc shell and core injections of SCH39166 on heroin seeking in FDR and 
sated rats 
Notably, active lever responses performed by sated rats with intra-NAc core vehicle 
injections (0.0 ng SCH39166) were considerably lower compared to rats with intra-NAc shell 
vehicle injections. This could prevent an effect of SCH39166 from being demonstrated (floor 
effect) in the sated intra-NAc core injected rats. Nevertheless, the sated vehicle-injected group 
performed a substantial number of lever responses (~85 lever presses), and under identical 
conditions, sated rats from the same cohorts did not show any attenuation of lever responding 
following treatment with SCH39166. 
DA D1-like receptors in the NAc have been strongly implicated in context and discrete 
cue-induced drug seeking for alcohol (Chaudhri, Sahuque, Schairer, & Janak, 2010; Marchant & 
Kaganovsky, 2015), morphine (Gao et al., 2013), and heroin (Bossert et al., 2007). However, the 
involvement of D1-like receptors in the NAc shell vs. core seems to be dependent on the self-
administered substance, as well as on the drug-seeking procedure. Renewal of extinguished or 
punished alcohol seeking was attenuated by antagonism of D1-like receptors in either NAc shell 
or core (Chaudhri et al., 2010; Marchant & Kaganovsky, 2015). In contrast, blockade of D1-like 
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receptors in the NAc shell, but not core, decreased context-induced reinstatement of heroin 
seeking, while intra-core injections decreased discrete cue-induced reinstatement of heroin 
seeking (Bossert et al., 2007). Gao et al (2013) reported that D1-like receptor antagonism in the 
shell attenuated morphine seeking using a withdrawal procedure (similar to the one used here); 
however, the role of D1-like receptors in the core was not assessed in that study. The implied 
critical role for D1-like receptors in the NAc shell in context- and cue-induced drug seeking 
corresponds with the attenuated heroin seeking, regardless of feeding condition, which we 
observed after intra-NAc shell injections of SCH39166.  
Finally, considering the findings of Bossert et al. (2007), the selective attenuation of 
heroin seeking in FDR rats that were injected with SCH39166 into the NAc core suggests that 
food restriction-induced augmentation of heroin seeking is mediated by an enhancement of the 
incentive motivational properties (Robinson & Berridge, 2003) of the discrete, rather than 
contextual, heroin-associated cues. 
There are several methodological issues that should be considered when interpreting the 
present findings. First, although the DA microdialysis sampling intervals were comparatively 
short (10 min), the temporal resolution of this technique makes it impossible to acquire very fast, 
phasic, changes in the DA signals that can be picked up using voltammetry (~100 ms). However, 
the microdialysis approach, as utilized here, successfully identified changes in extracellular DA 
levels over behaviourally relevant epochs, such as the switch from context exposure to the 
beginning of the heroin-seeking session (Figure 3.3B). Second, it is important to note that the 
current experimental design does not allow a clear dissociation between the contribution of 
contextual and discrete cues to heroin seeking once the test session commenced, a caveat that 
should be addressed in future studies (see Shalev et al., 2002 for a discussion of the relevant 
challenges in dissociating the effects of discrete and contextual cue on drug seeking). Third, the 
observed effects of the intracranial SCH39166 injections might be due to diffusion of the 
antagonist into surrounding tissue. However, this is most unlikely, as indicated by the differential 
effect of injections into the adjacent core and shell compartments of the NAc. Finally, we did not 
assess the involvement of NAc DA D2-like receptors in the food restriction effect, as explained 




Context-induced changes in DA levels in the NAc core of FDR rats following a period of 
withdrawal suggest a non-specific arousal effect. In contrast, the heroin-context selective 
increase in NAc shell DA levels in FDR rats, when first exposed to the test chambers, might 
reflect an enhancement of the incentive properties of the contextual cues. Future studies will 
address this hypothesis. In the NAc shell, food restriction-induced changes in DA presynaptic 
mechanisms, reflected by changes in extracellular DA levels during the heroin-seeking test, or 
postsynaptic adaptations in D1-like receptor function were not closely associated with heroin 
seeking driven by response-contingent discrete cues. In contrast, in the NAc core, changes in 
extracellular DA levels paralleled heroin seeking in FDR rats, with increased DA levels at the 
beginning of the test session, when lever pressing was most vigorous, that subsequently 
decreased as heroin seeking declined. In addition, intra-NAc core injections of SCH39166 
selectively decreased heroin seeking in FDR rats. We therefore conclude that changes in DA 
presynaptic mechanisms and postsynaptic adaptations in NAc core cells that express DA D1-like 
receptors mediate food restriction-induced augmentation of heroin seeking. The results we report 
for the sated rats support current neurobiological addiction theories that suggest a minor role for 
DA transmission in the NAc core in drug seeking (Kalivas & Volkow, 2005). However, in food-
restricted rats, DA in the NAc core plays a critical role in the augmentation of heroin seeking. An 






MATERIALS AND METHODS 
Subjects  
A total of 196 rats (Charles River, St. Constant, Quebec, Canada) were used in this series 
of experiments. Upon arrival, rats were pair-housed in clear shoebox cages, and allowed 1 week 
to acclimate to the animal colony prior to surgical procedures. The rats were kept under a reverse 
12 h light-dark cycle (lights OFF 9:30 am) at 21°C. Following recovery from surgery (described 
below) rats were individually housed in operant conditioning chambers with ad libitum food and 
water during heroin self-administration.  
At the completion of heroin self-administration training, rats were returned to the animal 
colony for the withdrawal and food restriction phase (described below). Prior to in vivo 
microdialysis sampling, rats were housed in clear Plexiglas chambers with a grid floor for 
baseline sampling prior to the heroin seeking test (described below). Following baseline 
microdialysis collection rats were transferred back to the operant conditioning chambers for the 
heroin-seeking test. Rats in the experiments with the DA D1-like receptor antagonist, were 
brought to the operant conditioning chambers for the heroin seeking test.   
Surgical procedures 
Intravenous surgery 
Intravenous catheterization was completed under ketamine and xylazine (90 and 13 
mg/kg, ip) as previously described (Sedki, D'Cunha, et al., 2013). Silastic catheters (Dow 
Corning, Midland, MI, USA) were inserted into the right jugular vein and secured with silk 
sutures. The tip of the catheter was attached to a modified 22-gauge cannula (Plastics One, 
Roanoke, VA) that was mounted on the rat’s skull with jeweler’s screws and dental cement. 
Following surgery rats were given penicillin (450,000 IU/rat, sc) and the analgesic ketoprofen (5 
mg/kg, sc, CDMV, Quebec, Canada). Throughout self-administration rats were flushed daily 
with heparin and gentamicin in sterile saline (7.5 IU + 12.0 µg per day per rat) to prevent 
catheter blockage. 
Intracranial surgery 
For rats in the microdialysis experiments, unilateral guide cannulae were implanted 
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targeting one of the following regions (coordinates in mm relative to Bregma): nucleus 
accumbens (NAc) shell AP +1.6, ML ±1.0, DV -5 (Experiment 1A and 1B); NAc core AP +1.6, 
ML ±1.5, DV -4.5 (Experiment 2A and 2B; (Paxinos & Watson, 2005b), during the intravenous 
surgical procedure. Cannulae were mounted adjacent to the modified catheter cannula on the 
skull using jewelers’ screws and dental cement. Cannulae placements were counterbalanced 
between the right and left hemispheres. Rats in the DA D1-like receptor antagonist experiments 
were instead implanted with bilateral guide cannulae targeting one of the following regions 
(coordinates in mm relative to Bregma): nucleus accumbens (NAc) shell AP +1.7, ML ±3.7, DV 
-4.8 with a 20° angle (Experiment 3); or, NAc core AP +1.8, ML ±2.5, DV -4.5 with a 6° angle 
(Experiment 4). 
Apparatus 
 Operant conditioning chambers (Med Associates Inc., St. Albans, VT; or Coulbourn 
Instruments, Holliston, MA) were used for heroin self-administration and the heroin-seeking 
tests. Operant chambers were located within individual sound attenuating boxes, and each 
chamber contained two levers located 5 cm above the grid floor. Responses on the “active” 
retractable lever activated the infusion pump (Med Associates). Conversely, responses on the 
“inactive” lever were recorded but had no programmed consequences. Prior to the in vivo 
microdialysis baseline sampling (or testing for context control experiments described 
subsequently in Experiments 1B & 2B), rats were habituated to a clear Plexiglas chamber (30 cm 
× 28 cm × 25 cm) with a metal grid floor in the animal facility. 
Procedure 
Training 
Rats were habituated to the operant conditioning chambers for 24 h prior to 10 days of heroin 
self-administration training. Rats underwent daily three-3 h sessions separated by a 3 h period, 
under a fixed-interval 20 s (FI-20) timeout schedule of reinforcement. The initial training session 
began shortly after the onset of the dark phase with the insertion of the active lever, illumination 
of the houselight, and activation of a compound tone/light cue (2.9 kHz, 10 dB above 
background/white light above the active lever), which remained on for 30 s or until the active 
lever was pressed. Responses on the active lever resulted in the delivery of 0.1 mg/kg of heroin 
(diacetylmorphine HCl; provided by the National Institute for Drug Abuse, Research Triangle 
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Park, NC, USA) in 0.13 ml over 12 s, and of the tone-light cue for 20 s during which the 
houselight was turned off. Responses on the active lever made during the timeout were recorded 
but not reinforced. At the end of each 3 h session the active lever retracted and the houselight 
was turned off. 
In vivo microdialysis and heroin-seeking tests 
Two days prior to the heroin seeking test, on the 12th day of food restriction, rats were 
habituated to the neutral clear Plexiglas chamber. Approximately 14 h prior to the heroin seeking 
test, on the 13th day of food restriction, probes were lowered into the targeted brain region, under 
light isoflurane anaesthesia. Probes were either purchased (Bioanalytical Systems Inc., West 
Lafayette, IN, USA) or made in the laboratory. Probes targeted at the NAc shell (Experiment 1) 
had a 2.0 mm semipermeable active membrane, whereas probes targeted at the NAc core 
(Experiment 2) had a 1.5 mm semipermeable active membrane. The active semipermeable 
membrane of the probe had a pore size of 13kD with an OD of 280 µm and ID of 200 µm. To 
prevent occlusion, probes were perfused with artificial cerebrospinal fluid (aCSF; 145mM Na+, 
2.7mM K+, 1.22mM Ca2+, 1.0mM Mg2+, 150mM Cl-, 2mM Na2PO4, pH 7.4 ± 0.1) at 1.0 µl/min 
for approximately 1 h. The flow rate was then lowered to 0.2 µl/min overnight. On the 14th day 
of food restriction, the flow rate was returned to 1.0 µl/min for approximately 1 h prior to 
baseline sampling. Baseline samples were then collected in 10 min time bins prior to the rat 
being moved to the operant conditioning chamber for the heroin-seeking test, where samples 
were further collected in 10 min time bins for the 3 h test. 
Intracranial injections and heroin-seeking tests 
Intracranial injections were made using a syringe pump (Harvard Apparatus, Holliston, MA) 
connected to a 10 µl Hamilton syringe. This syringe was attached via polyethelene-20 tubing to a 
28-gage injector (Plastics One) that extended 2.0 mm below the guide cannula. For all 
intracranial injections, drug was delivered in a volume of 0.5 µl over 1 min with injectors 
remaining in place for 1 min following the injection. Two days prior to the heroin seeking test, 
on the 12th and 13th days of food restriction rats received mock injections to habituate them to the 
injection procedure. For mock injections the syringe pump was run for 1 min, and short injectors 
not extending beyond the guide cannulae, were inserted into the guide cannulae. No solution was 
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administered during the mock injections to minimize tissue damage in the target areas. Rats were 
then administered SCH 39166 approximately 10 min prior to the heroin-seeking test.  
Analytical Chemistry 
Extracellular DA and its metabolites were isolated in the dialysate samples using high 
performance liquid chromatography (HPLC) and quantified using electrochemical detection 
(ED) as previously described (Hernandez, Rajabi, Stewart, Arvanitogiannis, & Shizgal, 2008). 
Dialysate samples were loaded through manual injection ports (Rheodyne 7125; Rheodyne LLC, 
Rhonert Park, CA; 20 µl loop) into a reverse-phase column (15 cm × 0.46 cm, Spherisorb-ODS, 
5µm; Higgins Analytical, Mountain View, CA). Following separation in the column the sample 
passed through dual-channel ESA (Chelmsford, MA) coulometric detectors (Coulochem 5100, 
with a model 5011 analytical cell), which were connected to a computer. Standard samples of 
solution containing DA was used to calibrate the equipment. Waters 515 HPLC pumps (Lachine, 
Quebec, Canada) were used to circulate the mobile phase (19% acetonitrile, 40mg 0.076M SDS, 
0.1M EDTA, 0.058M NaPO4, 0.03M citric acid, pH 3.35) at a flow rate of 1.2mL/min. EZChrom 
Chromatography Data System (Scientific Software Inc., San Ramon, CA) was used to analyze 
and integrate the data obtained for DA, DOPAC, and HVA. 
Histology 
 After completion of the experiment rats were euthanized with carbon dioxide gas and 
decapitated. Brains were fixed with 4% paraformaldehyde solution for a week before being 
sliced in 40 µm coronal sections. Sections were then stained with cresyl violet and cannula and 
probe locations were determined under a microscope with reference to a brain atlas (Paxinos & 
Watson, 2005). 
Statistical Analysis 
 All statistical analyses were conducted using SPSS Statistics software package. For the 
microdialysis experiments, total active and total inactive lever responses during the test session 
were analyzed separately using independent samples t-test (2-tailed) to compare FDR and sated 
groups. For the microdialysis experiments, active and inactive lever responses during the test 
session were analyzed separately using a mixed factorial analysis of variance (ANOVA) with a 
between subject factor of feeding condition (FDR, sated) and a within subject factor of time (18 x 
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10 min bins). To assess the effects of food restriction on NAc extracellular DA levels, baseline 
levels of DA were determined by averaging the 3 samples collected prior to the move to the 
operant or neutral chamber for each rat, and then converting the values of all test session samples 
to a percentage of baseline. Changes from baseline were analyzed separately for each experiment 
using a mixed factorial ANOVA with the between subjects factor of feeding condition and within 
subjects factor of time (baseline average, context change, and test samples 1-18). Statistically 
significant interactions were followed by post hoc tests with Bonferroni corrections.  
To assess the effects of SCH 39166 on the augmentation of heroin seeking induced by 
chronic food restriction, active and inactive lever responses were analyzed separately using a 
two-way ANOVA with the between subjects factors of feeding condition (FDR, sated) and SCH 
39166 dose (0.0,12.5, 25.0, 50.0 ng/side). Statistically significant main effects and interactions 
were followed by post hoc tests with Bonferroni corrections. Statistically significant results are 








CHAPTER 4: A ROLE FOR LEPTIN AND GHRELIN IN THE AUGMENTATION OF 
























Caloric restriction increases the risk of relapse in abstinent drug users. Similarly, in an animal 
model of relapse we have found that chronic food restriction augments heroin seeking during 
withdrawal, but the neural mechanisms are not fully elucidated. Hormones involved in the 
regulation of energy balance and food intake, such as leptin and ghrelin, are implicated in drug-
related behaviors. Thus, we investigated the role of leptin and ghrelin in the augmentation of 
heroin seeking induced by chronic food restriction. Rats self-administered heroin for 10 days 
followed by 14 days of drug withdrawal. During this time some of the rats were food restricted to 
90% of their original body weight while others were given free access to food. In Experiment 1 
we measured the plasma concentrations of leptin and ghrelin following heroin self-
administration and withdrawal. As expected, chronic food restriction significantly decreased 
plasma levels of leptin and elevated plasma levels of ghrelin. Next, in Experiment 2, leptin was 
administered centrally (0.0, 2.0, or 4.0 μg; i.c.v.) prior to a heroin-seeking test under extinction 
conditions. Surprisingly, central administration of leptin had no statistically significant effect on 
heroin seeking. Dopamine neurons in the ventral tegmental area (VTA) express a high density of 
both leptin and ghrelin receptors, suggesting a direct effect on reward and motivation. Hence, we 
administered leptin (Experiment 3; 0.000, 0.125, or 0.250 μg/side) or the ghrelin receptor 
antagonist JMV 2959 (Experiment 4; 0.0, 2.0, 10.0 μg/side) directly into the VTA prior to the 
heroin-seeking test. Intra-VTA administration of leptin (Experiment 3) and JMV 2959 
(Experiment 4) both dose-dependently decreased heroin seeking specifically in the food-
restricted rats. We conclude that leptin and ghrelin transmission in the VTA modulates the 
augmentation of heroin seeking induced by chronic food restriction. Subsequent studies will 
investigate if this is a result of direct interactions with the mesolimbic dopamine pathway in the 
VTA.  






 Dependent drug users are characterized by compulsive drug seeking, and cycling through 
stages of drug use, abstinence, and relapse (O'Brien, 1997; O'Brien & McLellan, 1996). The 
biggest obstacle in breaking this cycle of drug addiction is relapse, especially in heroin users. In 
dependent heroin users followed for three decades, 25% had relapsed even after 15 years of 
abstinence (Hser et al., 2001). Relapse to drug use is triggered by three factors: 1) exposure to 
the self-administered drug (de Wit, 1996), 2) cues associated with drug availability and drug 
effects (Carter & Tiffany, 1999; Childress et al., 1993), and 3) stress (Sinha, 2001). 
 These triggers to relapse are modulated by restricted food intake, or caloric restriction. 
For example, the risk for relapse in abstinent smokers was remarkably higher when subjects 
underwent concurrent caloric restriction (Hall et al., 1992). The effects of caloric restriction on 
increased drug seeking is also evident in animal models of relapse. We found that chronic food 
restriction during two weeks of drug withdrawal will augment heroin seeking in rats that 
previously self-administered heroin (D'Cunha et al., 2013).  
 The neural mechanisms underlying the augmentation of heroin seeking induced by 
chronic food restriction are not fully elucidated.  Recently, we have demonstrated that dopamine 
(DA) in the mesolimbic pathway plays a key role in the augmentation of heroin seeking induced 
by chronic food restriction. Specifically, chronic food restriction increased levels of extracellular 
DA in the nucleus accumbens and blocking DA receptors in the nucleus accumbens reduced the 
augmentation of heroin seeking induced by chronic food restriction.  
Dopamine in the mesolimbic pathway is modulated by the hormones leptin and ghrelin, 
which regulate food intake and energy homeostasis (Abizaid et al., 2006; Hommel et al., 2006). 
Leptin is released by peripheral adipocytes (Friedman & Halaas, 1998), and central 
administration of leptin decreases food intake and increases energy expenditure (Ahima et al., 
2000). Additionally, central administration of leptin attenuates the reinstatement of heroin 
seeking induced by acute food deprivation (Shalev, Yap, et al., 2001). Moreover, leptin receptors 
can be found in the mesolimbic dopamine pathway, particularly in the ventral tegmental area 
(VTA; Fulton et al., 2006). Intra-VTA leptin reduces cocaine-induced dopamine (DA) release in 
the mesolimbic pathway terminals, specifically in the nucleus accumbens (NAc), and decreases 
the expression of cocaine conditioned place preference, suggesting an attenuation in cocaine 
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reward (You et al., 2016). Taken together, the findings described above suggest that leptin is a 
likely modulator of the augmentation of heroin seeking induced by chronic food restriction. 
 Ghrelin is released by the gut and binds to the growth hormone secretagogue receptor 
(GHS-R1a; Kojima et al., 1999). Plasma ghrelin is elevated during food restriction and rapidly 
decreases following meal intake (Toshinai et al., 2001). As with leptin, the effects of ghrelin 
extend beyond energy balance and food intake and can affect drug use and drug seeking. Central 
administration of ghrelin increases alcohol intake (Jerlhag et al., 2009), and increases the 
breakpoint for heroin under a progressive ratio schedule of reinforcement (Maric, Sedki, 
Ronfard, Chafetz, & Shalev, 2012). Like leptin, ghrelin receptors are abundant in the VTA of the 
mesolimbic pathway, and the VTA is a target for ghrelin as shown in binding studies (Abizaid et 
al., 2006).  Ghrelin in the VTA increases DA neuronal activity, and intra-VTA infusions of 
ghrelin increase food intake in rats (Abizaid et al., 2006). Therefore, ghrelin may mediate heroin 
seeking induced by chronic food restriction.  
The current study was designed to elucidate the role of leptin and ghrelin in chronic food 
restriction-induced augmentation of heroin seeking. In experiment 1 we characterized basal 
plasma levels of circulating leptin and ghrelin in sated and food restricted rats, as well as changes 
in their levels following re-feeding. Moreover, since it is demonstrated that ghrelin levels 
fluctuate throughout the day, and peak prior to meals (Drazen, Vahl, D'Alessio, Seeley, & 
Woods, 2006), we wanted to assess if the increase in plasma ghrelin, that usually accompanies 
the onset of the dark phase, would be shifted in the chronically food restricted rats to precede 
their daily meal that was delivered in the middle of the dark phase. Next, in experiment 2 we 
tested the hypothesis that centrally administered leptin will attenuate food restriction-induced 
augmentation of heroin seeking. As a follow-up to experiment 2, in experiment 3, we selectively 
targeted leptin receptors in the VTA to elucidate their involvement on heroin seeking. Finally, 
experiment 4 examined whether ghrelin receptors (GHS-R1a) in the VTA are involved in the 
augmentation of heroin seeking induced by chronic food restriction.  
Materials and Methods  
Subjects 
A total of 206 rats (325-350 g on arrival; Charles River, St. Constant, Quebec, Canada or 
Raleigh, North Carolina, USA) were used in the 4 experiments. Rats were pair-housed in clear 
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shoebox cages and allowed 1 week to acclimate to the animal colony prior to undergoing any 
surgical procedures. Rats were kept on a reverse 12 h light-dark cycle (lights OFF 9:30 am) at 
21°C. Following recovery from surgery (described below) rats were individually housed in 
operant conditioning chambers with free access to food and water during heroin self-
administration. At the end of heroin self-administration phase rats were returned to the animal 
colony for the withdrawal and food restriction phase (described below). On the last day of the 
withdrawal phase rats were brought back to the operant conditioning chambers for the heroin-
seeking test. All animals were treated in accordance with the guidelines of the Canadian Council 
on Animal Care and the approval for all procedures was granted by the Concordia University 
Animal Research Ethics Committee.  
Surgical procedures 
 Intravenous catheterization was completed under ketamine and xylazine (90.0 and 13.0 
mg/kg, ip) anaesthesia as previously described (D'Cunha et al., 2013). Briefly, silastic catheters 
(Dow Corning, Midland, MI, USA) were inserted into the right jugular vein and secured with 
silk sutures. During the intravenous catheter surgery rats were also implanted with either a 
unilateral guide cannula (23 gauge; Plastics One, Roanoke, VA) aimed 2 mm above one of the 
lateral ventricles: AP = -0.5 mm, ML = ± 1.4 mm, DV = -3.0 mm relative to Bregma 
(Experiments 1A and 1B), or bilateral guide cannulae (23 gauge) targeting the VTA (coordinates 
relative to Bregma): AP = -5.8 mm, ML = ±2.2 mm, DV = -7.5 mm with a 12° angle. Following 
surgery rats were given penicillin (450,000 IU/rat, sc) and analgesic ketoprofen (5.0 mg/kg, sc; 
CDMV, Quebec, Canada). Throughout self-administration rats were flushed daily with heparin 
and gentamicin in sterile saline (7.5 IU + 12.0 µg per day per rat) to prevent catheter blockage. 
Following recovery from surgery in experiment 2, intracerebroventricular (i.c.v.) guide cannula 
placement was verified by demonstrating a short latency (< 60 s) vigorous drinking response to 
angiotensin II (100.0 nmol, i.c.v.). 
Apparatus 
Experiments were conducted in operant conditioning chambers (Coulbourn Instruments, 
Whitehall, PA, USA; 29.0 cm × 29.0 cm × 25.5 cm), placed in individual sound-attenuating 
cubicles. Each chamber contained two retractable levers located 9.0 cm above the grid floor. 
 Responses on the ‘active’ lever activated the infusion pump (Coulbourn Instruments), 
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whereas responses on the ‘inactive’ lever were recorded but had no programmed consequences. 
Rats were attached to the infusion pump via a liquid swivel (Lomir Biomedical, QC, Canada) 
and Tygon tubing shielded with a metal spring. 
Drugs 
 Heroin (diacetylmorphine HCl; National Institute on Drug Abuse, Baltimore, MD, USA) 
was dissolved in physiological saline and delivered at a concentration of 0.1 mg/kg per infusion. 
Recombinant murine leptin (Peprotech; Roanoke, VA) was dissolved in sterile water to 
concentrations of 0.25, 0.50, 1.0, or 2.0 µg/µl. Doses of hormone administered were based on 
previous reports (Fulton et al., 2000; Shalev, Yap, et al., 2001; You et al., 2016). GHS-R1a 
antagonist JMV 2959 (EMD Millipore, Billerica, Massachusetts, USA) was dissolved in 0.9% 
sterile saline to a concentration of 4.0 or 20.0 µg/µl. Administered doses were based on previous 
work (Skibicka et al., 2011).  
Procedure 
Experiments 2-4 all consisted of 3 phases: heroin self-administration, withdrawal and 
food restriction, and finally the heroin-seeking test. 
Training 
 Following recovery from surgery rats were housed in the operant conditioning chambers 
for a 24-h habituation period and 10 days of heroin self-administration training. Rats were given 
three 3-h training sessions per day separated by a 3 h period under a fixed interval (FI) 20 s 
schedule of reinforcement. The first self-administration session started at the onset of the dark 
phase and was marked by the insertion of both levers, the illumination of a red houselight and the 
activation of a white-light/tone complex cue (2.9 kHz; 10 dB above background level) above the 
active lever. The white-light/tone complex remained on for 30 s or until the active lever was 
pressed. A response on the active lever resulted in the activation of the infusion pump (5 s; 0.13 
ml/infusion) and the white-light/tone complex, and the houselight was turned off. Subsequent 
responses on the active lever for the following 20 s were recorded but not reinforced. Responses 
on the inactive lever had no programmed consequences. At the end of each 3 h session, the 
active lever was retracted and the houselight was turned off. To help with lever discrimination, 
the inactive lever remained extended until 1 h before the 1st session on the following day.  
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Withdrawal and Food Restriction 
 After the heroin self-administration training, rats were transferred back to the animal 
colony and individually housed throughout the withdrawal period. Following a 24 h drug 
washout period, rats were matched for average number of infusions, active lever responses, and 
body weight during the last 5 days of training and assigned to either the food restricted (FDR) or 
sated group. FDR rats were given approximately 15 g of standard rat chow daily at 1:30 pm. The 
food ration was titrated daily to bring the FDR rats to 90% of their original body weight at the 
beginning of the withdrawal period. 
Intracranial Injections 
Intracranial injections were made using a syringe pump (Harvard Apparatus, Holliston, 
MA, USA) connected to a 10 µl Hamilton syringe. The syringe was attached via polyethylene-20 
tubing to a 28-gauge injector (Plastics One) that extended either 2 mm beyond the guide cannula 
in experiment 2, or 1 mm beyond the guide cannula in experiments 3 and 4. In all experiments 
rats received mock injections on the 2 days preceding the heroin-seeking test to habituate them to 
the procedure. For mock injections the syringe pump was run for 1 minute, and short injectors, 
not extending beyond the guide cannulae, were inserted into the guide cannula. No solution was 
administered during the mock injections to minimize tissue damage in the target region.  
Experiment 1: Characterization of plasma levels of leptin and acylated ghrelin following chronic 
food restriction and re-feeding 
 Blood was collected from a separate group of rats that underwent a similar procedure of 
heroin self-administration for 10 days, 14 days of withdrawal and food restriction, and a heroin-
seeking test. A small nip was made at the tip of the tail, and blood was collected in Eppendorf 
tubes which contained 20 μl of heparin per 1 ml of blood collected. Plasma concentration levels 
of leptin and ghrelin were repeatedly quantified over time in food restricted and sated rats. At the 
onset of the dark phase (9:30 am), a baseline measure of blood was collected in chronically food 
restricted and sated rats. Next, rats that were food restricted were allowed 2 h of free access to rat 
chow in their home cage, followed by another tail blood collection from both 2 h re-fed and sated 
rats. Finally, 24 h following ad libitum access to food, a third and final tail blood collection was 
taken from the 24 h re-fed and sated rats. Since it was previously demonstrated that acylated 
ghrelin levels change throughout the day and peak prior to meal time (Drazen et al., 2006), in 
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another group of rats we also assessed plasma fluctuations of acylated ghrelin. First sample was 
collected at the onset of the dark phase (9:30 am), then again prior to the chronically food 
restricted rats’ meal time (1:30 pm), and lastly at the onset of the light phase (9:30 pm) in both 
chronically food restricted and sated rats. 
 Plasma was separated by centrifugation at 10,000 rpm for 10 minutes. Following 
centrifugation, blood plasma was aliquoted and stored at -80˚C until processed. To protect the 
acylated ghrelin molecule, 1.0 μl of 1.0 N HCl and 1.0 μl of the protease inhibitor 
phenylmethylsulfonyl fluoride (PMSF; Sigma-Aldrich) was added per 100 μl of blood plasma. 
Plasma leptin and ghrelin were determined in separate enzyme-linked immunosorbent assay 
(ELISA) kits (Millipore, MA, USA). The reported detection sensitivity for the ELISA kits was 
0.04 ng/ml for leptin and 7.9 pg/ml for acylated ghrelin. 
Experiment 2A: The effect of a single central administration of leptin on the augmentation of 
heroin seeking induced by chronic food restriction 
 On the 14th day of food restriction rats were injected with leptin (0.0 or 2.0 µg/rat, i.c.v.) 
approximately 30 min before the 3 h heroin-seeking test. Leptin was administered over 2 minutes 
at a rate of 1.0 µl/min and the injector was left in place for an additional 1 min. Sterile water was 
used as the vehicle.  
Experiment 2B: The effect of repeated central administration of leptin on the augmentation of 
heroin seeking induced by chronic food restriction 
 We have previously reported that 24 h of re-feeding the FDR rats eliminates the 
augmentation of heroin seeking induced by chronic food restriction (D'Cunha et al., 2013). 
Interestingly, in Experiment 1 in the current study we found a statistically significant increase in 
plasma leptin 24 h following re-feeding. Consequently, we wanted to investigate if we could 
mimic the re-feeding effects with leptin administration approximately 24 h and 30 min prior to 
the heroin-seeking test. Moreover, we have previously demonstrated that a similar repeated 
treatment with leptin was highly effective in blocking acute food deprivation-induced 
reinstatement of heroin seeking (Shalev et al. 2001). Rats received either 0.0, 2.0, or 4.0 µg of 
leptin into the ventricles on the 13th day of food restriction and the same dose on the 14th day of 
food restriction, approximately 22 h and 30 min prior to the 3 h heroin-seeking test, respectively. 
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Administration of leptin was identical to experiment 2A and sterile water was used as the 
vehicle.  
Experiment 3: The effects of intra-VTA leptin on the augmentation of heroin seeking induced by 
chronic food restriction 
 As previously mentioned there are leptin receptors located on neurons in the VTA of the 
mesolimbic dopamine pathway that modulate DA activity (Hommel et al., 2006). We suspected 
that i.c.v. administrated leptin affected mostly the hypothalamic nuclei around the 3rd ventricle, 
which are critically involved in the maintenance of energy balance, but may not be as important 
for the augmentation of heroin seeking induced by chronic food restriction. Therefore, the 
purpose of experiment 3 was to investigate the role of leptin administration directly into the 
VTA. Rats received a bilateral infusion of leptin (0.000, 0.125, 0.250 µg/side) into the VTA 
approximately 30 min prior to the heroin-seeking test on the 14th day of food restriction. Leptin 
was administered over 1 min at a flow rate of 0.5 µl/min. The injector was left in place for 1 min 
following each microinjection and sterile water was administered as the vehicle.  
Experiment 4: The effects of intra-VTA GHS-R1a antagonist, JMV 2959, administration on the 
augmentation of heroin seeking induced by chronic food restriction 
 On the 14th day of food restriction rats were administered the GHS-R1a receptor 
antagonist JMV 2959 (0.0, 2.0, or 10.0 µg/side) bilaterally into the VTA approximately 10 min 
prior to the 3 h heroin-seeking test. JMV 2959 was administered at a flow rate of 0.5 µl/min over 
1 min. Injector was left in place for an additional minute and 0.9% sterile saline was used as a 
vehicle.  
Histology 
 At the end of experiments 3 and 4 rats were euthanized with carbon dioxide and 
decapitated. Brains were fixed with 4% paraformaldehyde (Paxinos & Watson, 2005) solution 
for a week before being sliced in 40 µm coronal sections. Sections were then stained with cresyl 
violet and cannula placements were determined under a light microscope with reference to a 




 To characterize the changes of plasma levels of leptin and acylated ghrelin, separate 
mixed factorial analyses of variance (ANOVA) were used, with the between subjects factor of 
feeding condition (FDR, sated) and the within subjects factor of time (baseline, 2 h re-fed, 24 h 
re-fed, which correspond to the following sample times: 9:30 am, 1:30 pm, 9:30 pm). To assess 
the effects of leptin or JMV 2959 on the augmentation of heroin seeking induced by chronic food 
restriction, active and inactive lever responses made during the 3 h heroin-seeking test were 
analyzed separately using a two-way ANOVA with a between subjects factor of feeding 
condition (FDR, sated) and the second between subjects factor was either: experiment 2A leptin 
dose (0.0 or 2.0 µg/rat); experiment 2B leptin dose (0.0, 2.0, or 4.0 µg/rat); experiment 3 leptin 
dose (0.000, 0.125, 0.250 µg/side); experiment 4 JMV 2959 dose (0.0, 2.0, or 10.0 µg/side). 
Repeated measures ANOVAs were preceded by Mauchly’s sphericity test, and a Greenhouse-
Geisser correction was used when statistical significance was found. Statistically significant 
main effects and interactions are reported for p ≤ 0.05, and were followed up with post-hoc 
analyses with a Bonferroni correction.  
RESULTS 
All rats acquired reliable heroin self-administration behavior. Mean ± SEM number of 
infusions and number of active and inactive lever responses made on the last day of heroin self-
administration training for each experiment are shown in Table 4.1. For experiments 3 and 4, 102 
out of 120 rats had correct histological placements and were included in the analysis (Figure 
4.4). In all experiments, on test day the FDR rats were approximately 90% of their original body 
weight at the start of the withdrawal phase, or approximately 75% of the sated rats’ body weight 
(Table 4.1).  
Experiment 1: Characterization of plasma levels of leptin and acylated ghrelin following 
chronic food restriction and re-feeding 
 To assess the effects of chronic food restriction and re-feeding on plasma hormone levels, 
rats from a previous experiment that had an experience with heroin self-administration and food 
restriction were used. Following the heroin-seeking test, rats were maintained as either food 
restricted (FDR; n = 6) or sated (n = 6) and assessed for plasma hormone concentration levels at 
3 time-points.  
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 As seen in Figure 4.1A, plasma concentrations of leptin were significantly reduced in 
chronically food restricted rats (feeding condition, F (1,10) = 13.484, p = 0.004, η2 = 0.574). 
Plasma levels in FDR rats increased gradually following re-feeding (time, F (2,20) = 7.303, p = 
0.004, η2 = 0.337; feeding condition × time, F (2,20) = 4.397, p = 0.026, η2 = 0.203). Pairwise 
comparisons with a Bonferroni correction revealed that within the FDR rats, there was a trend 
difference for plasma leptin levels from baseline compared to 2 h following re-feeding (p = 
0.064), and a statistically significant increase from baseline to 24 h following re-feeding (p = 
0.003). There were no statistically significant changes in plasma leptin concentrations in the 
sated rats over time.  
For the analysis of plasma acylated ghrelin levels following re-feeding, Mauchly’s 
sphericity test was significant (p < 0.05), therefore data were analyzed using the Greenhouse-
Geisser correction. Plasma Ghrelin levels in FDR rats were higher than in sated rats but 
decreased rapidly following re-feeding (Figure 4.1B). The main effect of feeding condition was 
not statistically significant, although there was a large effect size, F (1,10) = 3.246, p = 0.102, η2 = 
0.245. The effect of feeding status on plasma ghrelin levels was reflected in the statistically 
significant main effect of time (F (2,20) = 19.859, p = 0.001, η2 = 0.490) and feeding condition × 
time interaction (F (2,20) = 10.688, p = 0.007, η2 = 0.264). Pairwise comparisons with a Bonferroni 
correction revealed that within the FDR rats, there was a statistically significant decrease in 
plasma acylated ghrelin levels from baseline compared to 2 h following re-feeding (p = 0.001) 
and to 24 h following re-feeding (p = 0.001). There were no statistically significant changes in 
plasma acylated ghrelin levels in the sated rats over time.  
For the analysis of changes in plasma acylated ghrelin levels at different time-points 
throughout the day, Mauchly’s Test of Sphericity was significant (p < 0.05), therefore data were 
analyzed using the Greenhouse-Geisser correction. As seen in Figure 4.1C plasma ghrelin levels 
were higher in FDR rats compared to the sated group (food restriction, F (1,10) = 37.822, p < 
0.001, η2 = 0.791). Plasma ghrelin levels in FDR rats fluctuated dramatically over time (time, F 
(2,20) = 25.263, p < 0.001, η2 = 0.366; food restriction × time, F (2,20) = 33.673, p < 0.001, η2 = 
0.488). Pairwise comparisons with a Bonferroni correction revealed that within the FDR rats, 
there was a statistically significant increase in ghrelin from the onset of the dark phase at 9:30 




Figure 4.1. Plasma concentrations of leptin and acylated ghrelin in chronically food restricted 
and sated rats. (A) Concentration of plasma leptin in food restricted (FDR; n = 6) and sated (n = 
6) rats under baseline conditions and following 2 h and 24 h of re-feeding the previously food 
restricted rats. # p = 0.003, 24 h re-feeding significantly higher than baseline within the FDR 
group. (B) Plasma concentration of acylated ghrelin in FDR (n = 6) and sated (n = 6) rats under 
baseline conditions and following 2 h and 24 h of re-feeding in the previously food restricted 
rats. & p = 0.001, FDR baseline significantly different from 2 h and 24 h re-feeding. (C) Plasma 
concentration of acylated ghrelin in FDR (n = 6) and sated (n = 6) rats at the onset of the dark 
phase (9:30 am), prior to meal time in the FDR group (1:30 pm) and at the onset of the light 
phase (9:30 pm). * p < 0.02, compared to 9:30 pm within the FDR group. @ p < 0.001, 
compared to 1:30 pm within the FDR group. 
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Table 4.1. Mean ± SEM of the number of infusions taken, and the number of active and inactive 
lever responses made on the last training day (9 h) in each experiment, as well as body weight 
for the FDR and sated rats on the 14th day of food restriction (the drug seeking test). 
 Mean ± SEM 
 Self-administration training day 10 Food-restriction day 14 










2A 36.10 ± 4.42 123.15 ± 31.36 9.15 ± 3.10 326.60 ± 4.93 447.00 ± 13.46 
2B 43.18 ± 6.44 139.13 ± 15.68 14.87 ± 4.02 322.61 ± 3.55 420.86 ± 6.21 
3 35.31 ± 2.59 110.71 ± 17.82 13.44 ± 2.60 323.96 ± 3.43 431.23 ± 6.74 





ghrelin from 1:30 pm to the onset of the light phase at 9:30 pm (p < 0.001). Plasma ghrelin levels 
at the onset of the dark phase at 9:30 am were also significantly higher than at the onset of the 
light phase at 9:30 pm, (p = 0.020). There were no statistically significant changes in plasma 
ghrelin levels in the sated rats.  
Experiment 2A: The effect of a single central administration of leptin on the augmentation of 
heroin seeking induced by chronic food restriction 
 The final analysis included 20 rats divided into 4 groups: FDR – 0.0 µg (n = 4), FDR – 
2.0 µg (n = 6), Sated – 0.0 µg (n = 4), Sated – 2.0 µg (n = 6). As seen in Figure 4.2A, overall the 
FDR groups pressed more on the active lever during the 3-hour heroin-seeking test compared to 
the sated groups (feeding condition, F (1,16) = 7.083, p = 0.017, η2 = 0.304). A single pre-test i.c.v. 
administration of leptin had no effect on active lever responses (leptin dose, F (1,16) = 0.244, p = 
0.628, η2 = 0.010), and there was no statistically significant interaction for feeding condition × 
leptin dose (F (1,16) = 0.010, p = 0.922, η2 = 0.000421).  
 Leptin injections resulted in a statistically significant increase in inactive lever responses 
(leptin dose, F (1,16) = 4.955, p = 0.041, η2 = 0.184). It should be noted that inactive lever 
responses were still much lower than active lever responses. There were no other significant 
effects observed for inactive lever responses during the heroin-seeking test (feeding condition, F 
(1,16) = 4.165, p = 0.058, η2 = 0.155; feeding condition × leptin dose (F (1,16) = 1.773, p = 0.202, η2 
= 0.066).  
Experiment 2B: The effect of repeated central administration of leptin on the augmentation of 
heroin seeking induced by chronic food restriction 
 The final analysis included 60 rats divided into 6 groups: FDR – 0.0 µg (n = 15), FDR – 
2.0 µg (n = 8), FDR – 4.0 µg (n = 8), Sated – 0.0 µg (n = 13), Sated – 2.0 µg (n = 7), Sated – 4.0 
µg (n = 9). As previously demonstrated, the FDR groups pressed significantly more on the active 
lever than the sated groups, (feeding condition, F (1,54) = 11.329, p = 0.001, η2 = 0.165; Figure 
4.2B). Although both feeding-condition groups showed a decrease in active lever responses 
following leptin administration, there was no statistically significant main effect of leptin dose (F 
(2,54) = 1.421, p = 0.250, η2 = 0.042) or an interaction of feeding condition × leptin dose (F (2,54) = 
0.153, p = 0.858, η2 = 0.0044). Inactive lever responses were not statistically significantly 




Figure 4.2. The effect of i.c.v. leptin injections on heroin seeking in food restricted (FDR) and 
sated rats. (A) Following a single leptin (2.0 μg) or vehicle administration, 30 min prior to the 
heroin-seeking test. (B) Leptin (2.0 or 4.0 μg) or vehicle injections were given twice, 24 h and 30 
min prior to the heroin-seeking test. * p < 0.05, compared to the sated groups.   
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 (F (2,54) = 0.931, p = 0.401, η2 = 0.030) or interaction of feeding condition × leptin dose (F (2,54) = 
2.020, p = 0.142, η2 = 0.066). 
 Although repeated administration of leptin into the ventricles had no statistically 
significant effect on heroin seeking, it was not due to a lack of efficacy of leptin. As seen in 
Figure 4.3, both 2.0 µg and 4.0 µg of leptin administered on FDR 13 and FDR 14 significantly 
reduced 24 h food intake in the sated rats as compared to vehicle. A one-way ANOVA 
performed on FDR 14 food consumption data, revealed a main effect of leptin dose (F (2,26) = 
5.006, p = 0.014, η2 = 0.278). Post-hoc analyses with Bonferroni corrections revealed that both 
the Sated – 2.0 µg and the Sated – 4.0 µg groups consumed less food than the Sated – 0.0 µg 
group (p = 0.034, p = 0.055, respectively). Similarly, a one-way ANOVA performed on FDR 15 
food consumption data (~24 h after the last leptin injection) revealed a statistically significant 
main effect of leptin dose (F (2,26) = 5.665, p = 0.009, η2 = 0.304). Post-hoc analyses with 
Bonferroni corrections revealed that both the Sated – 2.0 µg and the Sated – 4.0 µg groups 
consumed less food than the Sated – 0.0 µg group (p = 0.031, p = 0.027, respectively).   
Experiment 3: The effect of intra-VTA leptin administration on the augmentation of heroin 
seeking induced by chronic food restriction 
Only rats with correct cannula placements located in the VTA were included in the 
statistical analysis (Figure 4.4A). The final analysis included the following groups of rats: FDR – 
0.000 µg (n = 9), FDR – 0.125 µg (n = 8), FDR – 0.250 µg (n = 9), Sated – 0.000 µg (n = 9), 
Sated – 0.125 µg (n = 9), and Sated – 0.250 µg (n = 8).  
Food restriction augmented heroin seeking on test day, as indicted by the higher number of 
active lever responses compared to the sated rats (feeding condition, F (1,46) = 21.181, p < 0.001, 
η2 = 0.261). Intra-VTA leptin injections reversed the food restriction effect, without changing 
drug seeking in the sated groups (leptin dose F (2,46) = 1.688, p = 0.196, η2 = 0.042; food 
restriction × leptin, F (2,46) = 5.328, p = 0.008, η2 = 0.131; Figure 4.5). Post-hoc analyses with 
Bonferroni corrections revealed that the FDR – 0.000 µg had statistically significantly more 
active lever presses than all of the sated groups during the heroin-seeking test (p < 0.002). 
Furthermore, the FDR – 0.000 µg group had significantly more active lever presses than the FDR 




Figure 4.3. The effects of i.c.v. administration of leptin on food intake in sated rats. Leptin (2.0 
or 4.0 μg) or vehicle was injected twice, once on day 13, and again on day 14 of withdrawal 
approximately 30 min before the heroin-seeking test. * p < 0.05 compared to either the 2.0 or 4.0 




statistically significant effects on inactive lever responses (feeding condition, F (1,46) = 1.158, p = 
0.288, η2 = 0.021; leptin dose F (2,46) = 1.802, p = 0.176, η2 = 0.066; food restriction × leptin, F 
(2,46) = 1.783, p = 0.180, η2 = 0.066).  
Experiment 4: The effects of intra-VTA ghrelin receptor antagonist (JMV 2959) 
administration on the augmentation of heroin seeking induced by chronic food restriction 
 Only rats with correct cannula placements located in the VTA as assessed by histological 
verification were included in the final statistical analyses (Figure 4.4B). The final analyses 
included the following groups of rats: FDR – 0.0 µg (n = 9), FDR – 2.0 µg (n = 8), FDR – 10.0 
µg (n = 9), Sated – 0.0 µg (n = 8), Sated – 2.0 µg (n = 8), and Sated – 10.0 µg (n = 8). Food 
restriction significantly augmented heroin seeking, as the FDR groups pressed more on the active 
lever than the sated groups (feeding condition, F (1,44) = 8.834, p = 0.005, η2 = 0.140; Figure 4.6). 
Intra-VTA injections of JMV 2959 reversed the food restriction effect, without affecting drug 
seeking in the sated groups (JMV 2959 dose, F (2,44) = 1.116, p = 0.337, η2 = 0.048; feeding 
condition × JMV 2959 dose, F (2,44) = 4.095, p = 0.023, η2 = 0.129). Post-hoc analyses with 
Bonferroni corrections revealed that the FDR – 0.0 µg group had significantly more active lever 
presses than the Sated – 0.0 µg (p = 0.009), the Sated – 2.0 µg (p = 0.015) and the FDR – 10.0 
µg (p = 0.046) groups. Analysis of the inactive lever responses found only a significant effect of 
JMV 2959 dose (F (2,44) = 3.45, p = 0.041, η2 = 0.136), driven by an overall increase in inactive 
lever response in rats treated with the 10.0 µg dose. There were no other significant effects 
observed for inactive lever responses during the heroin-seeking test (feeding condition, F (1,44) = 
0.003, p = 0.953, η2 = 0.0000638; feeding condition × JMV 2959 dose, F (2,44) = 1.936, p = 0.156, 
η2 = 0.071). 
DISCUSSION 
 The neural mechanisms involved in the augmentation of heroin seeking following 
chronic food restriction have yet to be elucidated. In the current study, as we have previously 
demonstrated (D'Cunha et al., 2013), chronic food restriction over a period of drug withdrawal 
significantly augmented heroin seeking in rats with a history of heroin self-administration. Our 
data demonstrate that i.c.v. administration of leptin, either as single or repeated infusions had no 
selective effect on food restriction-induced augmentation of heroin seeking.  Notably, although 





Figure 4.4. Cannula placements for Experiments 3 & 4. Approximate anatomical position for 
microinjector tips of guide cannula targeting the VTA for (A) Experiment 3 (n = 52; open 
circles) or (B) Experiment 4 (n = 50; open triangles). Images modified from the brain atlas of 







Figure 4.5. The effect of intra-VTA leptin injections on heroin seeking in food restricted (FDR) 
and sated rats. Leptin (0.125 or 0.250 µg/side) or vehicle was injected 30 min before the heroin-
seeking test. * p < 0.05, compared to sated - Vehicle rats. # p < 0.05, FDR – vehicle vs. FDR – 







Figure 4.6. The effect of intra-VTA injections of the ghrelin receptor antagonist, JMV 2959, on 
heroin seeking in food restricted (FDR) and sated rats. JMV 2959 (2.0 or 10.0 µg/side) or vehicle 
was injected 30 min before the heroin-seeking test.  * p < 0.05, FDR – Vehicle vs. Sated – 




dose of leptin (4.0 µg) attenuated overall heroin seeking with a considerable effect size (Vehicle 
vs. 4.0 µg leptin-treated rats: Cohen’s d = 0.61; 95%CI [-30.19, 31.4]). Most importantly, 
administration of leptin directly into the VTA decreased heroin seeking selectively in the FDR 
rats. Lastly, administration of the ghrelin receptor antagonist JMV 2959 directly into the VTA 
also selectively decreased heroin seeking in the FDR rats.  
We also found that, as expected, leptin and ghrelin levels in rats with a history of heroin 
self-administration are modulated by chronic food restriction. Taken together our results suggest 
that the changes in hormones levels may act directly in the VTA to alter heroin seeking induced 
by chronic food restriction.  
Changes in plasma concentrations of leptin and acylated ghrelin in the FDR and sated rats 
 We found that in agreement with previous reports (Johansson et al., 2008; Kinzig, 
Hargrave, & Tao, 2009), 14 days of chronic food restriction following 10 days of heroin self-
administration significantly decreased plasma leptin levels. Absolute basal levels of plasma 
leptin in the current study were higher than previously reported. Possible reasons for these 
discrepancies include acute food deprivation of sated rats prior to blood collection, differences in 
time of blood collection (light vs. dark phase in the current study), and lower body weight of the 
rats at baseline in the previous studies. Nevertheless, the pattern of change in plasma leptin levels 
that we recorded is consistent with the effects of chronic food restriction that were observed in 
earlier studies. In addition, plasma leptin levels significantly increased following 2 or 24 h of 
free access to chow. This was an unexpected finding as leptin is thought of as a long-term energy 
balance signal that is strongly correlated with the amount of adipose tissue (Friedman & Halaas 
1998).  
 Chronically food restricted rats also had significantly higher plasma acylated ghrelin 
levels compared to the sated rats, a finding that is consistent with previous reports (Abou Heif, 
Deif, & Abdel Aziz, 2009; Kinzig et al., 2009). In contrast, (Johansson et al., 2008) report no 
changes in plasma ghrelin following 12 days of food restriction.  Here again, discrepancies may 
be accounted for by differences in methodology, with samples collected during the light phase, 
and comparisons to acutely food deprived (12 h) control rats in the Johansson et al. (2008) study. 
We did not see a peak in plasma ghrelin, that was reported by Drazen et al. (2006), in the sated 
rats at the onset of the dark phase. This intriguing discrepancy could be the result of the plasma 
ghrelin analysis method that targeted acylated ghrelin in the current study, while no information 
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is available for the method used by Drazen et al. (2006). We did however observe that plasma 
ghrelin levels were the highest prior to the delivery of the daily meal in the FDR rats, similar to 
the findings reported by Drazen et al., (2006). Finally, re-feeding the previously food restricted 
rats for 2 h or 24 h statistically significantly decreased plasma ghrelin levels. We therefore have 
demonstrated a considerable modulation of circulating levels of leptin and ghrelin in our 
experimental subjects, that coincided with the augmentation of heroin seeking in FDR rats.  
Effects of central administration of leptin on heroin seeking in the FDR and sated rats 
  Contrary to our hypothesis, i.c.v. administration of leptin did not statistically 
significantly decrease heroin seeking in the FDR rats. These results contrast with our previous 
report that the same doses of leptin attenuated acute food deprivation-induced reinstatement of 
heroin seeking (Shalev, Yap, et al., 2001). There are a few possible reasons for these 
discrepancies. Acute food deprivation is defined as having no food available for a short duration 
of time (24 – 48 h), whereas chronic food restriction occurs over an extended period of time with 
limited food availability. Not only are there distinctions in the metabolic consequences between 
acute food deprivation and chronic food restriction (Bi, Robinson, & Moran, 2003), but the 
neural mechanisms impacted by these manipulations are distinct. For example, administration of 
a corticotrophin releasing factor (CRF) antagonist attenuated acute food deprivation-induced 
reinstatement of heroin seeking (Shalev, Finnie, Quinn, Tobin, & Wahi, 2006) but had no effect 
on food restriction-induced augmentation of heroin seeking (Sedki, Abbas, et al., 2013). Another 
explanation for the differences may be that the current study investigated heroin seeking 
following a withdrawal period, whereas Shalev and colleagues (2001) investigated reinstatement 
of heroin seeking following extinction training.  The neural mechanisms mediating these 
procedures are, at least partially, distinct (Fuchs, Branham, & See, 2006).  
 Our findings also disagree with the demonstration that leptin can reverse the sensitization 
of brain stimulation reward in the lateral hypothalamus that is induced by chronic food restriction 
(Fulton et al., 2000). In addition, acute central leptin decreases the breakpoint for sucrose self-
administration under a progressive ratio schedule of reinforcement (Figlewicz et al., 2006). 
However, both these reports found that leptin decreased ongoing rewarded behavior, either by 
brain stimulation or sucrose, while our procedure is assessing drug seeking under extinction 
conditions. Interestingly, intravenous leptin attenuated cocaine seeking under “surprising” 
extinction conditions (You et al., 2016). The discrepancy between our results and You and 
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colleagues (2016) could be explained by the different procedures used (prolonged withdrawal 
versus a “surprise extinction” during the self-administration phase, respectively), but this 
explanation seems unlikely given that intra-VTA leptin injections effectively attenuated drug 
seeking in both studies (see below). Alternative explanations could be the different classes of 
self-administered drugs (opiate versus psychostimulant drugs, respectively), or the somewhat 
different route of leptin administration (intravenous vs. i.c.v.). 
 Finally, the small effect for repeated leptin treatment on heroin seeking could be 
explained by an insufficient dose or reduced sensitivity of the rats in our study.  However, 
Experiment 2B argues against this possibility. It is well established that leptin reduces food 
intake in a variety of species (reviewed in Bruijnzeel, Corrie, Rogers, & Yamada, 2011; Halaas 
et al., 1997; Hommel et al., 2006; Morton, Cummings, Baskin, Barsh, & Schwartz, 2006). 
Accordingly, we have found that centrally administered leptin significantly reduced food intake 
in the sated rats; therefore, the minor effects on heroin seeking are not due to the efficacy of the 
leptin treatment.  
Effects of intra-VTA leptin administration on heroin seeking in FDR and sated rats 
 We demonstrated that intra-VTA leptin significantly decreased the augmentation of 
heroin seeking induced by chronic food restriction. Although leptin’s primary role is in the 
hypothalamus to regulate food intake and energy metabolism (Ahima et al., 2000), it also acts on 
extrahypothalamic targets, specifically the VTA to affect food intake and reward function 
(Bruijnzeel et al., 2011). Within the VTA there is a high level of leptin receptor expression 
located on dopaminergic neurons, with lower levels of expression on gamma-aminobutyric acid-
ergic (GABAergic) neurons (Figlewicz, 2003; Fulton et al., 2006; Hommel et al., 2006). Leptin 
administration to the midbrain in vitro and systemic administration in anesthetized rats in vivo 
both significantly decrease the firing rate of DA neurons in the VTA (Hommel et al., 2006). 
These inhibitory actions of leptin on VTA DA neurons are thought to be mediated through a 
change in the intrinsic properties of these neurons (Hommel et al., 2006), and by presynaptic 
inhibition of glutamatergic release onto DA neurons (Thompson & Borgland, 2013). More 
recently, Shen et al. (2016) reported that selective knockdown of leptin receptors in the VTA 
resulted in increased extracellular DA levels in the NAc. In addition, intra-VTA administration 
of leptin inhibited the increase in extracellular DA in the NAc induced by cocaine in rats (You et 
al., 2016), while i.c.v. injections of a leptin antagonist, superactive mouse leptin antagonist 
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(SMLA), resulted in upregulation of DA and its metabolites in the NAc in mice (Shen, Jiang, 
Liu, Wang, & Ma, 2016). Importantly, the leptin-signal driven changes in DA transmission 
described above were associated with altered reward-related behaviours. Thus, You and 
colleagues (2016) found that intra-VTA leptin decreased conditioned place preference for 
cocaine, and i.c.v. administration of a leptin receptor antagonist increased cocaine conditioned 
place preference (Shen, et al. 2016). We have recently identified a selective increase in 
extracellular DA levels in the NAc of food-restricted rats during heroin seeking tests (D'Cunha et 
al., 2017). Moreover, we have found that blocking DA D1-like receptors in the NAc decreased 
the augmentation of heroin seeking induced by chronic food restriction (D'Cunha et al., 2017). 
Taken together with the previous findings described above, our current findings suggest 
that chronic food restriction-induced reduction in plasma leptin levels results in a decrease in the 
inhibitory signal of leptin on VTA DA neurons’ activity and disinhibition of these neurons. This, 
in turn, would make the FDR rats more responsive to drug-associated cues, leading to increased 
dopaminergic transmission in the terminals of the mesolimbic pathway, such as the NAc 
(D'Cunha et al., 2017), and to augmented heroin seeking. Accordingly, when leptin is 
administered directly into the VTA of FDR rats it reduces DA neurons excitability, effectively 
attenuating the impact of re-exposure to the heroin-taking context and cues. It has been 
previously suggested that under food restriction the DA system becomes highly responsive to 
leptin and its effects on appetitive motivation (Fernandes et al., 2015). Such an adaptation would 
help explain why we only see decreased heroin seeking in the FDR, but not sated, rats following 
intra-VTA leptin administration.  
The same mechanism could explain our previous findings that acute re-feeding (2 or 24 h 
before testing) reversed the augmentation of heroin seeking in food-restricted rats (D'Cunha et 
al., 2017). Thus, as demonstrated here, re-feeding increases plasma leptin in FDR rats, which 
would result in reduced/normalized excitability of VTA DA neurons and a reduction in DA 
levels in the NAc, eventually leading to decreased heroin seeking. Interestingly, with both the re-
feeding and intra-VTA leptin injections approaches, heroin seeking was reduced to the level 
demonstrated by the sated rats, but not completely eliminated. This suggests a “ceiling effect” or 
a limit to the inhibitory signal of leptin in the VTA, maybe due to receptor saturation.  
 It is unclear why central administration and direct infusion of leptin into the VTA resulted 
in different behavioral responses. One possibility is that leptin administered into the ventricles is 
 78 
 
unable to reach the local levels for sufficient receptor activation in the VTA to trigger significant 
behavioral effects. We tested heroin seeking 30 minutes following i.c.v. leptin infusion, and 
although this is reported to be enough time for leptin to diffuse the distance from the ventricles to 
the VTA (Maness, Kastin, Farrell, & Banks, 1998), it is likely in very low concentrations. These 
low concentrations may be due to significant degradation of leptin by endogenous enzymes, or 
leptin may be removed with the turnover of cerebrospinal fluid. It is recommended that nuclei be 
in close proximity to the ventricles or relatively large amounts of leptin should be delivered to 
ensure that sufficient concentrations reach the target (Maness et al., 1998). Therefore, the 
majority of the leptin infused in the ventricles may be absorbed in nuclei closer to the ventricles 
such as the hypothalamus. If indeed most i.c.v. leptin targets the hypothalamic nuclei, we would 
predict that these nuclei play a minimal role in drug seeking as their primary function is to 
regulate feeding and energy homeostasis (Ahima et al., 2000). Although speculative, we would 
predict that intra-hypothalamic leptin administration would have little or no effect on heroin 
seeking in the FDR rats.  
Effects of blocking ghrelin receptors in the VTA on heroin seeking in FDR and sated rats 
 Administration of the ghrelin receptor antagonist, JMV 2959, into the VTA selectively 
decreased heroin seeking in chronically food-restricted rats, suggesting an important role for 
ghrelin receptors activation in the augmentation of heroin seeking induced by chronic food 
restriction. This contrasts with previous findings in our laboratory that central administration of a 
ghrelin receptor antagonist had no effect on heroin self-administration, or on the reinstatement of 
heroin seeking induced by acute food deprivation (Maric et al., 2012). This may be explained by, 
first, the use of different ghrelin receptor antagonists: Maric et al. (2012) used the GHS-R1a 
antagonist D-Lys3-GHRP-6, whereas here we used JMV 2959. Although both these antagonists 
block GHS-R1a, D-Lys3-GHRP-6 is a peptide-based antagonist (Traebert, Riediger, Whitebread, 
Scharrer, & Schmid, 2002), whereas JMV 2959 is a small molecule-type antagonist (Moulin et 
al., 2007). Direct comparison of these two compounds has demonstrated that D-Lys3-GHRP-6 
has higher selectivity in attenuating alcohol, compared to water and food intake, but tolerance 
rapidly developed to its effects (Gomez & Ryabinin, 2014). Second, Maric et al. (2012) 
administered the antagonist centrally, whereas in the current study we directly targeted the VTA. 
Finally, the neural adaptations associated with acute food deprivation, used in the previous study, 
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versus chronic food restriction, used in this study, are distinct (Bi et al., 2003); as are the 
differences between the neural mechanisms mediating the reinstatement of extinguished drug 
seeking versus drug seeking following drug withdrawal and abstinence (Fuchs et al., 2006). 
We propose that intra-VTA administration of JMV 2959 directly altered dopaminergic 
transmission in the downstream terminals of the mesolimbic circuit, consequentially affecting 
heroin seeking. It is well documented that ghrelin transmission in the VTA modulates DA 
activity in the mesolimbic pathway (Abizaid et al., 2006). Approximately 35-60% of neurons in 
the VTA that express GHS-R1a are dopaminergic, with the remainder being GABAergic 
(Abizaid et al., 2006; van Zessen, van der Plasse, & Adan, 2012). However, it seems that ghrelin 
also increases the activation of VTA DA neurons by increasing excitatory presynaptic 
glutamatergic input and decreasing inhibitory GABAergic input through rearrangement of the 
synaptic input (Abizaid et al., 2006). Since chronic food restriction increases plasma ghrelin 
levels, it is possible that this lowering of the activation threshold in VTA neurons could increase 
DA levels in the terminal regions of the mesolimbic pathway, such as the NAc, upon exposure to 
drug cues. Indeed, we have recently reported that FDR rats are more responsive to drug-
associated cues, leading to increased DA transmission in the NAc and augmented heroin seeking 
(D'Cunha et al., 2017). Therefore, we suggest that administration of JMV 2959 blocked this 
ghrelin-mediated increase in VTA DA firing rates, subsequently reducing DA levels in the NAc 
and heroin seeking in the FDR rats. This process would also explain why JMV 2959 had no 
effect on heroin seeking in the sated rats, which demonstrated lower levels of circulating ghrelin.  
It is tempting to speculate that chronic food restriction-induced changes in both leptin and 
ghrelin levels in the VTA, would lead to altered DA transmission in the VTA and downstream 
mesolimbic targets, following exposure to heroin-associated cues. These changes in leptin and 
ghrelin in the VTA may be directly linked to the dopaminergic changes that we have observed in 
the NAc of food restricted rats during the heroin-seeking test (D’Cunha et al., 2017). Future 
studies should investigate this putative link between leptin and ghrelin in the VTA and 
downstream regulation of DA in the NAc in chronically food restricted rats.  
An important consideration when interpreting the current results is that the ghrelin 
receptor, GHS-R1a, has constitutive activity (Holst, Cygankiewicz, Jensen, Ankersen, & 
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Schwartz, 2003; Holst & Schwartz, 2004). The physiological role of this activity remains 
unclear, although it is hypothesized to be related to ligand-independent release of growth 
hormone (Holst & Schwartz, 2004). One option to ensure that our results are mediated by 
interfering with the action of ghrelin on its receptor and not by blocking the constitutive activity 
of GHS-R1a would be to block ghrelin from activating the receptor by preventing the conversion 
to its active form. This approach has been successfully implemented, using a ghrelin-O-
acyltransferase (GOAT) inhibitor, which prevented the addition of the acyl functional group 
(Abizaid & Horvath, 2012). However, ghrelin acylation occurs in the gut and this technique 
would not be able to dissociate the central role of ghrelin from its peripheral effects. Importantly, 
recent evidence suggests that the GHS-R1a receptor antagonist that we used, JMV 2959, does 
not affect growth hormone secretion, yet effectively reduces ghrelin-induced food intake 
(M'Kadmi et al., 2015). These findings suggest dissociated pathways that are involved in ghrelin 
actions on its receptor and the constitutive activity of the GHS-R1a (M'Kadmi et al., 2015).  
Lastly, we did not observe an effect of intra-VTA JMV 2959 administration on heroin seeking in 
sated rats, suggesting that the constitutive activity of GHS-R1a in the VTA has no role in heroin 
seeking.  
Conclusion 
 Surprisingly, central administration of leptin did not significantly attenuate heroin 
seeking induced by chronic food restriction. However, intra-VTA leptin selectively reduced 
heroin seeking in chronically food restricted rats. Similarly, intra-VTA administration of the 
ghrelin receptor antagonist JMV 2959, also reduced heroin seeking in only the FDR rats. Taken 
together, these results indicate that chronic food restriction alters leptin and ghrelin transmission 
in the VTA, which then modify downstream activity in the mesolimbic dopamine pathway. 
Future studies will directly address if changes in leptin and ghrelin transmission modulate DA 








CHAPTER 5: THE ROLE OF GLUTAMATE IN THE AUGMENTATION OF HEROIN 


























Caloric restriction and limited food intake increases the risk of relapse during drug 
abstinence. Our laboratory has demonstrated a similar finding in an animal model of relapse, 
where chronic food restriction augments heroin seeking following prolonged withdrawal in rats 
that previously self-administered heroin. Moreover, food-restricted (FDR) rats have elevated 
extracellular dopamine (DA) levels in the nucleus accumbens (NAc), and administration of a DA 
D1 receptor antagonist into the NAc decreased heroin seeking in the FDR rats. The NAc receives 
a multitude of glutamatergic innervations from a variety of brain regions, and dopamine can 
modulate glutamatergic activity in the NAc. Therefore, in this study we investigated extracellular 
levels of glutamate in the NAc subregions of the shell and core during ongoing heroin seeking. 
Next, we investigated the role of AMPA receptors in the augmentation of heroin seeking induced 
by chronic food restriction. First, rats were trained to self-administer heroin for 10 days. Rats 
were then moved to the animal colony for 14 days of drug withdrawal. During this time some 
rats were given unrestricted access to food and others were subjected to a mild chronic food 
restriction until they reached approximately 90% of their original body weight. On the 14th day 
of food restriction rats were returned to the operant conditioning chambers for a heroin-seeking 
test under extinction conditions. Extracellular glutamate in the NAc was assessed using in vivo 
microdialysis during baseline conditions and during the 3h heroin-seeking test. Food restriction 
significantly augmented heroin seeking compared to the sated rats. There were no significant 
changes in extracellular glutamate levels between the FDR and sated rats. Bilateral 
administration of the AMPA receptor antagonist NBQX (0.0, 0.3, 1.0 μg/side) into either the 
NAc shell or core had no statistically significant effect on heroin seeking, however it may have 
reduced heroin seeking in the sated rats, particularly following intra-NAc core injections. Taken 
together, these results suggest that glutamate transmission in the NAc through AMPA receptors 
is not involved in the augmentation of heroin seeking induced by chronic food restriction. Future 
studies will investigate if NMDA or metabotropic glutamate receptors play a role in food-
restriction induced augmentation of heroin seeking.  
 





 Even after decades of drug abstinence, over a quarter of heroin addicts relapsed back to 
drug use (Hser et al., 2001). Dependent drug users cycle through phases of drug use, abstinence, 
and relapse (O'Brien, 1997; O'Brien & McLellan, 1996), with relapse being the biggest obstacle 
to overcome. Exposure to the self-administered drug (de Wit, 1996), cues associated with drug 
availability (Carter & Tiffany, 1999; Childress et al., 1993), and stress (Sinha, 2001) are the 
major factors that trigger drug craving and subsequent relapse. These three triggers are also 
modulated by dietary manipulations such as caloric restriction. 
 Caloric restriction, or food restriction, increases both drug craving and drug seeking, 
leading to eventual relapse to drug use. For example, abstinent smokers undergoing a concurrent 
dietary program under caloric restriction reported higher rates of drug craving and relapse 
compared to non-restricted subjects (Hall et al., 1992). Similar findings on the effects of caloric 
restriction in animal models of relapse have also been validated. We have demonstrated that 
chronic food restriction during drug withdrawal will augment heroin seeking in rats with a 
history of heroin self-administration (D'Cunha et al., 2013). 
 Recently, we have established that dopamine (DA) in the nucleus accumbens (NAc), a 
terminal target region of the mesolimbic pathway, is critically involved in the augmentation of 
heroin seeking induced by chronic food restriction. Extracellular DA levels in both the NAc 
subregions, the shell and core, were significantly elevated during heroin seeking in the food 
restricted (FDR) rats (D'Cunha et al., 2017). Furthermore, administration of the DA D1 receptor 
antagonist SCH 39166 into the NAc shell generally decreased heroin seeking, whereas 
administration into the NAc core selectively decreased heroin seeking in the FDR rats. These 
results suggest that activation of the DA D1-like receptors in the NAc core is important for food 
restriction-induced augmentation of heroin seeking. 
 In addition to the DAergic afferents into the NAc, the NAc receives a multitude of 
glutamatergic afferents from a variety of brain regions (Brog et al., 1993). Previous work has 
demonstrated that these dopaminergic inputs can interact with glutamatergic activity in the NAc 
(Yagishita et al., 2014). Therefore, it is possible that glutamatergic and dopaminergic inputs into 
the NAc may interact to mediate heroin seeking.  
There is also ample evidence that glutamatergic transmission in the mesolimbic circuit, 
specifically the NAc, is critically involved in drug seeking. For example, presentation of an odor 
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previously paired with cocaine availability increased extracellular glutamate levels in both the 
NAc core and shell (Suto et al., 2013), and extracellular glutamate concentrations were also 
elevated in the NAc core during cue-induced reinstatement of heroin seeking (LaLumiere & 
Kalivas, 2008). Moreover, reducing evoked glutamate release in both the NAc core and shell 
significantly attenuated context-induced reinstatement of heroin seeking (Bossert, Gray, Lu, & 
Shaham, 2006). Taken together, these findings suggest that glutamate transmission in the NAc 
may be involved in the augmentation of heroin seeking induced by chronic food restriction.  
 To test this hypothesis, we first measured fluctuations in extracellular levels of glutamate 
in the NAc core and shell during ongoing heroin seeking in both FDR and sated rats. Next, to 
assess the role of glutamate receptors in the NAc core and shell, we administered the α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist NBQX prior to the 
test for heroin seeking.  
MATERIALS AND METHODS  
Subjects 
Male Long Evans rats (n = 160; Charles River, Raleigh, North Carolina, USA) weighing 
between 325 – 350 g upon arrival were used in four different experiments. Rats were pair-housed 
in clear Plexiglass cages and allowed one week to habituate to the animal colony. Rats were kept 
under reverse 12 h light-dark cycle (lights OFF 9:30am) at 21°C. Following recovery from 
surgery (described below) rats were individually housed in operant conditioning chambers with 
ab libitum access to food and water during heroin self-administration. 
At the completion of heroin self-administration training, rats were returned to the animal 
colony for the withdrawal and food restriction phase (described below). Prior to in vivo 
microdialysis sampling, rats were housed in clear Plexiglass chambers with a grid floor for 
baseline sampling prior to the heroin-seeking test (described below). Following baseline 
microdialysis collection rats were transferred back to the operant conditioning chambers for the 
heroin-seeking test. Rats in the experiments with the AMPA receptor antagonist were brought to 





 Rats were implanted with an intravenous catheter under ketamine and xylazine (90.0 and 
13.0 mg/kg, ip) anesthesia, as previously described (D'Cunha et al., 2013). Silastic catheters 
(Dow Corning, Midland, MI, USA) were inserted into the right jugular vein and secured in place 
with silk sutures. The other end of the catheter was subcutaneously guided to the rat’s head 
where it was attached to a modified 22-gauge cannula (Plastics One, Roanoke, VA) which was 
mounted to the rat’s skull using jeweller’s screws and dental cement. Following surgery rats 
were given penicillin (450 000 IU/rat, sc) and the analgesic ketoprofen (5.0 mg/kg, sc; CDMV, 
Quebec, Canada). Throughout heroin self-administration training rats were flushed daily with 
heparin and gentamicin in sterile saline (7.5 IU + 12.0 µg per day per rat) to prevent catheter 
blockage.  
Intracranial surgery 
 For the microdialysis experiments, rats were also implanted with a unilateral guide 
cannula targeting one of the following regions (coordinates relative to Bregma): nucleus 
accumbens (NAc) shell AP: +1.6 mm, ML: ±1.5 mm, DV: -5.0 mm (Experiment 1); NAc core 
AP: +1.6 mm, ML: ±1.0 mm, DV: -4.5 mm (Experiment 2). Cannulae were mounted adjacent to 
the modified catheter cannula on the skull using jeweller’s screws and dental cement. Cannula 
placements were counterbalanced between right and left hemispheres.  
 For the AMPA receptor antagonist experiments, in addition to the intravenous catheter, 
rats were implanted with bilateral guide cannula targeting one of the following regions 
(coordinates relative to Bregma): NAc shell AP: +1.7 mm, ML: ±3.7 mm, DV: -4.8 mm, 20° 
angle (Experiment 3); or NAc core AP: +1.8 mm, ML: ±2.5 mm, DV: -4.5 mm, 6° angle.  
Apparatus 
 Operant conditioning chambers (Med Associates Inc., St. Albans, VT or Coulbourn 
Instruments, Holliston, MA) were used for heroin self-administration training and the heroin-
seeking tests. Operant conditioning chambers were located within a sound-attenuating cubicle, 
and each chamber contained two levers located 5.0 cm above the grid floor. Responses on the 
‘active’ lever activated the infusion pump (Med Associates). Conversely, responses on the 
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‘inactive’ lever were recorded but had no programmed consequences. Prior to in vivo 
microdialysis baseline sampling rats were habituated to a neutral clear Plexiglass chamber (30 × 
28 × 25 cm) with a grid floor in the animal facility.  
Drugs 
 Heroin (diacetylmorphine HCl; National Institute on Drug Abuse, Baltimore, MD, USA) 
was dissolved in physiological saline and delivered at a concentration of 0.1 mg/kg per infusion. 
The AMPA receptor antagonist NBQX (2,3-dioxo-6-nitro-1,2,3,4-
tetrahydrobenzo[f]quinoxaline-7-sulfonamide) disodium salt (Abcam, Cambridge, MA, USA) 
was diluted in sterile saline to produce the following doses: 0.0, 0.3, 1.0 µg/side. These doses 
were previously shown to reduce cue-induced alcohol seeking (Sciascia, Reese, Janak, & 
Chaudhri, 2015). 
Procedure 
Experiments consisted of 3 main phases: heroin self-administration training in the 
operant conditioning chambers, withdrawal and food restriction in shoebox cages in the animal 
facility, and a heroin-seeking test in the operant conditioning chambers. 
Training 
 Rats were habituated to the operant conditioning chambers for 24 h prior to the 10 days 
of heroin self-administration training. Rats underwent 3-3 h sessions of self-administration 
separated by a 3 h period under a fixed interval (FI) 20 s schedule of reinforcement. The 
initiation of the self-administration session began with the onset of the dark phase and the 
insertion of the active lever, illumination of the houselight, and activation of a compound tone 
(2.9 kHz, 10 dB above background noise) and light cue above the active lever, that remained on 
for 30 s or until the active lever was pressed. Responses on the active lever resulted in the 
delivery of 0.1 mg/kg infusion of heroin in a volume of 0.13 ml over 12 s. Once the active lever 
was pressed it resulted in the initiation of the tone-light cue for 20 s and the houselight was 
turned off. Any additional responses on the active lever during that 20-s interval were recorded 
but not reinforced. At the end of each 3 h session, the active lever was retracted and the 
houselight was turned off.  
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Withdrawal and Food Restriction 
 Following heroin self-administration training, rats were transferred back to the animal 
facility for 24 h of drug wash-out. Rats were matched for body weight, infusions, and active 
lever presses over the last 5 days of training and assigned to either the food restricted (FDR) or 
sated group. FDR rats were given approximately 15.0 g of rat chow daily at 1:30 pm and the 
food ration was adjusted daily to bring the FDR group to approximately 90% of their body 
weight at the start of the withdrawal period.  
In vivo Microdialysis and Heroin-Seeking Test (Experiments 1 & 2) 
 Two days prior to the heroin-seeking test, on the 12th day of food restriction, rats were 
habituated to a neutral clear Plexiglass chamber. Approximately 14 h prior to testing, on the 13th 
day of food restriction, microdialysis probes were lowered into the targeted brain region under 
light isoflurane anesthesia. Probes were made in the laboratory and had either a 2.0 mm 
(Experiment 1) or 1.5 mm (Experiment 2) semipermeable active membrane. To prevent 
occlusion, probes were continually perfused with artificial cerebrospinal fluid (aCSF; 145 mM 
NA+, 2.7 mM K+, 1.22 mM Ca2+, 1.0 mM Mg2+, 150 mM Cl-, 2 mM Na2PO4, pH 7.4 ± 0.1) at 
1.0 µl/min for 1 h. The flow rate was then lowered to 0.2 µl/min overnight and returned to 1.0 
µl/min on the 14th day of food restriction approximately 1 h prior to baseline sample collection.  
 At 8:10 am baseline dialysate sample collection began, and samples were collected every 
10 min thereafter. At 9:30 am rats were transported in the clear Plexiglass chambers from the 
animal facility to the heroin self-administration room. Microdialysis pumps were plugged into a 
battery pack on a cart to ensure flow rate and sampling was uninterrupted. Rats were transferred 
to the operant conditioning chambers for the heroin-seeking test. After the move from the neutral 
chamber to the operant box, one dialysate sample was collected (corresponding to the context 
change) prior to the initiation of the testing session. Testing took place under extinction 
conditions over the 3 h session, and dialysate samples were collected in 10 min intervals. Active 
lever responses resulted in the same consequences as training with the exception that no heroin 
infusions occurred.  
Intracranial Injections and Heroin-Seeking Test (Experiments 3 & 4) 
Intracranial injections were made using a syringe pump (Harvard Apparatus, Holliston, 
MA, USA) connected to a 10 µl Hamilton syringe. The syringe was attached via polyethylene-20 
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tubing to a 28-gauge injector (Plastics One) that extended either 2.0 mm beyond the guide 
cannula. For all intracranial injections, NBQX was delivered in a volume of 0.5 µl over 1 min 
and injectors remained in place for 1 min following the injection. Two days prior to the heroin-
seeking test, rats received mock injections to habituate them to the injection procedure. For mock 
injections, the syringe pump was run for 1 min and short injectors that did not extend beyond the 
tip of the guide cannulae were inserted. No solution was administered during mock injections to 
minimize tissue damage in the target regions. Rats were bilaterally administered the AMPA 
receptor antagonist, NBQX (0.0, 0.3, 1.0 µg/side), approximately 10 min prior to being placed in 
the operant conditioning chambers for the heroin-seeking test. Testing took place under 
extinction conditions over a 3-h session, as in experiments 1 & 2.  
Analytical Chemistry 
 Glutamate was isolated and quantified in the dialysate samples using high performance 
liquid chromatography (HPLC) and fluorescence detection as in Placenza, Rajabi, & Stewart, 
(2008). Briefly, dialysate samples were derivatized with o-phthaladehyde and loaded through a 
manual injection port (Rheodyne 7125; Rheodyne LLC, Rhonert Park, CA; 20 µl loop). A C-18 
reverse phase column (5.0 µm, 15.0 cm, 4.0 mm ID, Higgins Analytical) was used to separate 
components in the sample. Glutamate was detected using Ultrafluor (Lab Alliance, Fisher 
Scientific, Montreal, Quebec, Canada) with an excitation wavelength of 340 nm and an emission 
wavelength of 460 nm. Water 515 HPLC pumps were used to circulate the phosphate buffer 
mobile phase at a rate of 1.1 ml/min through the HPLC system. After each sample the column 
was flushed with a 40% acetonitrile wash buffer for 2 min. Peaks were integrated and quantified 
by the EZ Chrom Chromatography Data System (Scientific Software Inc., San Ramon, CA, 
USA).  
Histology 
 At the end of the experiments rats were euthanized with carbon dioxide gas and 
decapitated. Brains were collected and fixed in 4% paraformaldehyde solution for one week 
before being sliced in 40.0 µm coronal sections. Sections were mounted and stained with cresyl 
violet. Cannula and probe locations were determined under a microscope with reference to a 




 For the microdialysis experiments 1 & 2, active and inactive lever responses were 
analyzed separately using a mixed factorial analysis of variance (ANOVA) with the between 
subjects factor of food restriction (FDR, Sated) and the within subjects factor of time (10 min 
bins of responses). To assess the effects of food restriction on glutamate transmission, baseline 
levels of glutamate were determined by averaging 3 samples collected prior to the move to the 
operant chamber for each rat, and then converting the values of all samples to a percentage of 
baseline. Changes from baseline were analyzed separately for each experiment using a mixed 
factorial ANOVA with the between subjects factor of food restriction (FDR, Sated) and the 
within subjects factor of time (baseline average, context change, and test samples 1 – 18). 
Statistically significant main effects and interactions were followed by post-hoc analyses with 
Bonferroni corrections. Significant results are reported for p ≤ 0.05.  
 To access the effects of NBQX on the augmentation of heroin seeking induced by chronic 
food restriction, active and inactive lever responses were analyzed separately using a univariate 
ANOVA with the between subjects factors of food restriction (FDR, Sated) and NBQX dose (0.0, 
0.3, 1.0 µg/side). Statistically significant main effects and interactions were followed by post-hoc 
analyses with Bonferroni corrections. Statistically significant results are reported for p ≤ 0.05.  
RESULTS 
For experiments 1 & 2, 40 rats were trained, but rats were excluded if they pulled out 
probes during the test session, or if there were technical problems with the analysis of the 
dialysate samples in the HPLC. In addition, only rats with correct histological placements were 
included in the final analysis (Figure 5.1), which left a total of 32 rats in experiments 1 & 2. For 
experiments 3 & 4, 120 rats were trained but only 102 had correct histological placements and 
were included in the final analysis (Figure 5.1). All rats acquired reliable heroin self-
administration (Table 5.1). In all experiments the FDR rats were approximately 90% of their 
body weight at the start of the withdrawal place or approximately 75% of the sated rats’ body 
weight (Table 5.1).  
Experiment 1: Changes in extracellular glutamate in the NAc shell 
 Fourteen days of chronic food restriction resulted in the augmentation of heroin seeking. 

























































Figure 5.1. Cannula placements for all experiments. Approximate locations of active region of 
microdialysis probe targeting the NAc shell (A) for Experiment 1 (n = 17; black rectangles), or the 
NAc core (B) for Experiment 2 (n = 16; black rectangles). Approximate anatomical position for 
microinjector tips targeting the NAc shell (C) for Experiment 3 (n = 50; open triangles) or NAc core 
(D) for Experiment 4 (n = 52; open circles). Images modified from the brain atlas of Paxinos and 
Watson (2005) of Figures 14 – 19 (+1.68 to +2.28 mm anterior to Bregma). 
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Table 5.1. Mean ± SEM of the number of infusions taken, and the number of active and inactive 
lever responses made on the last training day (9 h) in each experiment, as well as body weight 
for the FDR and sated rats on the 14th day of food restriction (the drug seeking test). 
 Mean ± SEM 
 Self-administration training day 10 Food-restriction day 14 
Experiment Infusions Active         











1 34.77 ± 2.18 86.12 ± 13.34 9.59 ± 3.90 310.88 ± 6.87 402.67 ± 4.54 
2 55.06 ± 12.90 224.06 ± 96.84 15.19 ± 7.60 301.00 ± 4.86 456.29 ± 15.22 
3 48.48 ± 3.90 175.76 ± 30.34 19.52 ± 5.43 325.96 ± 3.08 421.39 ± 8.79 




rats (n = 9; Figure 5.2A inset). Active lever responses recorded in 10 min time bins were higher 
in the FDR rats (feeding condition: F (1,15) = 6.104, p = 0.026, η2 = 0.289; Figure 5.2A). There 
was also a statistically significant effect of time (F (17,255) = 11.240, p < 0.001, η2 = 0.373) and a 
statistically significant interaction of feeding condition × time (F (17,255) = 3.886, p = 0.003, η2 = 
0.129). There were no statistically significant differences between groups on responses made on 
the inactive lever (Figure 5.2A inset).  
 There were no statistically significant differences in absolute baseline dialysate 
concentrations of glutamate (Table 5.2). Chronic food restriction had no effect on extracellular 
glutamate during the heroin-seeking test (feeding condition: F (1,15) = 0.226, p = 0.614, η2 = 
0.015; Figure 5.2B). Furthermore, there were no statistically significant effects for time (F (19,285) 
= 1.211, p = 0.267, η2 = 0.071) or feeding condition × time (F (19,285) = 0.732, p = 0.746, η2 = 
0.043). 
Experiment 2: Changes in extracellular glutamate in the NAc core 
 Like experiment 1, FDR rats (n = 9) displayed higher levels of heroin seeking, assessed 
by active lever responses, compared to the sated rats (n = 7; Figure 5.3A inset). Active lever 
responses recorded in 10 min bins were higher in the FDR rats compared to the sated rats 
(feeding condition: F (1,14) = 20.024, p = 0.001, η2 = 0.589; Figure 5.3A). There was also a 
statistically significant main effect of time (F (17,238) = 14.182, p < 0.001, η2 = 0.434) and a 
statistically significant interaction of feeding condition × time (F (17, 238) = 4.469, p = 0.005, η2 = 
0.137). There were no statistically significant differences between groups on responses made on 
the inactive lever (Figure 5.3A inset).  
 Absolute baseline dialysate levels of glutamate were not statistically significantly 
different between the FDR and sated rats (Table 5.2). There was no significant effect of food 
restriction on extracellular glutamate levels during the heroin-seeking test (feeding condition: F 
(1,13) = 0.305, p = 0.590, η2 = 0.023; Figure 5.3B). Moreover, there were no statistically 
significant effects of time (F (19,247) = 0.257, p = 0.999, η2 = 0.0194) or interaction of feeding 
condition × time (F (19, 247) = 0.360, p = 0.994, η2 = 0.026). 
Experiment 3: Administration of AMPA receptor antagonist, NBQX, into the NAc shell 
The final analysis included the following 6 groups: FDR – 0.0 µg (n = 10), FDR – 0.3 µg 





Figure 5.2. Chronic food restriction-induced augmentation of heroin seeking and extracellular 
glutamate in the NAc shell. (A) Total number of active and inactive lever responses for FDR (n = 
8) and sated (n = 9) rats (inset), and active lever responses in 10-min time intervals during the 3 h 
heroin-seeking test in Experiment 1, *p = 0.026 compared with sated rats. (B) Extracellular 
glutamate following re-exposure to the drug environment and during the heroin-seeking test in 







Figure 5.3. Chronic food restriction-induced augmentation of heroin seeking and extracellular 
glutamate in the NAc core. (A) Total number of active and inactive lever responses for FDR (n = 
9) and sated (n = 7) rats (inset), and active lever responses in 10-min time intervals during the 3 h 
heroin-seeking test in Experiment 2, *p = 0.001 compared with sated rats. (B) Extracellular 
glutamate levels following re-exposure to the drug environment and during the heroin-seeking 




Table 5.2. Mean ± SEM of the absolute concentrations of baseline glutamate levels of the FDR 
and sated rats. 
 Mean ± SEM absolute [Glutamate] in pg/µl Statistics 
Experiment FDR Sated t-test & Cohen’s d effect size 
1 31.21 ± 2.69 42.42 ± 9.14 t (15) = -1.115, p = 0.282, d = -0.58 





Figure 5.4. The effect of injections of the glutamate AMPA receptor antagonist NBQX into the 
NAc shell (A) or NAc core (B) on the augmentation of heroin-seeking induced by chronic food 
restriction, *p < 0.001 compared to the sated groups. 
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7). Overall, the FDR groups responded more on the active lever during the 3-h heroin-seeking 
test compared with the sated groups (feeding condition: F (1,44) = 15.819, p < 0.001, η2 = 0.259; 
Figure 5.4A). Administration of AMPA receptor antagonist, NBQX, into the NAc shell had no 
effect on heroin seeking (NBQX dose: F (2,44) = 0.292, p = 0.748, η2 = 0.010). Moreover, there 
was no statistically significant interaction of feeding condition × NBQX dose (F (2,44) = 0.342, p = 
0.712, η2 = 0.011). Even though the interaction of feeding condition × NBQX dose was not 
statistically significant, there appears to be a reduction in heroin seeking in the Sated – 1.0 µg 
compared to Sated – 0.0 µg rats based on a relatively large effect size, Cohen’s d = 0.725. 
Surprisingly, there was a main effect of feeding condition on inactive lever responses during the 
heroin-seeking test (F (1,44) = 8.272, p = 0.006, η2 = 0.139). Overall, the FDR groups had higher 
inactive lever responses (M = 54.91 ± 7.319) compared to the sated groups (M = 23.91 ± 7.912). 
There were no other statistically significant effects on inactive lever responses. Although there 
was no significant interaction, visual examination of Figure 5.4A shows that the FDR groups that 
received NBQX had higher inactive lever responses compared to the FDR-vehicle group.  
Experiment 4: Administration of AMPA receptor antagonist, NBQX, into the NAc core 
 The final analysis included the following 6 groups: FDR – 0.0 µg (n = 9), FDR – 0.3 µg 
(n = 8), FDR – 1.0 µg (n = 9), Sated – 0.0 µg (n = 9), Sated – 0.3 µg (n = 8), Sated – 1.0 µg (n = 
9). As previously reported, the FDR groups had significantly more active lever responses during 
the heroin-seeking test compared with the sated groups (feeding condition: F (1,46) = 14.391, p < 
0.001, η2 = 0.223; Figure 5.4B). Administration of NBQX into the NAc core had no statistically 
significant effect on heroin seeking (NBQX dose: F (2,46) = 1.787, p = 0.179, η2 = 0.055), and 
there was no significant interaction of feeding condition × NBQX dose (F (2,46) = 0.265, p = 0.768, 
η2 = 0.008). However, although the interaction of feeding condition × NBQX dose was not 
statistically significant, administration of NBQX in the NAc core of the sated rats reduced heroin 
seeking as evidenced by large effect sizes: Sated – 0.0 µg compared to Sated – 0.3 µg (Cohen’s d 
= 1.290) and Sated – 0.0 µg compared to Sated – 1.0 µg (Cohen’s d = 0.883). Interestingly, 
similar to experiment 3, there was a statistically significant main effect of feeding condition on 
inactive lever responses during the heroin-seeking test, F (1,46) = 8.199, p = 0.006, η2 = 0.133. 
Overall, the FDR groups had higher inactive lever responses (M = 51.35 ± 8.763) compared to 
the sated groups (M = 15.87 ± 8.763). Similar to experiment 3, although there was no significant 
interaction of feeding condition × NBQX dose, visual examination of Figure 5.4B shows that the 
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FDR groups that received the NBQX had higher inactive lever responses compared to the FDR-
vehicle group. There were no other statistically significant effects on the inactive lever 
responses.  
DISCUSSION 
 As previously demonstrated (D'Cunha et al., 2013), 2 weeks of chronic food restriction 
during drug withdrawal significantly augmented heroin seeking. However, there were no 
significant fluctuations in extracellular levels of glutamate in either the NAc shell or core during 
heroin seeking in the FDR and sated rats. Finally, administration of the AMPA receptor 
antagonist NBQX into the NAc shell or core had no statistically significant impact on heroin 
seeking in the FDR rats, but may have reduced heroin seeking in the sated rats.  
Extracellular glutamate in the NAc shell and core of FDR and Sated rats 
 Contrary to our expectations, chronic food restriction had no effect on extracellular 
glutamate levels in either the NAc shell or core subregions. Furthermore, there were no changes 
in extracellular glutamate levels in the sated rats. This is in direct contrast to numerous other 
reports that demonstrated increased extracellular glutamate during drug seeking and following 
exposure to drug-associated cues (Hotsenpiller, Giorgetti, & Wolf, 2001; LaLumiere & Kalivas, 
2008; McFarland et al., 2003; Suto et al., 2013). For example, extracellular glutamate levels are 
significantly elevated in the NAc core during cue-induced reinstatement of heroin seeking 
(LaLumiere & Kalivas, 2008). Moreover, glutamate levels in both the NAc shell and core are 
significantly elevated in the presence of both discrete and environmental drug-associated cues 
(Hotsenpiller et al., 2001; Suto et al., 2013).  
 The NAc receives numerous glutamatergic innervations from a variety of brain regions 
including the prefrontal cortex (PFC), ventral hippocampus, and medial thalamic nuclei (Brog et 
al., 1993). Extracellular glutamate levels increased during cocaine-primed reinstatement and 
inhibiting the activation of the glutamate projection from the PFC blocks this rise in glutamate 
(McFarland et al., 2003). A leading hypothesis is that there is impaired communication from 
these glutamatergic inputs from the PFC (a region critical to executive function) to the NAc, 
which is why drug addicted individuals are unable to effectively regulate drug seeking (Chen et 
al., 2013; Kalivas, 2009).  
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Kalivas (2009) proposes that glutamate homeostasis in the NAc is critical to maintaining 
the correct levels of glutamate in the synaptic cleft, and prolonged drug use leads to alterations in 
the homeostatic mechanisms maintaining adequate glutamate levels. Heroin self-administration 
followed by extinction training does in fact result in a reduced ability for the NAc to efficiently 
eliminate glutamate from the synaptic cleft via the glutamate transporter, GLT-1 (Shen, Scofield, 
Boger, Hensley, & Kalivas, 2014b). This excess of glutamate in the synaptic cleft can result in 
increased stimulation of post-synaptic receptors, such as AMPA, which results in synaptic 
potentiation, eventually leading to drug craving and relapse (Shen et al., 2014b; Wolf, 2010).  
 The major difference between these studies and ours that may account for the 
discrepancy in findings is the animal model of relapse that was used. We investigated heroin 
seeking following a period of withdrawal whereas most of the aforementioned studies 
investigated drug seeking following extinction training. Previous work indicates that the neural 
mechanisms mediating drug seeking following a withdrawal period versus extinction training are 
distinct (Fuchs et al., 2006). Therefore, the changes in the ability of GLT-1 to remove glutamate 
from the synaptic cleft of the NAc may only be altered following extinction training. Although 
our heroin-seeking test is also an extinction session, these changes to glutamate homeostasis in 
the NAc may be a neuroadaptation that develops over time with repeated extinction sessions. 
Thus, a probable explanation for the lack of observed changes in extracellular glutamate during 
ongoing heroin seeking is that our procedure does not lead to the same neuroadaptations seen 
with extinction training. As a result, we suggest that changes in tonic glutamate levels in the 
NAc, do not mediate the augmentation of heroin seeking induced by chronic food restriction.  
Effects of Intra-NAc Shell and Core Injections of NBQX on Heroin Seeking in FDR and 
Sated Rats 
 Administration of the AMPA receptor (AMPAR) antagonist NBQX into the NAc shell 
and core had no statistically significant effect on the augmentation of heroin seeking induced by 
chronic food restriction. However, relatively large effect sizes suggest that NBQX administration 
into the NAc core and possibly the shell reduced heroin seeking in the sated rats. These results 
complement numerous other reports that blockade of AMPAR in the NAc decreased drug 
seeking (Cornish & Kalivas, 2000; Di Ciano & Everitt, 2001; LaLumiere & Kalivas, 2008). The 
reduction in heroin seeking seen in the sated rats directly parallels evidence that administration 
of the AMPAR antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; which is similar to 
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NBQX) into the NAc core reduced cue-induced reinstatement of heroin seeking (LaLumiere & 
Kalivas, 2008). This evidence corresponds with the finding that drug self-administration and 
withdrawal results in the upregulation of AMPAR on medium spiny neurons (MSNs) in the NAc 
(Wolf, 2010). In the early phase of drug withdrawal following cocaine self-administration, 
AMPAR are initially downregulated. However, over the period of prolonged drug withdrawal 
levels of synaptic AMPARs in the NAc shell and core are significantly increased (Conrad et al., 
2008). In particular, there is an upregulation of GluA2-lacking AMPARs, which are calcium 
permeable, in the NAc following long access to cocaine self-administration and withdrawal 
(Loweth, Tseng, & Wolf, 2014). Incorporation of these receptors into the post-synaptic 
membrane can strengthen synapses and alter post-synaptic signalling by increasing the 
responsiveness of MSNs to incoming glutamatergic inputs (Loweth et al., 2014).  
 The increase in AMPAR in the NAc following prolonged drug withdrawal is also 
demonstrated following chronic food restriction. Like prolonged withdrawal from cocaine, 
chronic food restriction increased GluA2-lacking calcium-permeable AMPARs in the NAc 
(Ouyang et al., 2017). Specifically, food restriction increased the surface expression of GluA1 
subunits and increased phosphorylation at the Ser845 site on the GluA1 subunit, which is 
thought to facilitate the trafficking of GluA1 to the post-synaptic density of the MSNs in the 
NAc. In addition, administration of Naspm, a specific antagonist for calcium-permeable 
AMPARs decreased the amplitude of excitatory post-synaptic potentials in the NAc shell. 
Naspm also suppressed the enhanced locomotion induced by administration of the DA D1R 
agonist SKF-82958 in food restricted, but not sated, rats. Consequently, synaptic incorporation of 
these calcium-permeable AMPARs in the D1-type MSNs of the NAc may increase the 
responsiveness of food restricted rats to both natural rewards and drugs of abuse (Carr, 2016; 
Jung et al., 2016; Ouyang et al., 2017; Zheng, Cabeza de Vaca, Jurkowski, & Carr, 2015).  
 There are several possible explanations for the finding that blockade of AMPARs in the 
NAc had no effect on the augmentation of heroin seeking induced by chronic food restriction. 
First, since both drug withdrawal (Conrad et al., 2008; Loweth et al., 2014; Wolf, 2010) and 
chronic food restriction (Carr, 2016; Ouyang et al., 2017) can increase calcium-permeable 
AMPARs in the NAc, the combination of heroin withdrawal and food restriction in our 
procedure may have resulted in a synergistic elevation of AMPARs in the NAc. As a result, 
perhaps the doses of NBQX used were not sufficient to saturate of the synaptic AMPARs in the 
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NAc and cause a reduction in heroin seeking. Our doses of NBQX were based in a previous 
report that demonstrated a reduction in cue-induced alcohol seeking, but the animals in that 
experiment were not food restricted (Sciascia et al., 2015). Future studies should perhaps try a 
higher dose of NBQX in the NAc to assess its effects on heroin seeking induced by chronic food 
restriction.  
 Second, as we have previously mentioned, the discrepancy between our results and the 
other reports may also be accounted for by the distinct procedures used to study drug seeking. 
Previous reports that found that blockade of AMPAR in the NAc reduced drug seeking used the 
reinstatement model with extinction training, which has been demonstrated to have distinct 
neural mechanisms that mediate it compared to a period of withdrawal (Fuchs et al., 2006). 
Furthermore, the majority of evidence reported above used cocaine as the training drug. 
Psychostimulants, like cocaine, lead to divergent neuroadaptations and drug-associated behaviors 
that are not always paralleled in other drug classes, such as opiates (Badiani et al., 2011). 
Therefore, glutamate transmission in the NAc may not mediate the behavioral outcome in our 
procedure because the rats in our experiments self-administered heroin and went through a 
withdrawal period.  
In addition to AMPAR, glutamate binds to a variety of other receptor subtypes. One 
possibility is a role for NMDA ionotropic glutamate receptors in the augmentation of heroin 
seeking induced by chronic food restriction. Previous research does suggest that NMDARs are 
involved in opiate seeking (Ma, Chu, Guo, Han, & Cui, 2007; Shen, Moussawi, Zhou, Toda, & 
Kalivas, 2011; Shen et al., 2014a). For example, morphine-primed reinstatement of CPP is 
associated with increased levels of the NMDAR 2B (NR2B) subunit in the NAc, and 
administration of a selective NR2B antagonist attenuated the reinstatement of CPP induced by a 
priming injection of morphine (Ma et al., 2007). Similarly, heroin self-administration results in 
an upregulation of NR2B-containing NMDARs in the NAc core, and blocking these receptors 
prevented cue-induced heroin seeking (Shen et al., 2011). However, these findings are reported 
in procedures that have been shown to have distinct neuroadaptations compared to the one that 
was used in our experiments (Fuchs et al., 2006; Weise-Kelly & Siegel, 2001).  
Finally, metabotropic glutamate receptors may also play a role in the augmentation of 
heroin seeking induced by chronic food restriction. Blockade of the group I metabotropic 
glutamate receptor, mGluR5 in the NAc has been shown to attenuate both cue-induced cocaine 
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and heroin seeking (Lou, Chen, Liu, Ruan, & Zhou, 2014; Wang, Moussawi, Knackstedt, Shen, 
& Kalivas, 2013). In a procedure similar to ours, administration of an mGluR5 antagonist into 
the NAc shell dose-dependently reduced cue-induced heroin seeking following 2 weeks of 
withdrawal after heroin self-administration (Lou et al., 2014). Furthermore, administration of the 
group II metabotropic glutamate receptors (mGluR2/3) agonist LY379268 into the NAc shell and 
core decreased context-induced reinstatement of heroin seeking (Bossert et al., 2006). Activation 
of mGluR2/3 in the NAc decreases DA release, and we have previously demonstrated that DA 
transmission in the NAc is involved in heroin seeking induced by chronic food restriction 
(D'Cunha et al., 2017). However, the activation of mGluR2/3 decreased glutamate levels as 
assessed by microdialysis, and as mentioned before we did not find that extracellular glutamate 
levels were altered during heroin seeking in either the FDR or sated rats, suggesting that these 
receptors may not play a critical role in food restriction-induced augmentation of heroin seeking.   
Conclusion 
 Contrary to many other reports, we found no changes in extracellular glutamate levels in 
the NAc shell and core in either the FDR or sated rats. Furthermore, there are no indications that 
chronic food restriction had an effect on the function of post-synaptic AMPA receptors in the 
NAc, as administration of the AMPA receptor antagonist NBQX had no effect on heroin seeking 
in the FDR rats. Although it was not statistically significant, relatively large effect sizes suggest 
that in agreement with other reports, NBQX administered in the NAc core and possibly the NAc 
shell reduced heroin seeking in the sated rats.  In conclusion, our results suggest that glutamate 
neurotransmission through AMPA receptors in the NAc are not involved in the augmentation of 
heroin seeking induced by chronic food restriction. Future studies will investigate the role of 
NMDA receptors, as well as the metabotropic classes of glutamate receptors to assess their 





CHAPTER 6: GENERAL DISCUSSION 
 This thesis explored the neural mechanisms that mediate the augmentation of heroin 
seeking induced by chronic food restriction. In Chapter 3, we demonstrated that chronic food 
restriction resulted in differential changes in extracellular DA in the NAc shell and core when 
rats were re-exposed to the heroin-associated context. Administration of the DA D1 receptor 
antagonist SCH 39166 into the NAc shell reduced heroin seeking regardless of feeding 
condition. However, in the NAc core SCH 39166 selectively decreased heroin seeking in the 
FDR rats. Results from this chapter suggest that DA transmission through the D1 receptors in the 
NAc core is critical to the augmentation of heroin seeking induced by chronic food restriction. In 
the following sections it will be discussed how food restriction-induced alterations in DA 
transmission in the NAc can modify the motivational state of the animal, thereby directly 
affecting drug seeking.  
 In Chapter 4, we observed that leptin and ghrelin can modulate heroin seeking induced by 
chronic food restriction. Contrary to our predictions, central administration of leptin had little 
effect on heroin seeking in either the FDR or sated rats. However, intra-VTA leptin 
administration dose-dependently reduced the augmentation of heroin seeking induced by chronic 
food restriction. Similarly, the administration of the ghrelin receptor antagonist JMV 2959 into 
the VTA also selectively and dose-dependently reduced heroin seeking in the FDR rats. Taken 
together, these results suggest that leptin and ghrelin transmission in the VTA can modulate 
heroin seeking induced by chronic food restriction. It is plausible that the effects of leptin and 
ghrelin in the VTA are mediated through interactions with the mesolimbic DA pathway, which 
will be discussed in subsequent sections of this discussion. 
 Finally, in Chapter 5, contrary to our hypotheses we found that chronic food restriction 
did not alter extracellular glutamate levels in the NAc during heroin seeking. Unexpectedly, 
administration of the AMPA receptor antagonist NBQX into the NAc had no effect on heroin 
seeking in the FDR group, and resulted in a trend for attenuation in the sated rats. It remains a 
possibility that glutamate in regions other than the NAc may be involved in the augmentation of 
heroin seeking induced by chronic food restriction.  
 Collectively, these data promote a framework where heroin seeking induced by chronic 
food restriction is mediated through dopaminergic modulation within the NAc. Moreover, 
hunger and satiety signals coming into the VTA through leptin and ghrelin can also modulate 
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heroin seeking, likely by affecting downstream dopaminergic transmission in the mesolimbic 
pathway. Although glutamate transmission through AMPA receptors in the NAc does not seem 
to be involved in heroin seeking induced by chronic food restriction, other glutamate receptors in 
the NAc, such as NMDA receptors or mGluRs, should to be evaluated in the future to help 
elucidate glutamate’s role in this behavior.  
The Role of Dopamine in Heroin Seeking 
 There are multiple theories on the role of DA in learning and motivation. One hypothesis 
posits that DA transmission mediates the impact of the hedonic properties of rewards in behavior 
(Wise, 1982). This is theorized to operate by DA modulating the motivational properties of 
rewards that are primary unconditioned reinforcers, in addition to affecting the motivational 
properties of secondary conditioned reinforcers (Wise, 1982). However, this theory is opposed 
by evidence that DA cell body lesions and administration of DA antagonists do not completely 
abolish the rewarding properties of electric brain stimulation, suggesting that DA is not solely 
responsible for signaling reward in the brain (Wise & Rompre, 1989). An alternative approach, 
known as the incentive salience model, explains this discrepancy by arguing that DA is not 
responsible for signaling the hedonic properties of a stimulus (Berridge & Robinson, 1998; 
Robinson & Berridge, 1993). Instead, this theory proposes that there are 2 distinct aspects to 
reward-related stimuli: the “wanting” or incentive salience of the stimuli and the “liking” or 
hedonic response that is elicited by the stimuli. The “wanting” or incentive salience is mediated 
by the mesolimbic DA pathway, whereas the “liking” is mediated by opioid systems in the brain 
(Berridge, 2007; Berridge & Robinson, 1998; Robinson & Berridge, 1993). Furthermore, DA 
transmission in the NAc can mediate and magnify the “wanting” of a reward that is triggered by 
a reward-associated cue (Wyvell & Berridge, 2001). Thus, the elevated DA levels in the NAc of 
the FDR rats may drive an increased “wanting” of the drug following exposure to the drug-
associated cues, leading to the augmentation of heroin seeking. Blocking D1 receptors in the 
NAc may then block the “wanting” of the drug which would decrease heroin seeking.  
 Another hypothesis, Wolfram Schultz’s Reward Prediction Error Theory, proposes that 
DA encodes the reward prediction error, defined as the difference between predicted and 
received rewards (Schultz et al., 1997). When the received reward is better than predicted, there 
is a positive reward prediction error and DA neurons show phasic excitatory activity. However, 
if the received reward matches the prediction then the DA neurons remain at baseline firing rates. 
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When the received reward is less than predicted, or is completely omitted, there is a negative 
reward prediction error and DA neurons show a transient suppression in firing. Additionally, 
over time the reward-associated DA neural activity transfers from the reward itself to the 
preceding reward-predicting stimuli (Schultz, 1998). This type of information processing is 
efficient for learning about long chains of events. Positive reward prediction errors (when we 
receive a better than expected reward), drive us toward ever-increasing rewards, as once the 
prediction error is updated each subsequent reward needs to be larger to elicit a positive 
prediction error (Schultz, 2016). Hence, drugs of abuse and then drug-associated cues result in 
positive prediction errors and drive motivation to obtain a larger reward to continually activate 
the DA neurons. In our experiments, due to methodological limitations we are unable to quantify 
changes in phasic DA to specifically assess reward prediction error by means of in vivo 
microdialysis. It may be possible that in vivo microdialysis could detect some aspects of the 
phasic DA signal overlaid on the tonic DA signal. If this is the case, then the possibility exists 
that the increases in extracellular concentrations of DA in the NAc core of chronically food-
restricted rats may display some aspects of a positive reward prediction error which would lead 
to the continued heroin-seeking demonstrated by this group. In addition, when DA D1 receptors 
are blocked in the NAc core of the FDR rats, it may suppress the positive reward prediction error 
signal thereby attenuating heroin seeking.  
 The NAc is only one of the major inputs of the mesolimbic DA pathway. In addition to 
the NAc, the DA neurons of the mesolimbic pathway in the VTA send projections to other 
regions including the basolateral amygdala (BLA). The BLA in turn has direct projections to the 
NAc (Zorrilla & Koob, 2013), which modulate DA released within the NAc core (Jones et al., 
2010). As a result, the BLA is thought to play a critical role in drug seeking. For example, 
inactivation of the BLA attenuates the reinstatement of cue-induced heroin seeking (Fuchs & 
See, 2002). Moreover, extracellular DA in the BLA is elevated during cue-induced cocaine 
seeking following a period of withdrawal and in the reinstatement procedure (Tran-Nguyen et 
al., 1998; Weiss et al., 2000). Despite this evidence, preliminary findings we obtained (presented 
in the Appendix) found that there were no changes in extracellular DA levels in the BLA during 
the augmentation of heroin seeking induced by chronic food restriction. The discrepancy 
between our preliminary results and those previously mentioned is likely due to the difference in 
drugs of abuse, as the neural mechanisms mediating psychostimulant addiction and opiate 
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addiction are at least partially distinct (Badiani et al., 2011). Based on these findings, DA in the 
BLA may not be directly involved in heroin seeking induced by chronic food restriction.  
 In addition to the mesolimbic DA pathway, the nigrostriatal DA pathway also plays a 
critical role in reward and motivation (Wise, 2009). Dopaminergic cell bodies in this pathway 
originate in the substantia nigra and project predominantly to the dorsal striatum. One 
subdivision of the dorsal striatum, the dorsolateral striatum (DLS), has been implicated in drug 
seeking. Dopamine in the DLS, and not in the dorsomedial portion of the striatum, is elevated 
during cue-induced reinstatement of cocaine seeking, and in response to the presentation of 
cocaine-paired cues (Ito, Dalley, Robbins, & Everitt, 2002). Extracellular DA levels in the DLS 
are also elevated during cocaine seeking following 14 days of withdrawal (Gabriele, Pacchioni, 
& See, 2012), and administration of a DA D1-like receptor antagonist into the DLS attenuated 
context-induced reinstatement of heroin seeking (Bossert, Wihbey, Pickens, Nair, & Shaham, 
2009).  
 Consequently, it remains plausible that DA in the nigrostriatal pathway, specifically the 
DLS may be involved in heroin seeking following chronic food restriction. However, 
preliminary results we obtained (presented in the Appendix) revealed that there are no 
statistically significant changes in extracellular DA in the DLS during the augmentation of 
heroin seeking induced by chronic food restriction. One reason for these inconsistencies may be 
that the dorsal striatum is thought to mediate stimulus-response or habit learning, while the 
ventral striatum mediates goal-directed behavior (Everitt & Robbins, 2013). Perhaps heroin 
seeking remains a goal-oriented behavior in FDR rats, which is why we see significant increases 
in DA in the ventral striatum, i.e. the NAc, and not the DLS.  
 Although our preliminary results indicate that there are no significant changes in 
extracellular DA in the BLA or DLS during heroin seeking, the role of DA D1-like receptors in 
these regions remains to be tested. Fluctuations in extracellular DA may implicate presynaptic 
adaptations that have emerged but would not reflect postsynaptic changes at the level of the DA 
receptors. Therefore, future studies should address the role of DA D1-like receptors in the BLA 
and DLS in the augmentation of heroin seeking induced by chronic food restriction.  
In addition to other brain regions, DA also acts on multiple receptor subtypes. Thus far, 
our research has focused on the involvement of D1-like receptors in heroin seeking. Previous 
research indicates that administration of the D2 antagonist raclopride completely blocks cue-
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induced reinstatement of cocaine seeking (Cervo, Carnovali, Stark, & Mennini, 2003). 
Moreover, administration of the D2 receptor antagonist sulpiride into the NAc shell, but not the 
core, dose-dependently attenuated the reinstatement of cocaine seeking induced by a priming 
injection (Anderson et al., 2006). Similarly, intra-shell administration of the D2 receptor 
antagonist eticlopride also attenuates cocaine-primed reinstatement (Bachtell, Whisler, Karanian, 
& Self, 2005). In contrast, previous work from our laboratory indicates that D2-like receptors 
may not be involved in heroin seeking. In particular, we have shown that systemic administration 
of the D1-like receptor antagonist SCH 23390 and not a D2 or D3 receptor antagonist, dose-
dependently decreased food deprivation-induced reinstatement of heroin seeking (Tobin et al., 
2009). As previously mentioned, these discrepancies may be because psychostimulant and opiate 
addiction are mediated by overlapping but distinct neural circuits, and lead to different 
neuroadaptations (Badiani et al., 2011). Furthermore, the neural mechanisms mediating drug 
seeking in a reinstatement model versus a withdrawal-based procedure are distinct (Fuchs et al., 
2006). This is also supported by evidence that intra-shell administration of a D1 antagonist SCH 
23390, but not the D2 antagonist eticlopride, blocked cue-induced morphine seeking in a 
withdrawal-based procedure similar to ours (Gao et al., 2013). We therefore conclude that 
although we did not directly assess other DA receptors, it is likely that D1-like and not D2-like 
receptors are involved in heroin seeking following chronic food restriction.  
Interactions of Dopamine and the Endocrine System 
 The hypothalamus is pivotal in regulating feeding and energy balance and is the primary 
site of action for circulating hormones such as leptin and ghrelin (DiLeone, 2009). Leptin, which 
is released by peripheral adipocytes, binds to numerous hypothalamic nuclei (Ahima et al., 2000; 
Friedman & Halaas, 1998). Once bound to the leptin receptor (LepR), it leads to dimerization 
and subsequent activation of Janus kinase (Jak) and phosphorylation of signal-transducer-and-
activator-of-transcription-3 (STAT3; Fulton et al., 2006). These signaling pathways result in the 
inhibition of the neuropeptide Y (NPY)/ agouti-related protein (AgRP) orexigenic neurons and 
excitation of the pro-opiomelanocortin (POMC) anorexigenic neurons within the arcuate nucleus 
of the hypothalamus, which then signals satiety leading to decreased food intake and subsequent 
body weight loss (DiLeone, 2009; van Zessen et al., 2012). In contrast, the hormone ghrelin is 
released from the gut and binds to its receptors, GHS-R1As, which are located on the 
NPY/AgRP neurons in the arcuate nucleus to stimulate feeding by increasing meal frequency 
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(Horvath, Diano, & Tschop, 2003; Tschop, Smiley, & Heiman, 2000). Moreover, ghrelin is also 
critically involved in food anticipatory activity (Verhagen et al., 2011), as ghrelin receptor 
knockout animals show a marked reduction in food anticipatory activity (Blum et al., 2009).  
 Feeding and food intake is an evolved behavior that engages and integrates many 
physiological systems and neural circuits (DiLeone, 2009). As it is a highly complex behavior 
that is key to an organism’s survival, these systems and circuits work in a concerted effort to 
regulate the various aspects of feeding, such as the motivational drive, the anticipation of food, 
and assessing the current metabolic state (van Zessen et al., 2012). These homeostatic signaling 
circuits from the hypothalamus eventually converge with the circuits that mediate reward and 
motivation via the mesolimbic DA pathway (DiLeone, 2009). The hypothalamic nuclei that 
leptin and ghrelin bind to, especially the arcuate nucleus, the lateral hypothalamus, and the 
ventromedial hypothalamus, all send projections to the VTA, either onto the DA cell bodies or 
the GABAergic interneurons (van Zessen et al., 2012). When circulating signals such as leptin or 
ghrelin bind to these hypothalamic sites they may result in downstream modulation of the 
mesolimbic DA circuit. 
 However, it is documented that DA depletion in the mesolimbic circuit is not sufficient 
completely eliminate feeding behavior (Salamone, Correa, Mingote, & Weber, 2005; Salamone, 
Cousins, & J., 1997; Salamone, Wisniecki, Carlson, & Correa, 2001). This is likely because 
feeding behavior is critical to survival, and evolutionary pressures have resulted in many 
redundant circuits to ensure adequate food intake. Therefore, DA may not be essential in 
mediating food intake and consumption but rather acts to integrate and drive motivation towards 
food rewards (Salamone et al., 1997). It is suggested that the hypothalamic circuits mediate food 
seeking and food intake, and the mesolimbic DA system only has modulatory effects on these 
behaviors. Similarly, the mesolimbic DA system mediates drug reinforcement and reward, 
whereas hypothalamic systems modulate it (DiLeone, 2009). These theories are supported by our 
results from Chapter 4.  
As previously mentioned, centrally administered leptin had no effect on heroin seeking 
induced by chronic food restriction. This is probably because most of the leptin when 
administered into the ventricles was taken up by hypothalamic sites, and perhaps these pathways 
do not modulate heroin seeking induced by chronic food restriction. Although we did not directly 
assess the effects of ghrelin in our procedure, we have previously demonstrated that central 
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administration of a ghrelin receptor antagonist had no effect on heroin seeking following acute 
food deprivation (Maric et al., 2011). Thus, it is likely that leptin and ghrelin’s actions on 
hypothalamic circuits that mediate food intake do not mediate heroin seeking in chronically food 
restricted rats. 
On the other hand, direct administration of leptin or a ghrelin receptor antagonist into the 
VTA dose-dependently reduced the augmentation of heroin seeking induced by chronic food 
restriction. Our results therefore suggest that the effects of leptin and ghrelin are mediated by 
their actions directly on the mesolimbic DA system. It is well established that both leptin and 
ghrelin receptors are expressed in the VTA (Abizaid et al., 2006; Fulton et al., 2006; Hommel et 
al., 2006). Briefly, LepR have been located on both DA cell bodies in the VTA and GABAergic 
interneurons (Fulton et al., 2006; Hommel et al., 2006). Evidence indicates that leptin 
administration directly into the VTA decreases the firing rate of DA neurons (Hommel et al., 
2006) which then results in a reduction of DA levels in the terminal regions of the mesolimbic 
pathway, such as the NAc (You et al., 2016). We demonstrated in Chapter 3 that blockade of D1 
receptors in the NAc would attenuate heroin seeking induced by chronic food restriction. 
Therefore, it is possible that leptin’s effects are upstream of these changes in DA 
neurotransmission in the NAc. 
Similar to leptin, ghrelin’s receptors are also located in the VTA, and ghrelin acts directly 
on DA neurons by increasing their activity (Abizaid et al., 2006). Since administration of a 
ghrelin receptor antagonist in the VTA attenuated heroin seeking induced by chronic food 
restriction, ghrelin may also be acting upstream in the VTA and modulating DA 
neurotransmission in the NAc to drive heroin seeking. Future studies should address if and how 
leptin and ghrelin are modulating DA transmission in the mesolimbic pathway to alter heroin 
seeking induced by chronic food restriction. One potential method to investigate if leptin and 
ghrelin’s actions are mediated directly upstream from DA in the NAc would be to administer 
leptin or a ghrelin receptor antagonist into one hemisphere of the VTA and a D1 receptor 
antagonist in the contralateral hemisphere NAc to assess if they are part of one circuit. 
Furthermore, since we also found changes in plasma levels of leptin and ghrelin following heroin 
self-administration and chronic food restriction, it would be interesting to investigate the 
corresponding molecular intracellular effects of leptin and ghrelin in the VTA.  
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Interactions of Dopamine and Glutamate Systems 
 The dense dopaminergic innervations that the NAc receives from the VTA as part of the 
mesolimbic DA system is well established in reward and addiction (Di Chiara et al., 1993; 
Ungerstedt, 1971). Therefore, it is not surprising that we found that DA transmission in the NAc 
is involved in the augmentation of heroin seeking induced by chronic food restriction. In addition 
to the DA afferents, the NAc also receives dense glutamatergic innervations from a variety of 
other limbic and cortical regions (Brog et al., 1993). It was unexpected that we found no changes 
in glutamate transmission in the NAc, which is in contrast to numerous other reports that find 
changes (Hotsenpiller et al., 2001; LaLumiere & Kalivas, 2008; McFarland et al., 2003; Suto et 
al., 2013). Moreover, blocking AMPA receptors in our procedure had no effect on drug seeking 
in the FDR rats, which is also in contrast to other reports that find that administration of an 
AMPAR antagonist decreased drug seeking (Cornish & Kalivas, 2000; Di Ciano & Everitt, 
2001; LaLumiere & Kalivas, 2008; Suto et al., 2004). One possibility for these discrepancies 
may be accounted for by differences in methodology, such as testing drug seeking following 
extinction training as opposed to a withdrawal period, or differences in the type of substance 
studied, i.e., psychostimulants versus opiates.  
  Prior to exposure to any drugs of abuse, naïve animals have AMPARs that are primarily 
composed of GluA1 subunits associated with GluA2 subunits. This combination of subunit type 
(GluA1 + GluA2) results in AMPARs that are Ca2+ impermeable. This is also accompanied with 
decreased intrinsic excitability of MSNs in the NAc (Conrad et al., 2008; Wolf & Ferrario, 
2010). In the NAc core of drug-naïve animals, these GluA2-containing Ca2+ impermeable 
AMPARs are responsible for 90-95% of the evoked excitatory post-synaptic current (EPSC) 
(Wolf & Ferrario, 2010). However, following cocaine self-administration and prolonged drug 
withdrawal beyond 3 weeks, there is a marked increase in the synaptic levels of Ca2+ permeable 
AMPARs in the NAc core (Conrad et al., 2008). These AMPARs lack the GluA2 subunit and are 
primarily homomers of GluA1 subunits, which makes them permeable to Ca2+ (Wolf, 2016). 
This elevation of GluA2-lacking AMPARs results in higher conductance and increased intrinsic 
excitability of NAc MSNs. Thus, even a minor change in the insertion or removal of these 
receptors from the synapse can lead to robust changes in the synaptic strength and properties of 
excitatory transmission in the NAc (Wolf & Ferrario, 2010), resulting in strengthened 
responsiveness of MSNs to incoming glutamatergic drive (Wolf, 2016).  
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 This increased sensitivity to incoming glutamatergic drive accompanied by elevations of 
DA in the NAc following drug exposure may provide insights on how maladaptive behaviors 
like drug seeking are established. As previously mentioned, DA’s role is hypothesized to 
facilitate learning of contingencies related to obtaining rewards. Dopaminergic terminals are 
anatomically well-positioned to modulate synaptic plasticity in the NAc MSNs as evidenced by 
the fact that both dopaminergic and glutamatergic innervations converge onto the same dendritic 
spines of MSNs (Sesack, Carr, Omelchenko, & Pinto, 2003). Specifically, stimulation of D1Rs 
may prime for the insertion of GluA2-lacking AMPARs by facilitating their externalization to 
allow for translocation to the synapse (Wolf, 2010). Therefore, when drugs of abuse artificially 
increase DA in the NAc, it may lead to inappropriate modulation of Ca2+ permeable AMPARs 
being trafficked to the synapse and the strengthening of excitatory synapses (Wolf, 2010). In 
combination with the increased intrinsic excitability of MSNs in the NAc core, these adaptations 
result in an augmented drug-seeking response when animals are re-exposed to drug-associated 
cues. Thus, incoming glutamatergic transmission into the NAc core plays a key role in 
translating motivational signals into the motor output of drug seeking (Wolf, 2016).  
  Drug-induced neural adaptations in plasticity, particularly in glutamate transmission in 
the NAc contribute to the inability to inhibit drug seeking (Kalivas, Lalumiere, Knackstedt, & 
Shen, 2009). Both psychostimulant and opiate addiction share the common adaptation of altered 
glutamatergic transmission in the NAc, which is a key neurobiological substrate of reward and 
motivation (Hearing, Graziane, Dong, & Thomas, 2018). However, caution must be taken when 
generalizing the glutamate homeostasis hypothesis of addiction (Kalivas, 2009) to opioids, as the 
majority of evidence used to formulate that hypothesis is based on studies conducted with 
psychostimulants (particularly cocaine), and there is abundant data that demonstrates that 
psychostimulant and opioid addiction are distinct (Badiani et al., 2011). Perhaps in our procedure 
we saw no changes in NAc glutamatergic transmission because the alterations in synaptic 
plasticity following heroin exposure do not parallel the adaptations found following cocaine 
exposure. In particular, there is insufficient data to conclude if there are increased 
AMPA/NMDA ratios (indicative of synapses being in a potentiated state) (Kalivas, 2009) or if 
there is increased expression of GluA2-lacking AMPARs in both the NAc and VTA following 
opiate exposure (Wolf, 2010; Wolf & Tseng, 2012). Even though psychostimulants and opioids 
result in differing neural adaptations in NAc MSNs, they may produce similar behavioral output 
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of drug seeking (Hearing et al., 2018). Consequently, more evidence is needed on the precise 
mechanisms of synaptic plasticity in opioid addiction.  
 Although there is insufficient data on the effects of heroin self-administration and 
withdrawal on neuroadaptations of AMPARs in the NAc, recent evidence indicates that chronic 
food restriction itself may alter AMPARs. Specifically, chronic food restriction significantly 
increased GluA1 but not GluA2 subunits in the postsynaptic density of the NAc. These results 
suggest that there is increased incorporation of GluA2-lacking calcium-permeable AMPARs in 
the NAc following chronic food restriction (Ouyang et al., 2017). This is supported by 
electrophysiological evidence that spontaneous excitatory postsynaptic currents in the MSNs of 
the NAc shell of FDR rats have a higher amplitude and frequency compared to the sated rats, 
which is indicative of synaptic insertion of calcium-permeable AMPARs (Carr, 2016; Ouyang et 
al., 2017). Moreover, administration of Naspm, an antagonist specific to calcium-permeable 
AMPARs, into the NAc shell decreased the amplitude of excitatory postsynaptic currents. 
Naspm also reduced the enhanced locomotor response to a D1R agonist but not a D2R agonist in 
only the FDR rats (Ouyang et al., 2017). As with psychostimulant self-administration and 
withdrawal, the increased synaptic incorporation of AMPAR in the NAc is proposed to enhance 
DA encoded stimulus reward magnitude. In conjunction with increased signaling downstream of 
D1Rs, intracellular calcium signaling may increase stimulus-induced synaptic plasticity 
involving the upregulation of calcium-permeable AMPARs in the postsynaptic density of the 
NAc (Carr, 2016). These neuroadaptations of AMPARs in the NAc may increase synaptic 
strengthening through LTP resulting in increased reward-directed behavior, specifically 
increasing the likelihood to approach food and drugs of abuse (Carr, 2016).  
 Future experiments need to address the changes in glutamate transmission in the NAc 
following exposure to opioids in combination with chronic food restriction. One possibility is to 
investigate the role of other iGluRs, such as NMDA, in heroin seeking induced by chronic food 
restriction. This could be assessed through administration of an NMDA receptor antagonist in the 
NAc prior to the heroin-seeking test. Another possibility is to investigate the role of mGluRs in 
heroin seeking following chronic food restriction. As previously mentioned, the presynaptic 
mGluR2/3 receptors act as autoreceptors to regulate glutamate in the synapse. In fact, 
administration of an mGluR2/3 agonist reduced cue-induced reinstatement of heroin seeking 
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(Bossert, Ghitza, Lu, Epstein, & Shaham, 2005). These possibilities should be further 
investigated to elucidate the mechanisms and synaptic changes within opioid addiction.  
Neural Circuitry Underlying the Augmentation of Heroin Seeking induced by Chronic Food 
Restriction 
 As previously mentioned, both leptin and ghrelin can modulate the excitability of VTA 
DA neurons which would subsequently alter DA levels in the terminals regions of the 
mesolimbic pathway, such as the NAc (Abizaid et al., 2006; Hommel et al., 2006). The increased 
excitability of VTA DA neurons by decreased leptin levels and increased ghrelin levels may 
have a concerted effect on the FDR rats, making them more responsive to drug-associated cues. 
Indeed, in FDR rats the higher levels of heroin seeking paralleled the increased DA we measured 
in the NAc during the heroin-seeking test in Chapter 3. Based on these findings, we suggest that 
chronic food restriction may sensitize the neural systems that are involved in incentive 
motivational processes, i.e. the mesolimbic DA pathway (Berridge & Robinson, 1998), resulting 
in cue-induced elevation of NAc core and shell DA. This idea is further substantiated by the fact 
that the sated group of rats had no significant changes in NAc DA and displayed lower levels of 
heroin seeking compared to the FDR rats.  
 Learning the predictive relationships, or contingencies, between salient stimuli and 
responses that will lead to beneficial outcomes is a key aspect of motivation (Di Chiara, 2002). 
Motivation can be defined as the process by which organisms react to stimuli in relation to their 
predicted outcomes to promote the survival of the organism and ultimately the species (Di 
Chiara, 2002; Dickinson & Balleine, 1994; Toates, 1998). Adaptations in the brain in response to 
chronic food restriction likely evolved as an adaptive function during times of food scarcity. 
Therefore, it is likely that chronic food restriction increases the motivational state of the 
organism by enhancing the incentive motivational effects of food-related cues (Carr, 1996, 
2011). Increasing the rewarding efficacy of food when the organism has an energy deficit is of 
adaptive value (Bindra, 1978). Thus, it is not surprising that the incentive-motivating effects of 
external stimuli are dependent on the internal state of the organism (Stewart, de Wit, & 
Eikelboom, 1984). This enhancement of food reward and salience of associated cues may 
generalize to drugs of abuse because of their shared neural substrate (Di Chiara et al., 1993; 
Kelley & Berridge, 2002). We would therefore expect that chronic food restriction alters the 
incentive salience of both food-related and drug-related stimuli, which is mediated by 
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adaptations in the mesolimbic DA pathway (Berridge, 2007; Berridge & Robinson, 1998; 
Robinson & Berridge, 1993).  
 In summary, chronic food restriction may alter the motivational state of the animal due to 
the negative energy balance state. This state of negative energy balance may subsequently 
sensitize the neural circuitry that mediates reward and result in the attribution of more incentive 
salience to reward-related stimuli. The increased attribution of incentive salience to reward-
related stimuli may extend to cues previously paired with drug availability and drug effects, 
which are a main trigger to increase drug seeking. Therefore, chronic food restriction may 
ultimately increase drug seeking in animals with a history of drug self-administration. Translated 
to the human condition, food restriction or dieting will result in a negative state of energy 
balance which may increase the incentive salience or “wanting” of drug-associated cues thereby 
increasing drug craving and the vulnerability to relapse in an abstinent drug addict.  
Conclusion 
 In summary, the experiments presented in this thesis provide insights into the neural 
mechanisms underlying the augmentation of heroin seeking induced by chronic food restriction. 
Briefly, DA transmission in the NAc through D1 receptors mediates augmented heroin seeking 
induced by chronic food restriction. Furthermore, hormones involved in metabolic processes 
may modulate this behavior by acting upstream on the cell bodies of the mesolimbic pathway in 
the VTA. Unexpectedly, there were no changes in extracellular glutamate levels in the NAc 
during heroin seeking and administration of an AMPAR antagonist had no effect on the 
augmentation of heroin seeking induced by chronic food restriction.  
 Taken together, these findings provide insights on the interactions between dietary 
manipulations and the neural circuitry mediating drug seeking. It is well established that chronic 
food restriction and limited food intake can increase drug seeking in animal models of relapse. In 
addition, this increase in drug seeking is accompanied by neural adaptations in the mesolimbic 
DA pathway and alterations in hormones that mediate metabolic processes, which may interact 
to modify reward-related processing. Therefore, the findings from these preclinical experiments 
should be extrapolated to inform and guide clinical research in humans. It is clear that chronic 
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APPENDIX: THE ROLE OF DOPAMINE IN THE BASOLATERAL AMYGDALA AND 
DORSOLATERAL STRIATUM IN THE AUGMENTATION OF HEROIN SEEKING 
INDUCED BY CHRONIC FOOD RESTRICTION  
MATERIALS AND METHODS 
 Experiments follow the same methodology, procedures, and statistical analyses as 
Experiment 1A and 2A in Chapter 3.  
 
Surgical Procedures 
 Intravenous catheterization surgery is outlined in Chapter 3 Materials and Methods. For 
rats in the in vivo microdialysis experiments, immediately following the intravenous 
catheterization, unilateral guide cannula were implanted targeting one of the following regions 
(coordinates in mm relative to Bregma): basolateral amygdala (BLA; Supplemental Experiment 
1) AP -2.6, ML ±5.0, DV -5.6; or, dorsolateral striatum (DLS; Supplemental Experiment 2) AP 
+1.2, ML ±3.4, DV -2.6 (Experiment 4; Paxinos & Watson, 2005). Cannula were mounted 
adjacent to the modified catheter cannula on the skull using jeweller’s screws and dental cement. 
Cannula placements were counterbalanced between the right and left hemispheres. 
RESULTS 
Rats were excluded if they pulled out probes during the test session, or if there were 
technical problems with the analysis of the dialysate samples in the HPLC. In addition, only rats 
with correct histological placements were included in the final analysis (Supplemental Figure 
S.1). 
Supplemental Experiment 1: Changes in extracellular DA in the BLA 
FDR rats (n = 13) demonstrated augmented heroin seeking as indicated by the 
significantly higher number of active lever responses made compared to the sated rats (n = 8) 
during the test (t (19) = 2.293, p = 0.033, d = 1.216; Supplemental Figure S.2 inset). 
Supplemental Figure S.2A shows active lever responding for the FDR and sated rats in 10-
minute time intervals across the 3 h test session, with significant effects of food restriction (F 





Figure S.1. Cannula placements for supplemental experiments. Approximate locations of active 
region of microdialysis probe targeting the BLA (A) for Supplemental Experiment 1 (n = 13; 
black rectangles), or the DLS (B) for Supplemental Experiment 2 (n = 18; black rectangles). 
Images modified from the brain atlas of Paxinos and Watson (2005) of Figures 53 – 56 (-2.40 to 
-2.76 mm anterior to Bregma) for the BLA and Figures 22 – 24 (+1.28 to +1.08 mm anterior to 





interaction (F (17,323) = 1.848, p = 0.022). There were no statistically significant differences in the 
number of inactive lever responses.  
Absolute baseline dialysate concentrations of DA in the FDR and sated groups were 
0.0657 ± 0.00900 pg/µl and 0.0596 ± 0.00917 pg/µl, respectively (t (19) = 0.448, p = 0.660, d = 
0.229). Overall, there were no changes in extracellular DA in the BLA compared to baseline in 
either group during the heroin seeking test (Supplemental Figure S.2B). There was a statistically 
significant main effect of time (F (19,361) = 1.977, p = 0.009), which likely reflects slight variations 
in DA throughout the 3 h test session. However, there were no significant effects of food 
restriction (F (1,19) = 0.696, p = 0.414), and no significant interaction of time × food restriction (F 
(19,361) = 1.524, p = 0.074). 
Supplemental Experiment 2: Changes in extracellular DA in the DLS 
The FDR rats (n = 10) demonstrated significantly higher number of active lever 
responses compared to the sated rats (n = 8; t (16) = 2.742, p = 0.014, d = 1.358; Supplemental 
Figure S.3A inset) and there were no statistically significant differences in inactive lever 
responses. Supplemental Figure S.3A shows active lever responding for the FDR and sated rats 
in 10-minute time intervals across the 3 h test session, with significant effects of food restriction 
(F (1,16) = 7.517, p = 0.014), time (F (17,272) = 6.995, p < 0.001), and time × food restriction 
interaction (F (17,272) = 1.657, p = 0.051). Absolute baseline dialysate concentrations of DA were 
0.3466 ± 0.07689 pg/µl in the FDR rats, and 0.3880 ± 0.04242 pg/µl in the sated rats, t (16) = -
0.438, p = 0.667, d = 0.218. Extracellular DA in the DLS appeared to increase slightly in both 
FDR and sated groups upon initiation of the heroin seeking test (Supplemental Figure S.3B), but 
the change was only significant in the sated group as compared to baseline (t (17) = -3.358, p = 
0.004). In addition, extracellular DA levels remained slightly elevated in the sated group 
throughout the test session. Repeated measures ANOVA revealed a significant main effect of 
time (F (19,304) = 1.904, p = 0.014) and a significant interaction of time × food restriction (F (19,304) 






Figure S.2. Chronic food restriction-induced augmentation of heroin seeking and extracellular 
DA in the BLA (A) Total number of active and inactive lever responses for FDR (n = 13) and 
sated (n = 8) rats (inset), and active lever responses in 10-min time intervals during the 3 h 
heroin-seeking test in Supplemental Experiment 1, *p = 0.033 compared with sated rats. (B) 
Extracellular DA following re-exposure to the drug environment and during the heroin-seeking 





Figure S.3. Chronic food restriction-induced augmentation of heroin seeking and extracellular 
DA in the DLS (A) Total number of active and inactive lever responses for FDR (n = 10) and 
sated (n = 8) rats (inset), and active lever responses in 10-min time intervals during the 3 h 
heroin-seeking test in Supplemental Experiment 2, *p = 0.014 compared with sated rats. (B) 
Extracellular DA following re-exposure to the drug environment and during the heroin-seeking 
test in the FDR and sated rats. 
 
 
